UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

the Securities Exchange Act of 1934 (Amendment

(Amendment No.)

Filed by the Registrant  ☒

Filed by a Party other than the Registrant  ☐

Check the appropriate box:

 

Preliminary Proxy Statement

Preliminary Proxy Statement

Confidential, for Use of the Commission Only (as permitted byRule 14a-6(e)(2))

Definitive Proxy Statement

Definitive Additional Materials

Soliciting Material under§240.14a-12

MOELIS & COMPANY

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box)all boxes that apply):

No fee required.required

Fee computed on table below per Exchange ActRules 14a-6(i)(1) and 0-11.
(1)

Title of each class of securities to which transaction applies:

(2)

Aggregate number of securities to which transaction applies:

(3)

Per unit price or other underlying value of transaction computed pursuant to Exchange ActRule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

(4)

Proposed maximum aggregate value of transaction:

(5)

Total fee paid:

Fee paid previously with preliminary materials.materials

Check box if any part of the fee is offset as provided

Fee computed on table in exhibit required by Item 25(b) per Exchange ActRule 0-11(a)(2) andRules 14a-6(i)(1) identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

(1)

Amount Previously Paid:

(2)

Form, Schedule or Registration Statement No.:

(3)

Filing Party:

(4)

Date Filed:

0-11

 

 

 


399 PARK AVENUE

54TH FLOOR

NEW YORK, NEW YORK 10022

 

LOGO

April 22, 202020, 2022

Dear Stockholder,

We cordially invite you to attend our 20202022 Annual Meeting of Stockholders, to be held on Thursday, June 4, 20202, 2022 at 8:30 a.m. (Eastern Time) at the offices of Moelis & Company located at 399 Park Avenue, 54th Floor, New York, NY 10022.

The Notice of Annual Meeting of Stockholders and the proxy statementProxy Statement that follow describe the business to be conducted at the meeting.

Your vote is important. We encourage you to vote by proxy in advance of the meeting, whether or not you plan to attend the meeting.

Sincerely,

 

LOGO

Kenneth Moelis

ChairmanChair and Chief Executive Officer


399 PARK AVENUE

54TH FLOOR

NEW YORK, NEW YORK 10022

 

LOGO

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

 

Meeting Date:

  Thursday, June 4, 20202, 2022

Time:

  8:30 a.m. (Eastern Time)

Place:

  

Offices of Moelis & Company

399 Park Avenue

New York, NY 10022

We are holding our 20202022 annual meeting of stockholders (the “Annual Meeting”) for the following purposes, which are described in more detail in the proxy statement:Proxy Statement:

 

1.

to elect eightfive directors to our boardBoard of directors;Directors;

 

2.

to approve, on an advisory basis, the compensation of our named executive officers as disclosed in the accompanying Proxy Statement;

 

3.

to ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020;2022; and

 

4.

to transact any other business as may properly come before the meeting or any adjournment or postponement thereof.

Only stockholders of record as of the close of business on April 9, 20207, 2022 will be entitled to attend and vote at the annual meeting.Annual Meeting.

As permitted by the rules of the Securities and Exchange Commission (the “SEC”), we are sending our stockholders a Notice of Internet Availability of Proxy Materials (the “Notice”) rather than a paper set of the proxy materials. The Notice includes instructions on how to access our proxy materials over the internet, as well as how to request the materials in paper form.

Your vote is important. We encourage you to vote by proxy in advance of the meeting, whether or not you plan to attend the meeting. The Notice includes instructions on how to vote, including by internet and telephone. If you hold your shares through a brokerage firm, bank, broker-dealer or other similar organization, please follow their instructions.

Although weWe intend to hold the annual meetingAnnual Meeting in person, we are monitoringperson. We continue to monitor the protocols that federal, state and local governments may recommend or require in light of the evolving coronavirus(COVID-19) outbreak.pandemic. The health and well-being of our team members and our stockholders are paramount. As a result, we may impose additional procedures or limitations on meeting attendees (beyond those described herein) or may decide to hold the meeting in a virtual-only format over the Internet. Any such changes regarding the Annual Meeting will be announced in a press release and the filing of additional proxy materials with the SEC.

By order of the boardBoard of directors,Directors,

 

LOGO

Osamu Watanabe,

General Counsel and Secretary

April 22, 202020, 2022


IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS

FOR THE ANNUAL MEETING TO BE HELD ON JUNE 4, 2020.2, 2022.

The Company’s Proxy Statement and 20192021 Annual Report onForm 10-K

are also available at www.proxyvote.com.


TABLE OF CONTENTS

 

PROXY STATEMENT HIGHLIGHTS

1

GENERAL INFORMATION

   15 

PROPOSAL 1: ELECTION OF DIRECTORS

   510

Directors

10

Director Nomination Rights of Partner Holdings

13

Director Nominees and Board Recommendation

13

EXECUTIVE OFFICERS

15 

CORPORATE GOVERNANCE

   617

Board of Directors Leadership Structure

17

Board Size

18

Director Independence

18

Board of Directors Role in Risk Oversight, Succession Planning and Environmental, Social and Governance Matters Oversight

18

Board Committees

19

Board and Committee Meetings; Annual Meeting Attendance

21

Board Evaluation

21

Director Qualifications and Nominating Process

21

Shareholder Engagement

23

Communication with the Board of Directors

23

Corporate Responsibility

23

Code of Business Conduct and Code of Ethics

25

Corporate Governance Guidelines

25

Compensation Committee Interlocks and Insider Participation

25 

DIRECTOR COMPENSATION

   1426 

EXECUTIVE COMPENSATION

   1627

Compensation Discussion and Analysis

27

Performance Highlights

27

Key Compensation Practices

28

How Compensation is Determined

29

Compensation Philosophy

29

Framework to Determine Executive Compensation

29

Overview of Compensation Elements

31

2021 Named Executive Officer Compensation

32

Other Compensation Program Features

33

2021 Say on Pay Vote

34

Summary of Compensation Table for 2021

35

Grants of Plan-Based Awards in 2021

36

Moelis & Company Annual Equity Awards

36

Employment Agreements

38

Outstanding Equity Awards at 2021 Fiscal Year-End

39

Options Exercised and Stock Vested in 2021

41

Nonqualified Deferred Compensation for 2021

41

Potential Payments upon Termination of Employment or Change in Control

41

Other Compensation Arrangements

42

Assessment of Risk of Our Compensation Program

42

CEO Pay Ratio

43 

COMPENSATION COMMITTEE REPORT

   2244 


PROPOSAL 2: ADVISORY VOTE ON EXECUTIVE COMPENSATION

   3245 

STOCK OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

   3346 

DELINQUENT SECTION 16(a) REPORTS

   3547 

CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS

   3648

Transactions with Our Directors, Executive Officers and 5% Holders

48

Transactions with Moelis Asset Management LP

51

Transactions with Atlas Crest

53

Director and Officer Indemnification and Insurance

54

Policies and Procedures for Related Person Transactions

54 

PROPOSAL 3: RATIFICATION OF INDEPENDENT AUDITOR

   4355

Deloitte Fees

55

Audit Committee Pre-Approval

55 

AUDIT COMMITTEE REPORT

   4456 

ADDITIONAL INFORMATION

   4557

Procedures for Submitting Stockholder Proposals

57 

ANNEX A: A—NON-GAAP FINANCIAL MEASURES

   A-1 

Although we refer to our website in this Proxy Statement, the contents of our website are not included or incorporated by reference into this Proxy Statement. All references to our website in this Proxy Statement are intended to be inactive textual references only.


LOGO

PROXY STATEMENT HIGHLIGHTS

20202022 ANNUAL MEETING OF STOCKHOLDERS

TO BE HELD ON JUNE 4, 20202, 2022

GENERAL INFORMATION

Moelis & Company is makingThis section highlights certain information that you should consider before voting on the matters presented at this proxy statement available to its stockholders on or about April 22, 2020 in connection with the solicitation of proxies by the board of directors for our 2020year’s Annual Meeting of Stockholders to be held on Thursday, June 4, 20202, 2022 at 8:30 a.m. (Eastern Time) at the offices of Moelis & Company, 399 Park Avenue, New York, NY 10022 and any adjournment or postponement of that meeting (the “Annual Meeting”). You should read this entire Proxy Statement carefully before voting. Your vote is important. We encourage you to vote by proxy in advance of the Annual Meeting, whether or not you plan to attend the Annual Meeting. Additional information about our Annual Meeting, including details about how to participate in our Annual Meeting and how to cast your votes, is provided under “General Information” beginning on page 5.

2022 Annual Meeting of Stockholders

Meeting Date:Thursday, June 2, 2022
Time:8:30 a.m. (Eastern Time)
Place:

Offices of Moelis & Company

399 Park Avenue

New York, NY 10022

Matters to be Voted on at our 2022 Annual Meeting

AGENDA AND BOARD RECOMMENDATIONS

PROPOSAL

BOARD VOTING
RECOMMENDATION

PAGE REFERENCE
    (FOR MORE DETAIL)    

◾  Election of the 5 nominees named in this Proxy Statement to serve on our Board of Directors until the 2023 annual meeting

FOR each nominee10

◾  Non-binding, advisory vote to approve executive compensation of our named executive officers

FOR45

◾  Ratification of Deloitte & Touche LLP as our independent registered public accounting firm for 2022

FOR55


Performance Highlights and Executive Compensation

Our compensation program is designed to align the interests of our named executive officers and other employees with the long-term interests of the Firm and its shareholders. The overall performance of the Company is a significant factor in determining our named executive officer compensation.

Our 2021 performance was exceptionally strong. We saw substantial growth in revenue, profitability, and returns to our shareholders on both an absolute and relative basis.

2021 FINANCIAL HIGHLIGHTS

(dollars in thousands, except per share data)

Adjusted Revenues(1)

$1,557,997

65% LOGO  YoY

Adjusted Diluted EPS(1)

$5.40

86% LOGO  YoY

Adjusted Net Income(1)

$410,254

96% LOGO  YoY

Dividends Declared Per Share(2)

$6.85

(1)   Adjusted Revenues, Adjusted Diluted Earnings Per Share, and Adjusted Net Income are non-GAAP measures.

See Annex A for further information and reconciliations to our GAAP results.

(2)   Dividends declared related to each performance year.

Strong Growth in Revenue and Our Firm

We reported total record annual GAAP revenues of $1,540.6 million and Adjusted revenues of $1,558.0 1 million in 2021, up 65% from 2020, which was our previous record.

We continued to exhibit strong internal talent development by promoting eight banker Managing Directors in early 2021 and 16 in early 2022 ; nearly 50% of all Managing Directors are internal promotes.

Extraordinary Profitability

We reported diluted net income per share of $5.34 on a GAAP basis and $5.40 on an Adjusted basis in 2021, up 86% from the prior year.2

Our Adjusted pre-tax margin of 34% in the current year led the public independent boutique investment banks.

We maintained a strong cash position and no debt.

1

See Annex A for a reconciliation between GAAP and Adjusted (non-GAAP) financial information

2

We reported diluted net income of $5.34 on a GAAP basis for 2021. See Annex A for a reconciliation between GAAP and Adjusted (non-GAAP) financial information

Excellent Shareholder Returns

In total, for the 2021 performance year, we returned approximately $575 million in capital to shareholders through dividends and a record level of share repurchases.

º

We declared $6.85 per share in dividends with respect to the 2021 performance year.

º

We increased our regular dividend by 9% to $0.60 per share currently.

º

We have declared a special dividend in each year since becoming a public company.

º

We have executed share repurchases totaling 1.9 million shares.

Shareholder Alignment

The following provides highlights of our 2021 compensation program, which seeks to align the interests of our named executive officers with the long–term interests of the Firm and its shareholders.

Align pay with firmwide performance. Our program emphasizes variable incentive compensation, versus fixed base salaries, and serves to reward executives for Company performance and their individual contributions and accomplishments while retaining discretion.

Grant a significant portion of compensation in equity. Our total incentive pay is delivered in the form of cash and equity-based compensation.The equity-based compensation allocation is designed to align the interests of our named executive officers with those of our shareholders, promote retention, and mitigate excessive risk taking. In 2021, equity-based compensation represented almost 80% of 2021 total incentive compensation awarded to our CEO and a minimum of 40% of total incentive compensation awarded to our other named executive officers.

Multi-year vesting that is longer than most of our peers. We have imposed a five-year vesting schedule for the portion of incentive compensation that is delivered in unvested equity. We have elected a vesting schedule that is longer than the three-year standard of our industry because we believe it better aligns management’s interests with those of shareholders.

Clawback Policies. We apply clawback policies to annual incentive cash compensation in line with encouraging a long term Firm focus.

Significant Equity Ownership by NEOs. All of our named executive officers currently have significant equity ownership as a result of multi-year vesting schedules applied to annual incentive equity compensation. As of December 31, 2021, each of our named executive officers own equity of the Company (in the form of vested and unvested equity, including LP Units and RSUs) representing greater than 10x their base salaries.

Hedging Prohibition. We prohibit hedging of our common stock and equity-based awards by our named executive officers and employees.

Our Board of Directors

Our Board is comprised of directors with diverse skills, experiences and backgrounds, which contribute to the Board’s ability to effectively oversee the Company and execute on its long-term strategy. In determining that each director should be nominated for re-election, our Board considered his or her service, business experience, prior directorships, qualifications, attributes and skills described in the biographies set forth below under “Proposal 1: Election of Directors—Directors.”

Diverse Skills and Experiences of Our Director Nominees

  Executive/Strategic Leadership

Risk Management

  Corporate CEO Experience

Financial Services (non-Investment Banking)

  Finance/Accounting/Auditing

Media/Branding/Marketing

  Law/Public Policy/Regulatory

Compensation

  IT/Cybersecurity Oversight

Academia/Education

  Corporate Social Responsibility

Corporate Governance

We are committed to corporate governance that serves the best interests of our Company and shareholders and encourages active engagement with our shareholders. The following are our highlights of our key board and governance practices and policies.

Independent Board

We have a majority independent board

All committees of our Board are comprised entirely of independent directors

Strong Board Leadership

Combined Chair/CEO providing focused strategic leadership

Lead Independent Director with active role and responsibilities

Qualified and Engaged Board

Diverse qualifications, skills and experiences

Overall attendance by our directors at board and committee meetings averaged over 95% in 2021

Increasing Board Size

Commenced a process to add an additional independent director that would provide the Board with additional experience and a diverse set of knowledge and skills that will be complimentary to our existing board members

Executive Sessions

Independent directors meet regularly with CEO and without management

Accountability

Director nominees must receive a majority of the votes cast (for and against) in an uncontested election

See “General Information—What vote is required for each proposal?” on page 6 for more information

Annual Self-Assessments

The Board and each committee conduct an annual self-assessment, which is overseen by the Nominating and Corporate Governance Committee.

Corporate Responsibility

Our core values of trust, partnership and commitment to long-term relationships allow us to deliver differentiated advice to our clients, attract and develop exceptional talent and maintain a diverse, innovative and agile culture. Please see “Corporate Governance–Corporate Responsibility” for more information on our commitment to our values.

Diversity & Inclusion. We are dedicated to maintaining an inclusive workplace that promotes and values diversity. As a global firm, we are committed to building a workforce with diversity of thought and perspective that are representative of the range of clients we advise around the world.

Sustainability Report. We look forward to releasing our inaugural Corporate Responsibility and Sustainability report this year, which details key Company focus areas in pursuit of our environmental, social and governance strategy.

GENERAL INFORMATION

Moelis & Company is making this Proxy Statement available to its stockholders on or about April 20, 2022 in connection with the solicitation of proxies by the Board of Directors for our Annual Meeting. As a stockholder, you are invited to attend the Annual Meeting and are entitled and encouraged to vote on the proposals described in this proxy statement.Proxy Statement. On or about April 22, 2020,20, 2022, we mailed our stockholders a Notice of Internet Availability of Proxy Materials containing instructions on how to access our proxy statementProxy Statement and our 20192021 Annual Report onForm 10-K.

Although Moelis intends to hold the annual meetingAnnual Meeting in person,person. Moelis is monitoringcontinues to monitor the protocols that federal, state and local governments may recommend or require in light of the evolving coronavirus(COVID-19)COVID-19 outbreak.pandemic. The health and well-being of Moelis team members and Moelis stockholders are paramount. As a result, Moelis may impose additional procedures or limitations on meeting attendees (beyond those described herein) or may decide to hold the meeting in a virtual-only format over the Internet. Any such changes regarding the Annual Meeting will be announced in a press release and the filing of additional proxy materials with the SEC.Securities Exchange Commission (the “SEC”).

We are a leading global independent investment bank that provides innovative strategic and financial advice to a diverse client base, including corporations, governments and financial sponsors.

Moelis & Company is a holding company and its only assets are its partnership interests in Moelis & Company Group LP (“Group LP”), its equity interest in the sole general partner of Group LP, Moelis & Company Group GP LLC (“GP LLC”), and its interests in its subsidiaries. Moelis & Company operates and controls all of the business and affairs of Group LP and its operating entity subsidiaries indirectly through its equity interest in Moelis & Company Group GP LLC.

In this proxy statement,Proxy Statement, unless the context requires otherwise, the words “Company,” “Firm,” “we,” “us” and “our” refer to Moelis & Company and its subsidiaries, and for periods prior to the reorganization in connection with our initial public offering refer to the advisory business of our predecessor company, Moelis & Company Holdings LP (“Old Holdings”). In the reorganization, Old Holdings was renamed Moelis Asset Management LP. Unless the context requires otherwise, all references herein to “MAM” refer to Moelis Asset Management LP.

Moelis & Company was formed in January 2014 and completed an initial public offering of its Class A common stock in April 2014. Our Class A common stock trades on the New York Stock Exchange under the symbol “MC.”

Below are answers to common questions stockholders may have about the Proxy Materials and the Annual Meeting.

What are the Proxy Materials?

The “Proxy Materials” are this proxy statementProxy Statement and our annual report to stockholders for the fiscal year ended December 31, 2019.2021. If you request printed versions of the Proxy Materials, you will also receive a proxy card.


Why did I receive a Notice of Internet Availability of Proxy Materials instead of a full set of materials?

Under rules adopted by the Securities and Exchange Commission (the “SEC”),SEC, we are furnishing Proxy Materials to many of our stockholders on the internet, rather than mailing printed copies. If you received a Notice of Internet Availability of Proxy Materials by mail, you will not receive printed copies of the Proxy Materials unless you request them. Instead, the notice will instruct you how to access and review the Proxy Materials on the internet. If you would like printed copies of the Proxy Materials, please follow the instructions on the notice.

What items will be voted on at the Annual Meeting and how does the boardBoard of directorsDirectors recommend that I vote?

There are three proposals to be voted on at the Annual Meeting:

 

 1.

the election of eightfive directors to our boardBoard of directors;Directors;

 

 2.

the approval, on an advisory basis, of the compensation of our named executive officers; and

 

 3.

the ratification of the appointment of Deloitte & Touche LLP (“Deloitte”) as our independent registered public accounting firm for the fiscal year ending December 31, 2020.2022.

Our amended and restatedby-laws require that we receive advance notice of any proposals to be brought before the Annual Meeting by our stockholders. We have not received any such proposals. We do not anticipate any other matters will come before the Annual Meeting. If any other matter properly comes before the Annual Meeting, the proxy holders appointed by our boardBoard of directorsDirectors will have discretion to vote on those matters.

The boardBoard of directorsDirectors recommends:

 

 1.

that you vote FOR“FOR” each of the nominees in Proposal 1;

 

 2.

that you vote FOR“FOR” the approval of the advisory resolution approving the compensation of our named executive officers as disclosed in this Proxy Statement in Proposal 2; and

 

 3.

that you vote FOR“FOR” the ratification of the selection of Deloitte as our independent registered public accounting firm for 20202022 in Proposal 3.

Who may vote at the meeting?

Holders of Class A common stock and holders of Class B common stock as of the close of business on April 9, 20207, 2022 (the “Record Date”) may vote at the Annual Meeting.

How many shares may be voted at the Annual Meeting?

Only stockholders of record as of the close of business on the Record Date will be entitled to vote at the Annual Meeting. As of the close of business on the Record Date, there were 53,419,33664,956,709 shares of Class A common stock and 10,397,9154,685,898 shares of Class B common stock entitled to vote.

How many votes do I have?

Holders of our Class A common stock are entitled to one vote for each share held as of the Record Date. Holders of our Class B common stock are entitled to ten votes for each share held as of the Record Date. Holders of our Class A common stock and Class B common stock will vote as a single class on all matters at the Annual Meeting.

What vote is required for each proposal?

For the election of directors, each incumbent director must be elected byreceive a pluralitymajority of the votes cast. This meanscast (for and against) with respect to such director (meaning that the eight nominees receiving the largest number of votes cast “for” a director’s election must exceed the number of votes cast “against” that director’s election) in an uncontested election. Pursuant to our by-laws, each incumbent director nominated for election must submit an irrevocable resignation, contingent on (i) not receiving a majority of the votes cast in an uncontested election, and (ii) the acceptance of that proffered resignation by the Board of Directors in accordance with the policies and procedures adopted by the Board of Directors for such purpose. In the event an incumbent director does not receive a majority of the votes cast in an uncontested election, the Nominating and Corporate Governance Committee of the Board of Directors will be elected as directors. We do not have cumulative voting.make

a recommendation to the Board of Directors whether to accept or reject such incumbent director’s resignation or whether other action should be taken. The Board of Directors, taking into account the Nominating and Corporate Governance Committee’s recommendation, will decide whether to accept or reject such incumbent director’s resignation and will publicly disclose its decision, including, if the Board of Directors determines to reject such resignation, the rationale of the decision. The Board of Directors is not required to accept the resignation of an incumbent director that fails to receive a majority of the votes cast in an election that is not a Contested Election. If the Board of Directors accepts a director’s resignation, or if a nominee for director is not elected and the nominee is not an incumbent director, then the Board of Directors may fill the resulting vacancy by vote of a majority of the Board of Directors then in office, even if less than a quorum, or by a sole remaining director, or may decrease the size of the Board of Directors in accordance with the Company’s by-laws. The foregoing is subject to the rights and obligations of the Company pursuant to the stockholders agreement between the Company, Moelis & Company Partner Holdings LP and certain stockholders. See “Certain Relationships and Related Person Transactions—Transaction with Our Directors, Executive Officers and 5% Holdings—Rights of Partner Holdings and Stockholders Agreement” below.

The approval, on an advisory basis of the compensation of our named executive officers, the ratification of the Company’s independent registered public accounting firm and any other proposals that may come before the Annual Meeting will be determined by the majority of the votes cast.

As of the Record Date, Moelis & Company Partner Holdings LP (“Partner Holdings”) owned all of our outstanding Class B shares. Partner Holdings is controlled by Kenneth Moelis, our ChairmanChair and Chief Executive Officer. As a result of his beneficial ownership of shares and control of nearly a majority of the voting power of our shares, Mr. Moelis has thesubstantial ability to decide all matters to be voted upon at the Annual Meeting. See “Certain Relationships and Related Person Transactions—Transactions with Our Directors, Executive Officers and 5% Holders—Rights of Partner Holdings and Stockholders Agreement” below.

How are abstentions and brokernon-votes counted?

Abstentions (shares present at the meeting in person or by proxy that are voted “abstain”) and brokernon-votes (explained below) are counted for the purpose of establishing the presence of a quorum, but are not counted as votes cast.

What is the difference between a stockholder of record and a beneficial owner of shares held in street name?

Stockholder of Record.If your shares are registered directly in your name with our transfer agent, Computershare, you are a stockholder of record.

Beneficial Owner of Shares Held in Street Name.If your shares are held in an account at a brokerage firm, bank, broker-dealer or other similar organization, then you are a beneficial owner of shares held in “street name.” The organization holding your account is considered the stockholder of record. As a beneficial owner, you have the right to direct the organization holding your account on how to vote the shares you hold in your account.

How do stockholders of record vote?

There are four ways for stockholders of record to vote:

 

  

Via the internet.You may vote via the internet until 11:59 p.m. (Eastern Time) on the day before the Annual Meeting by visiting http://www.proxyvote.com and entering the unique control number for your shares located on the Notice of Internet Availability of Proxy Materials.

 

  

By telephone.You may vote by phone until 11:59 p.m. (Eastern Time) on the day before the Annual Meeting by calling(800) 690-6903. You will need the control number from your Notice of Internet Availability of Proxy Materials.

 

  

By mail.If you requested that Proxy Materials be mailed to you, you will receive a proxy card with your Proxy Materials. You may vote by filling out and signing the proxy card and returning it in the envelope provided. The proxy card must be received by the close of business on the day before the Annual Meeting.

 

  

In person.You may also vote your shares in person by completing a ballot at the Annual Meeting.

How do beneficial owners of shares held in street name vote?

If you hold your shares through a brokerage firm, bank, broker-dealer or other similar organization, please follow their instructions.

Can I change my vote after submitting a proxy?

Stockholders of record may revoke their proxy before the Annual Meeting by delivering to the Company’s General Counsel and Secretary a written notice stating that a proxy is revoked, by signing and delivering a proxy bearing a later date, by voting again via the internet or by telephone or by attending and voting in person at the Annual Meeting.

Street name stockholders who wish to change their votes should contact the organization that holds their shares.

If I hold shares in street name through a broker, can the broker vote my shares for me?

If you hold your shares in street name and you do not vote, the broker or other organization holding your shares can vote on certain “routine” proposals but cannot vote on other proposals. Proposals 1 and 2 are not considered “routine” proposals. Proposal 3 is a “routine” proposal. If you hold shares in street name and do not vote on Proposals 1 and 2 your shares will be counted as “brokernon-votes.”

Who is paying for this proxy solicitation?

The Company is paying the costs of the solicitation of proxies. Members of our boardBoard of directorsDirectors and officers and employees may solicit proxies by mail, telephone, fax, email or in person. We will not pay directors, officers or employees any extra amounts for soliciting proxies. We may, upon request, reimburse brokerage firms, banks or similar entities representing street name holders for their expenses in forwarding Proxy Materials to their customers who are street name holders and obtaining their voting instructions.

The Company has engaged D.F. King & Co., Inc. (“D.F. King”) to assist in the solicitation of proxies for the Annual Meeting. The Company will bear the entire cost of proxy solicitation, including the preparation, assembly, printing, mailing and distribution of the proxy materials, and will pay D.F. King a fee of approximately $20,000, plus reimbursement of out-of-pocket expenses. The address of D.F. King is 48 Wall Street, 22nd Floor, New York, NY 10005. You can call D.F. King at (800) 714-3312 or email at MC@dfking.com.

What do I need to do if I want to attend the meeting?

You will need to provide evidence that you are a stockholder as of the Record Date. This can be a copy of your proxy card or a brokerage statement showing your shares. You shouldmust also bring photo identification. If you hold your shares in street name and wish to vote in person at the meeting, you will need to contact the organization that holds your shares in order to obtain a legal proxy from that organization.

We intend to hold the annual meeting in person, we continue to monitor the protocols that federal, state and local governments may recommend or require in light of the evolving COVID-19 pandemic. The health and well-being of our team members and our stockholders are paramount. As a result, we may impose additional procedures or limitations on meeting attendees (beyond those described herein) or may decide to hold the meeting in a virtual-only format over the Internet. Any such changes regarding the Annual Meeting will be announced in a press release and filing with the SEC.

Where can I find voting results?

We will file a Current Report onForm 8-K with the SEC including the final voting results from the Annual Meeting within four business days of the Annual Meeting.

I share an address with another stockholder. Why did we receive only one set of Proxy Materials?

Some banks, brokers and nominees may be participating in the practice of “householding” Proxy Materials. This means that only one copy of our Proxy Materials may be sent to multiple stockholders in your household. If you hold your shares in street name and want to receive separate copies of the Proxy Materials in the future, or if you are receiving multiple copies and would like to receive only one copy for your household, you should contact the bank, broker, or other nominee who holds your shares.

Upon written or oral request, the Company will promptly deliver a separate copy of the Proxy Materials to any stockholder at a shared address to which a single copy of any of those documents was delivered. To receive a separate copy of the Proxy Materials, you can contact our Investor Relations department at(212) 883-3800, investor.relations@moelis.com or 399 Park Avenue, 5th4th Floor, New York, NY 10022.

Who should I contact if I have additional questions?

You can contact our Investor Relations department at(212) 883-3800, investor.relations@moelis.com or at our principal executive offices at 399 Park Avenue, 5th4th Floor, New York, NY 10022. Stockholders who hold their shares in street name should contact the organization that holds their shares for additional information on how to vote. If you have any questions about how to vote your shares, you may contact our proxy solicitor at:

D.F. King & Co, Inc.

48 Wall Street, 22nd Floor

New York, NY 10005

Call Toll-Free: (800) 714-3312

Banks and Brokers Call: (212) 269-5550

PROPOSAL 1: ELECTION OF DIRECTORS

Our boardBoard of directorsDirectors is currently comprised of eightfive directors. At the Annual Meeting, stockholders will vote to elect as directors of the Company the eightfive nominees named in this proxy statement.Proxy Statement. Each of the directors elected at the Annual Meeting will hold office until the 20202023 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified.

The boardBoard of directorsDirectors has nominated Kenneth Moelis, Navid Mahmoodzadegan, Jeffrey Raich, Eric Cantor, Elizabeth Crain,Kenneth L. Shropshire, John A. Allison IV and Yolonda Richardson and Kenneth L. Shropshire for election at the Annual Meeting. The persons named as proxies will vote to elect each of these nominees unless a stockholder indicates that his or her shares should be withheld with respect to one or more of such nominees.

Directors

The following table sets forth information regarding our directors, including their ages as of the date hereof.

Name

Age

Position

Kenneth Moelis

63

Chair of the Board of Directors and Chief Executive Officer

Eric Cantor

58

Managing Director, Vice Chair of the Company and Director

Kenneth L. Shropshire

67

Lead Independent Director

John A. Allison IV

73

Independent Director

Yolonda Richardson

60

Independent Director

LOGO

Kenneth Moelis is the Chair of our Board of Directors and has served as our Chief Executive Officer since 2007. Mr. Moelis has over 30 years of investment banking and mergers and acquisitions experience. Prior to founding our Company, Mr. Moelis worked at UBS from 2001 to 2007, where he was most recently President of UBS Investment Bank and previously Joint Global Head of Investment Banking. Before joining UBS, Mr. Moelis was Head of Corporate Finance at Donaldson, Lufkin & Jenrette, where he worked from 1990 through 2000. Mr. Moelis began his career as an investment banker with Drexel Burnham Lambert in 1981. Mr. Moelis is the Non-Executive Chairman of the Board of the Atlas Crest Entities (as defined in “Certain Relationships and Related Persons Transactions—Transactions with Atlas Crest” below). Mr. Moelis serves on the University Of Pennsylvania Board Of Trustees, the Wharton Board of Overseers, the Ronald Reagan UCLA Medical Center Board of Advisors and was formerly Chair and Director on the Tourette Association of America Board. Mr. Moelis holds a B.S. and an M.B.A. from the Wharton School at the University of Pennsylvania.

Mr. Moelis’ knowledge of and extensive experience in investment banking and the financial services industry give the Board of Directors valuable industry-specific knowledge and expertise on these and other matters. In addition, as our Founder and Chief Executive Officer, he has an unparalleled understanding of our business and operations, which positions him well to serve on our Board of Directors.

LOGO

Eric Cantor has served as a Managing Director, Vice Chair of the Company and a director of our Company since September 2014. Mr. Cantor, who has more than 25 years of political and business experience, was formerly United States Representative for Virginia’s 7th Congressional District and U.S. House Majority Leader. He served in the U.S. House of Representatives from 2001 to 2014. He was elected by his colleagues in the House to serve as the Majority Leader for the 112th

and 113th Congresses where he led the public policy agenda for the House. During his time in office, Mr. Cantor was a leading voice on the economy, job creation and policies focused on improving the lives of the American middle class. He championed pro-growth solutions including lowering taxes, eliminating excessive regulation, strengthening businesses, and encouraging entrepreneurship. He was also regularly featured in publications focusing on a wide range of topics including both domestic and international matters. Mr. Cantor holds a B.A. from The George Washington University, a J.D. from The College of William and Mary, and an M.A. from Columbia University.

Mr. Cantor’s knowledge of public and economic policy, his extensive experience in public policy, international business and geo-politics and his investment banking experience position him well to serve on our Board of Directors.

LOGO

Kenneth L. Shropshire has been a director since July 2014. Mr. Shropshire is the Adidas Distinguished Professor of Global Sport and CEO of Global Sport Institute at Arizona State University. Mr. Shropshire is the David W. Hauck Professor Emeritus at the Wharton School at the University of Pennsylvania and the former Faculty Director of its Wharton Sports Business Initiative. Mr. Shropshire joined the Wharton faculty in 1986 specializing in sports business and law and served as Chairman of the Wharton School’s Legal Studies and Business Ethics department from 2000 to 2005. His consulting roles have included work for the NFL, the NCAA, the NFL Players Association and USA Track and Field, and he was an executive on the organizing committee for the 1984 Los Angeles Olympic Games. Mr. Shropshire was previously a member of the board of directors of Peace Players International and Valley Green Bank in Philadelphia and a trustee of the Women’s Sports Foundation. He is a former president of the Sports Lawyers Association, the largest such organization in the world, and Program Chair of the ABA Forum Committee, Sports Law Section. Mr. Shropshire is the author of numerous books and articles on the business of sports. He holds an A.B. in Economics from Stanford University and a J.D. from Columbia Law School.

Mr. Shropshire’s knowledge of corporate and business law and his extensive experience with business law and ethics, negotiation and dispute resolution position him well to serve on our Board of Directors.

LOGO

John A. Allison IV has been a director since October 2015. Mr. Allison is Executive in Residence at Wake Forest School of Business and Chairman of the Executive Advisory Council of the Cato Institute’s Center for Monetary and Financial Alternatives, and a member of the Cato Institute’s Board of Directors. Mr. Allison was president and CEO of the Cato Institute from October 2012 to April 2015. Mr. Allison served as the Chief Executive Officer of BB&T Corporation from 1989 to 2008. Mr. Allison was also a director of BB&T Corporation from 1986 to 2014, serving as Chairman from 1989 to 2008, and a Branch Bank & Trust Company director from 1986 to 2008 and 2013 to 2014. Mr. Allison served as Chairman and Chief Executive Officer of Branch Bank & Trust Company from 1989 to 2008. He also served as a Distinguished Professor of Practice on the faculty of the Wake Forest University Schools of Business from 2009 to 2012. Mr. Allison is a Phi Beta Kappa graduate of the University of North Carolina—Chapel Hill. He received his master’s degree in management from Duke University, and is also a graduate of the Stonier Graduate School of Banking.

Mr. Allison’s knowledge of and extensive experience with finance, banking and investments, in addition to his years of experience and expertise as a senior corporate executive and public company board member, position him well to serve on our Board of Directors.

LOGO

Yolonda Richardson has been a director since January 2019. Ms. Richardson is the Executive Vice President of Global Programs for the Campaign for Tobacco Free Kids and the Global Health Advocacy Incubator, where she leads several initiatives in global health, most notably the Bloomberg Global Initiative to Reduce Tobacco Use. Ms. Richardson joined the Campaign in 2009. From 2008 to 2010, Ms. Richardson served as the President and Founder of Richardson Consulting, a management consulting firm specialized in providing strategic support to nonprofit organizations, foundations, corporate philanthropies, and global development agencies. From 2003 to 2008, Ms. Richardson served as President and CEO of the Centre for Development and Population Activities (CEDPA), which seeks to advance women’s rights and expand their access to health and other services. Prior to CEDPA, Ms. Richardson was a Senior Vice President at Africare from 1999 to 2002 and served as the Special Counsel for the African Development Foundation — a government-funded granting agency that provides financial support to African NGOs and small businesses to enhance the participation of the poor in the development of their countries. From 1989 to 1999, Ms. Richardson worked at the Carnegie Corporation of New York, a global foundation, where she managed an international grant program focused on improving women’s health programs and promoting improved democracy and governance. Ms. Richardson started her career on Wall Street as a corporate attorney at Cahill Gordon & Reindel. She is a member of the New York State Bar Association and the Council on Foreign Relations. She holds a B.A., summa cum laude, from Dillard University in New Orleans, a Master’s degree in Public Health from Columbia University, and a J.D. from Yale University School of Law.

Ms. Richardson’s senior management and operational experience with leading non-profit organizations and international foundations positions her well to serve on our Board of Directors.

Our Board is comprised of directors with diverse skills, experiences and backgrounds, which contribute to the Board’s ability to effectively oversee the Company and execute on its long-term strategy.

LOGO

LOGO

LOGO

1.

The demographic information presented is based on the voluntary self-identification of each director nominee.

2.

One director nominee, out of a total of five director nominees, identifies as female.

Director Nomination Rights of Partner Holdings

In connection with our initial public offering, we entered into a stockholders agreement with Partner Holdings, an entity controlled by our ChairmanChair and Chief Executive Officer, Kenneth Moelis, pursuant to which our boardBoard of directorsDirectors is required to nominate individuals designated by Partner Holdings equal to a majority of the boardBoard of Directors, and to take all actions necessary to cause such directors to continue in office, as long as the Class B Condition is satisfied. The designees of Partner Holdings nominated by the boardBoard of directorsDirectors for election at the Annual Meeting are Kenneth Moelis Navid Mahmoodzadegan, Jeffrey Raich,and Eric Cantor,Cantor. Although the Class B Condition is satisfied, Partner Holdings has notified the Company that Partners Holdings will not designate a third nominee to our Board of Directors this year. This is because the Company, which is no longer a “controlled company” under New York Stock Exchange (“NYSE”) rules, is required to satisfy NYSE independence requirements, including the requirement to have independent directors constitute a majority of our Board of Directors. In addition, in the event that a vacancy is created at any time by the death, disability, retirement, resignation or removal of any director who is designated by Holdings in accordance with the stockholders agreement, the Company agrees to take at any time and Elizabeth Crain.from time to time all actions necessary to cause the vacancy created thereby to be filled as promptly as practicable by a designee of Holdings, including without limitation, in the event of a resignation of a Holdings’ designee as a result of a failure to obtain a majority vote. The stockholders agreement and the Class B Condition are described under “Certain Relationships and Related Person Transactions—Transactions With Our Directors, Executive Officers and 5% Holders—Rights of Partner Holdings and Stockholders Agreement” below. Mr. Moelis’ beneficial ownership of our shares is set forth under “Stock Ownership of Certain Beneficial Owners and Management” below.

Director Nominees and Board Recommendation

In the event that any nominee for director becomes unavailable or declines to serve as a director at the time of the Annual Meeting, the persons named as proxies will vote the proxies in their discretion for any nominee who is designated by the current

board of directors to fill the vacancy. All of the nominees are currently serving as directors and we do not expect that any of the nominees will be unavailable or will decline to serve.

In determining that each director should be nominated forre-election, our boardBoard considered his or her service, business experience, prior directorships, qualifications, attributes and skills described in the biography set forth below under “Corporate Governance—Executive Officers and Directors.”above.

The boardBoard of directorsDirectors recommends that you vote “FOR” each of the director nominees in this Proposal 1.

CORPORATE GOVERNANCEEXECUTIVE OFFICERS

Executive Officers and Directors

The following table sets forth information regarding our executive officers, and directors, including their ages as of the date hereof. Information relating to Mr. Moelis, our Chair and Chief Executive Officer, is set forth above in “Proposal 1: Election of Directors.”

 

Name

  Age   

Position

Kenneth Moelis

61Chairman of Board of Directors and Chief Executive Officer

Navid Mahmoodzadegan

   5152   

Co-President and Managing Director and Director

Jeffrey Raich

53Co-President, Managing Director and Director

Eric Cantor

56Managing Director, Vice Chairman of the Company and Director

Elizabeth Crain

   55   Chief Operating Officer

Co-President and Managing Director

John A. Allison IVElizabeth Crain

   7157   Director

Yolonda RichardsonChief Operating Officer

58Director

Kenneth L. Shropshire

65Director

Joseph Simon

   6163   

Chief Financial Officer

Osamu R. Watanabe

   5961   

General Counsel and Secretary

Kenneth Moelis is the Chairman of our Board of Directors and has served as our Chief Executive Officer since 2007. Mr. Moelis has over 30 years of investment banking and mergers and acquisitions experience. Prior to founding our Company, Mr. Moelis worked at UBS from 2001 to 2007, where he was most recently President of UBS Investment Bank and previously Joint Global Head of Investment Banking. Before joining UBS, Mr. Moelis was Head of Corporate Finance at Donaldson, Lufkin & Jenrette, where he worked from 1990 through 2000. Mr. Moelis began his career as an investment banker with Drexel Burnham Lambert in 1981. Mr. Moelis serves on the University of Pennsylvania Board of Trustees, the Wharton Board of Overseers, the Ronald Reagan UCLA Medical Center Board of Advisors and was formerly Chair and Director on the Tourette Association of America Board. Mr. Moelis holds a B.S. and an M.B.A. from the Wharton School at the University of Pennsylvania.

Mr. Moelis’ knowledge of and extensive experience in investment banking and the financial services industry give the board of directors valuable industry-specific knowledge and expertise on these and other matters. In addition, as our Founder and Chief Executive Officer, he has an unparalleled understanding of our business and operations, which positions him well to serve on our board of directors.

LOGO

Navid Mahmoodzadegan is aCo-Founder and has served asCo-President since September 2015 and as a Managing Director of our Company since 2007. Mr. Mahmoodzadegan has beenserved as a director sinceof our Company from April 2014. Mr. Mahmoodzadegan’s expertise are rooted in a deep understanding of the broadcasting, cable, publishing, entertainment, satellite and digital media sectors.2014 to April 2021. Prior to founding our Company, Mr. Mahmoodzadegan worked at UBS from 2001 to 2007, where he was most recently Global Head of Media Investment Banking and was a member of the UBS Investment Banking Department Americas Executive Committee. Before joining UBS, Mr. Mahmoodzadegan was an investment banker at Donaldson, Lufkin & Jenrette from 1995 to 2001. He began his career as an attorney with Irell & Manella. Mr. Mahmoodzadegan serves on the Taft School Board of Trustees. Mr. Mahmoodzadegan previously served as Chairman ofBoard Chair for the Carlthorp School Board of Trustees.Trustees and served on the National Board of Directors of JumpStart. He holds an A.B. with Highest Distinction from the University of Michigan (Phi Beta Kappa) and a J.D. from Harvard Law School, magna cum laude.

Mr. Mahmoodzadegan’s knowledge of and extensive experience in investment banking and the financial services industry give the board of directors valuable industry specific knowledge and expertise on these and other matters. In addition, as aCo-Founder andCo-President of our Company, he has an extensive understanding of our business, which positions him well to serve on our board of directors.

LOGO

Jeffrey Raich is aCo-Founder and has served asCo-President since September 2015 and as a Managing Director of our Company since 2007. Mr. Raich has beenserved as a director sinceof our Company from April 2014.2014 to April 2021. Prior to founding our Company, Mr. Raich worked at UBS from 2001 to 2007, where he was most recently Joint Global Head of

Mergers and Acquisitions. Prior to joining UBS, Mr. Raich was a Managing Director and Head of West Coast Mergers and Acquisitions at Donaldson, Lufkin & Jenrette, where he worked from 1996 to 2000. He began his career as an investment banker with PaineWebber in 1989. Mr. RaichHe is a member of the McIntire School of Commerce Advisory Board at the University of Virginia andVirginia. He is a Board Member of the UCLA Health System.System and is also Co-Chair of the Lung Health Advisory Board at UCLA. Mr. Raich also serves on the Marlborough School Board of Trustees and The Posse Foundation National Board of Directors. He holds a B.S. in Commerce with Distinction from the McIntire School of Commerce at the University of Virginia.

Mr. Raich’s knowledge of and extensive experience in investment banking and the financial services industry give the board of directors valuable industry specific knowledge and expertise on these and other matters. In addition, as aCo-Founder and Co-President of our Company, he has an extensive understanding of our business, which positions him well to serve on our board of directors.

Eric Cantor has served as a Managing Director, Vice Chairman of the Company and a director of our Company since September 2014. Mr. Cantor, who has more than 25 years of political and business experience, was formerly United States Representative for Virginia’s 7th Congressional District and U.S. House Majority Leader. He served in the U.S. House of Representatives from 2001 to 2014. He was elected by his colleagues in the House to serve as the Majority Leader for the 112th and 113th Congresses where he led the public policy agenda for the House. During his time in office, Mr. Cantor was a leading voice on the economy, job creation and policies focused on improving the lives of the American middle class. He championedpro-growth solutions including lowering taxes, eliminating excessive regulation, strengthening businesses, and encouraging entrepreneurship. He was also regularly featured in publications focusing on a wide range of topics including both domestic and international matters. Mr. Cantor holds a B.A. from The George Washington University, a J.D. from The College of William and Mary, and an M.A. from Columbia University.LOGO

Mr. Cantor’s knowledge of public and economic policy and extensive experience in public policy, business andgeo-politics position him well to serve on our board of directors.

Elizabeth Crain is aCo-Founder and has served as our Chief Operating Officer since 2007, where she leads the firm’sFirm’s global strategy, infrastructure and business management functions. Ms. Crain served as a director of our Company from July 2018 to April 2021. Ms. Crain has been in the investment banking and private equity industries for over 25 years as a banker, principal and operations executive. Prior to founding our Company, Ms. Crain worked at UBS from 2001 to 2007, where she was most recently a Managing Director in the UBS Investment Bank Office of the CEO and President, Manager of the Investment Bank Client Committee, a member of the Investment Bank Board, and previously Chief Operating Officer and Chief Administrative Officer of the UBS Investment Banking Department Americas franchise. Before joining UBS, Ms. Crain was in the private equity industry from

1997 to 2001. She began her career in investment banking in 1988 at Merrill Lynch. Ms. Crain serves on the Board of Directors of Exscientia Ltd., the Graduate Executive Board of The Wharton School and the Board of Trustees of The Windward School and The Royal Academy America and the Dean’s Council of the W. P. Carey School of Business at Arizona State University.School. Ms. Crain holds a B.S. from Arizona State University and an M.B.A. from the Wharton School at the University of Pennsylvania.

Ms. Crain’s experience in management positions in investment banking give the board of directors valuable knowledge and expertise on these matters. Ms. Crain, as Chief Operating Officer, has an extensive understanding of our business and operations, which positions her well to serve on our board of directors.LOGO

John A. Allison IV has been a director since October 2015. Mr. Allison is Executive in Residence at Wake Forest School of Business and Chairman of the Executive Advisory Council of the Cato Institute’s Center for Monetary and Financial Alternatives, and a member of the Cato Institute’s Board of Directors. Mr. Allison was president and CEO of the Cato Institute from October 2012 to April 2015. Mr. Allison served as the Chief Executive Officer of BB&T Corporation from 1989 to 2008. Mr. Allison was also a director of BB&T Corporation from 1986 to 2014, serving as Chairman from 1989 to 2008, and a Branch Bank & Trust Company director from 1986 to 2008 and 2013 to 2014. Mr. Allison served as Chairman and Chief Executive Officer of

Branch Bank & Trust Company from 1989 to 2008. He also served as a Distinguished Professor of Practice on the faculty of the Wake Forest University Schools of Business from 2009 to 2012. Mr. Allison is a Phi Beta Kappa graduate of the University of North Carolina—Chapel Hill. He received his master’s degree in management from Duke University, and is also a graduate of the Stonier Graduate School of Banking.

Mr. Allison’s knowledge of and extensive experience with finance, banking and investments, in addition to his years of experience and expertise as a senior corporate executive and public company board member, position him well to serve on our board of directors.

Yolonda Richardson has been a director since January 2019. Ms. Richardson is the Executive Vice President of Global Programs for the Campaign for Tobacco Free Kids and the Global Health Advocacy Incubator, where she leads several initiatives in global health, most notably the Bloomberg Global Initiative to Reduce Tobacco Use. Ms. Richardson joined the Campaign in 2009. From 2008 to 2010, Ms. Richardson served as the President and Founder of Richardson Consulting, a management consulting firm specialized in providing strategic support to nonprofit organizations, foundations, corporate philanthropies, and global development agencies. From 2003 to 2008, Ms. Richardson served as President and CEO of the Centre for Development and Population Activities (CEDPA), which seeks to advance women’s rights and expand their access to health and other services. Prior to CEDPA, Ms. Richardson was a Senior Vice President at Africare from 1999 to 2002 and served on the Special Counsel for the African Development Foundation — a government-funded granting agency that provides financial support to African NGOs and small businesses to enhance the participation of the poor in the development of their countries. From 1989 to 1999, Ms. Richardson worked at the Carnegie Corporation of New York, a global foundation, where she managed an international grant program focused on improving women’s health programs and promoting improved democracy and governance. Ms. Richardson started her career on Wall Street as a corporate attorney at Cahill Gordon & Reindel. She is a member of the New York State Bar and the Council on Foreign Relations. She holds a B.A., summa cum laude, from Dillard University in New Orleans, a Master’s degree in Public Health from Columbia University, and a J.D. from Yale University School of Law.

Ms. Richardson’s senior management and operational experience with leadingnon-profit organizations and international foundations positions her well to serve on our board of directors.

Kenneth L. Shropshire has been a director since July 2014. Mr. Shropshire is the Adidas Distinguished Professor of Global Sport and CEO of Global Sport Institute at Arizona State University. Mr. Shropshire is the David W. Hauck Professor Emeritus at the Wharton School at the University of Pennsylvania and the former Faculty Director of its Wharton Sports Business Initiative. Mr. Shropshire joined the Wharton faculty in 1986 specializing in sports business and law and served as Chairman of the Wharton School’s Legal Studies and Business Ethics department from 2000 to 2005. His consulting roles have included work for the NFL, NCAA, the NFL Players Association and USA Track and Field, and he was an executive on the organizing committee for the 1984 Los Angeles Olympic Games. Mr. Shropshire was previously a member of the board of directors of Peace Players International and Valley Green Bank in Philadelphia and a trustee of the Women’s Sports Foundation. He is a former president of the Sports Lawyers Association, the largest such organization in the world, and Program Chair of the ABA Forum Committee, Sports Law Section. Mr. Shropshire is the author of numerous books and articles on the business of sports. He holds an A.B. in Economics from Stanford University and a J.D. from Columbia Law School.

Mr. Shropshire’s knowledge of corporate and business law and his extensive experience with business law and ethics, negotiation and dispute resolution, position him well to serve on our board of directors.

Joseph Simon has served as our Chief Financial Officer since 2010. Prior to joining our Company, Mr. Simon served as Chief Financial Officer of Financial Security Assurance from 2002 to 2010. Prior to joining Financial Security Assurance, Mr. Simon served as Chief Financial Officer of IntraLinks and TENTV.com from 2000 to 2002. Prior to that, Mr. Simon worked at Cantor Fitzgerald where he served as Chief Financial Officer,

Global Controller and Global Head of Operations from 1993 to 1999. Before joining Cantor Fitzgerald, Mr. Simon was a Fixed Income Product and Legal Entity Controller at Morgan Stanley from 1986 to 1993. He began his career at Price Waterhouse from 1983 to 1986. Mr. Simon holds a B.S. from Cornell University and an M.B.A. from The University of Michigan. He is a Certified Public Accountant.

LOGO

Osamu R. Watanabe has served as our General Counsel and Chief Compliance Officer since 2011. Prior to joining our Company in 2010, he was General Counsel and Chief Compliance Officer of Sagent Advisors from 2009 to 2010. Prior to joining Sagent Advisors, Mr. Watanabe held senior legal positions at UBS from 2002 to 2009, Credit Suisse First Boston from 2001 to 2002 and Donaldson, Lufkin & Jenrette from 1997 to 2001. From 1987 to 1997, Mr. Watanabe was in private practice at Sullivan & Cromwell in New York, Tokyo, Hong Kong and Melbourne. Prior to that, he clerked for the Honorable Morey L. Sear, Eastern District of Louisiana. Mr. Watanabe holds a B.A. from Antioch College and a J.D. from Yale Law School (1985).

Controlled Company Status

Because Mr. Moelis, our Chairman and Chief Executive Officer, holds more than 50% of the voting power of our shares eligible to vote, we are

CORPORATE GOVERNANCE

The Company is governed by a “controlled company” under the rules of the New York Stock Exchange (“NYSE”). Under these rules, a company of which more than 50% of the voting power in the election of directors is held by an individual, group or another company is a “controlled company” and may elect not to comply with certain corporate governance requirements, including the requirements that (i) a majority of the board of directors consist of independent directors and (ii) that the board of directors have compensation and nominating and corporate governance committees composed entirely of independent directors. For at least some period, we intend to continue to utilize these exemptions.

The NYSE rules required us to have an audit committee comprised entirely of independent directors within one year of our initial public offering. From February 2015, our audit committee has been comprised entirely of directors meeting the NYSE audit committee independence requirements.

Director Independence

The board of directors has reviewed its composition, the composition of its committees and the independence of each director and considered whether any director has a material relationship with us that could compromise his or her ability to exercise independent judgment in carrying out his or her responsibilities. The board of directors and various committees of the Board that meet regularly throughout the year. Our Board has three standing committees, the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee. Each committee has adopted and operates under a written charter. You are encouraged to visit our website at www.moelis.com to view or to obtain copies of our Corporate Governance Guidelines, committee charters and Code of Business Conduct and Ethics. Additional information relating to the corporate governance of our Company is also set forth below and included in other sections of this Proxy Statement.

Board of Directors Leadership Structure

Mr. Moelis serves as our Chair and Chief Executive Officer in accordance with the terms of his employment agreement. As Mr. Moelis is the founder, Chief Executive Officer and among the largest shareholders of the Company, we believe that combining the roles of Chair of the Board and Chief Executive Officer encourages focused, strategic leadership.

Under our Corporate Governance Guidelines, the Board of Directors does not require the separation of the offices of the Chair of the Board and the Chief Executive Officer. If at any time the Chair is not an independent director, then the Board of Directors will elect a Lead Independent Director. Our Board of Directors periodically reviews its leadership structure.

In February 2022, in consultation with our Nominating and Corporate Governance Committee, our Board of Directors voted to update our Corporate Governance Guidelines to add the role of Lead Independent Director to our Board leadership structure. Effective March 1, 2022, Ken Shropshire was elected our Lead Independent Director. Mr. Shopshire is an independent director and active board member and also serves as the Chair of our Audit Committee.

The specific duties and responsibilities of the Lead Independent Director include the following:

Meetings and Executive Sessions

Presides at all meetings of the Board at which the Chair is not present, including executive sessions of the independent directors.

Has discretion to call meetings of the independent directors.

Facilitates discussion and open dialogue among the independent directors during Board meetings, executive sessions and outside of Board meetings.

Liaison with the Chair and Management

Serves as the principal liaison between the independent directors and the Chair, without inhibiting direct communication between them.

Communicates to the Chair and management, as appropriate, any decisions reached, suggestions, views or concerns expressed by independent directors in executive sessions or outside of Board meetings.

Provides the Chair with feedback and counsel concerning the Chair’s interactions with the Board.

Oversight of Information Provided to the Board

Works with the Chair to develop and approve Board meeting agendas and meeting schedules, including to ensure that there is sufficient time for discussion of all agenda items.

Works with the Chair on the appropriateness (including quality and quantity) and timeliness of the information provided to the Board.

Authorizes the retention of advisors and consultants who report directly to the Board when appropriate.

Board and Leadership Evaluation

In consultation with the Nominating and Corporate Governance Committee, reviews and reports on the results of the Board and Committee performance self-evaluations.

Periodically meets with independent directors to discuss Board and Committee and Chair performance, effectiveness and composition.

Coordinate with the CEO regarding the agenda for the annual review of the CEO succession plan.

Stockholder Communication

If requested, and in coordination with executive management, is available for consultation and direct communication with stockholders.

Crisis Management

Play an increased role in crisis management oversight, as appropriate under the circumstances.

The Lead Independent Director shall be appointed annually and serve until his or her successor is duly appointed and qualified, or until his or her earlier removal or resignation, or such time as he or she is no longer an independent director or such time as the Chair is an independent director. Although elected annually, the Lead Independent Director is generally expected to serve for more than one year.

Board Size

With the growth of our Company, the Nominating and Corporate Governance Committee has commenced a process to add an additional independent director that would provide the Board with additional experience and a diverse set of knowledge and skills that will be complimentary to our existing board members.

Director Independence

The Board of Directors has reviewed the composition of its committees and the independence of each director and considered whether any director has a material relationship with us that could compromise his or her ability to exercise independent judgment in carrying out his or her responsibilities. The Board of Directors has determined that each of John A. Allison IV, Yolonda Richardson and Kenneth L. Shropshire is an “independent director” under applicable NYSE standards and that each such director has no relationships with the Company that would interfere with such director’s exercise of independent judgment in carrying out his responsibilities as a director of the Company.

Board of Directors Role in Risk Oversight, Succession Planning and Environmental, Social and Governance Matters Oversight

We are exposed to a number of risks, and we regularly identify and evaluate these risks and our risk management strategy. Management is principally responsible for identifying, evaluating and managing the risks on a day-to-day basis, under the oversight of the Board and the Audit Committee. Our Managing Directors and certain business committees of our Managing Directors are responsible for various aspects of risk management

associated with our business, and our executive officers have the primary responsibility for enterprise-wide risk management. Our Chief Operating Officer, Chief Financial Officer and General Counsel work closely with our Managing Directors, our management and operations teams (including our finance and accounting, legal and compliance, human capital management and information technology and security teams) and our outsourced internal audit function to monitor and manage risk. Our executive officers meet with the Audit Committee at least four times a year in conjunction with a review of our quarterly and annual periodic SEC filings to discuss important risks we face. Our executive officers meet regularly with the Board to discuss important risks we face, including without limitation, those related to information security and coronavirus (COVID-19). Our Audit Committee focuses on oversight of financial risks relating to the company and the Compensation Committee determines named executive officer compensation plans and arrangements. The full Board keeps itself regularly informed regarding risks overseen by the Audit Committee through management and committee reports and otherwise.

The Board will annually evaluate succession planning with respect to the CEO and the executive officers. In addition, the Company’s emergency succession plan is reviewed by the Board (or a committee designated by the Board) at least annually.

The Board will conduct a periodic review of matters related to environmental, social and governance (“ESG”) (other than within the purview of other committees of the Board), including the overall ESG strategy, sustainability initiatives and stakeholder engagement. The Board will also periodically review and monitor the Company’s policies and initiatives in the areas of diversity and inclusion (other than within the purview of other committees of the Board).

Board Committees

Our Board of Directors has the authority to appoint committees to perform certain management and administrative functions. Our Board of Directors has established an Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee, each of which has the composition and the responsibilities described below. Our Board of Directors may from time to time establish other committees.

Audit Committee

Our Audit Committee oversees our accounting and financial reporting process and the audit of our financial statements and assists our Board of Directors in monitoring our financial systems and our legal and regulatory compliance. Our Audit Committee is responsible for, among other things:

appointing, compensating and overseeing the work of our independent auditors, including resolving disagreements between management and the independent registered public accounting firm regarding financial reporting;

approving engagements of the independent registered public accounting firm to render any audit or permissible non-audit services;

reviewing the qualifications and independence of the independent registered public accounting firm;

reviewing our financial statements and related disclosures and reviewing our critical accounting policies and practices;

reviewing the adequacy and effectiveness of our internal control over financial reporting;

establishing procedures for the receipt, retention and treatment of accounting and auditing related complaints and concerns;

preparing the Audit Committee report required by SEC rules to be included in our annual proxy statement;

reviewing and discussing with management and the independent registered public accounting firm the results of our annual audit, our quarterly financial statements and our publicly filed reports; and

reviewing and approving in advance any proposed related person transactions.

We believe that the functioning of our Audit Committee complies with the applicable requirements of the NYSE and SEC rules and regulations.

The members of our Audit Committee are Mr. Allison, Ms. Richardson and Mr. Shropshire. Since November 2015, our Audit Committee has been comprised of three entirely independent directors as defined under NYSE rules. Mr. Allison is our Audit Committee financial expert, as defined under SEC rules.

Mr. Shropshire is the Chairperson of our Audit Committee.

Our Board of Directors has considered the independence and other characteristics of each member of our Audit Committee. Audit Committee members must satisfy the NYSE independence requirements and additional independence criteria set forth under Rule 10A-3 of the Exchange Act of 1934 (the “Exchange Act”). In addition, the NYSE requires that, subject to specified exceptions, including certain phase-in rules, each member of a listed company’s audit committee be independent and that audit committee members also satisfy independence criteria set forth in Rule 10A-3. In order to be considered independent for purposes of Rule 10A-3, an audit committee member may not, other than in his or her capacity as a member of the Board, accept consulting, advisory or other fees from us or be an affiliated person of us. Our Board of Directors has determined that each of Mr. Allison, Ms. Richardson and Mr. Shropshire qualifies as an independent director pursuant to NYSE rules and Rule 10A-3.

Our Board of Directors has adopted a written charter for the Audit Committee. The Audit Committee charter is available in the Corporate Governance section of our Investor Relations website at investors.moelis.com.

Compensation Committee

The Compensation Committee is responsible for, among other things:

reviewing and recommending policies, plans and programs relating to compensation and benefits of our directors, officers and employees;

reviewing and recommending compensation and the corporate goals and objectives relevant to compensation of our executive officers, including our Chief Executive Officer;

evaluating the performance of our Chief Executive Officer and other executive officers in light of established goals and objectives and determining and approving the Chief Executive Officer’s and other executive officers compensation level based on this evaluation;

administering our equity compensation plans for our employees and directors; and

approving the appointment of a retained independent compensation consultant.

The members of our Compensation Committee are Mr. Allison, Ms. Richardson and Mr. Shropshire. From February 2015, our Compensation Committee has been comprised of entirely independent directors meeting NYSE requirements. Ms. Richardson is the Chairperson of the Compensation Committee.

As permitted under the 2014 Omnibus Incentive Plan, the Board has authorized our Chief Operating Officer and Chief Financial Officer, acting together, to grant awards of up to 2,500,000 shares in any fiscal quarter.

The Compensation Committee Charter is available in the Corporate Governance section of our Investor Relations website at investors.moelis.com. The charter allows the Compensation Committee to form and delegate its responsibility to subcommittees of the Compensation Committee for any purpose it deems appropriate, with certain limits.

Nominating and Corporate Governance Committee

Our Nominating and Corporate Governance Committee was formed on February 23, 2021 and advises on identifying individuals qualified to become members of our Board of Directors. The Nominating and Corporate Governance Committee is responsible for, among other things:

assisting in identifying, recruiting and, if appropriate, interviewing candidates to fill positions on the Board;

reviewing the background and qualifications of individuals being considered as director candidates;

recommending to the Board of Directors the director nominees for election by the stockholders or appointment by the Board of Directors, as the case may be, pursuant to the Company’s Corporate Governance Guidelines; and

reviewing the suitability for continued service as a director of each board member when his or her term expires and when he or she has a change in status.

The members of our Nominating and Corporate Governance Committee are Mr. Allison, Ms. Richardson and Mr. Shropshire. From April 19, 2021, our Nominating and Corporate Governance Committee has been comprised of entirely independent directors meeting NYSE requirements. John Allison is the Chairperson of the Nominating and Corporate Governance Committee.

Our Board of Directors has adopted a written charter for the Nominating and Corporate Governance Committee. The Nominating and Corporate Governance Committee Charter is available in the Corporate Governance section of our Investor Relations website at investors.moelis.com. The charter allows the Nominating and Corporate Governance Committee to form and delegate its responsibility to subcommittees of the Compensation Committee for any purpose it deems appropriate, with certain limits.

Board and Committee Meetings; Annual Meeting Attendance

Between January 1, 2021 and December 31, 2021 our Board of Directors held seven meetings, our Audit Committee held seven meetings, our Compensation Committee held five meetings and our Nominating and Corporate Governance Committee held three meetings. During 2021, each director attended at least 95% of the total number of meetings of the Board of Directors Leadership Structure

Under our Corporate Governance Guidelines, the board of directors does not require the separation of the offices of the chairman of the board and the chief executive officer. These guidelines provide that the board of directors shall be free to choose its chairman in any way that it deems best for the Company at any given point in time. The board of directors periodically reviews its leadership structure and may make changes in the future. The Company’s employment agreement with Kenneth Moelis provides that Mr. Moelis is the Company’s Chief Executive Officer and the Chairman of its board of directors.

Board of Directors Role in Risk Oversight

We are exposed to a number of risks, and we regularly identify and evaluate these risks and our risk management strategy. Management is principally responsible for identifying, evaluating and managing the risks on aday-to-day basis, under the oversight of the board and the audit committee. Our Managing Directors and

certain business committees of our Managing Directors are responsible for various aspects of risk management associated with our business, and our executive officers have the primary responsibility for enterprise-wide risk management. Our Chief Operating Officer, Chief Financial Officer and General Counsel work closely with our Managing Directors, our management and operations teams (including our finance and accounting, legal and compliance, human capital management and information technology and security teams) and our outsourced internal audit function to monitor and manage risk. Our executive officers meet with the audit committee at least four times a year in conjunction with a review of our quarterly and annual periodic SEC filings to discuss important risks we face. Our executive officers meet regularly with the board to discuss important risks we face, including without limitation, those related to information security, and most recently, coronavirus(COVID-19). Our audit committee focuses on oversight of financial risks relating to the company and the compensation committee makes recommendations to the board regarding executive compensation plans and arrangements. The full board keeps itself regularly informed regarding risks overseen by the audit committee through management and committee reports and otherwise.

Board Committees

Our board of directors has the authority to appoint committees to perform certain management and administrative functions. Our board of directors has established an audit committee and a compensation committee, each of which has the composition and the responsibilities described below. We do not currently have a separately designated nominating committee. Our board of directors may from time to time establish other committees.

Audit Committee

Our audit committee oversees our accounting and financial reporting process and the audit of our financial statements and assists our board of directors in monitoring our financial systems and our legal and regulatory compliance. Our audit committee is responsible for, among other things:

appointing, compensating and overseeing the work of our independent auditors, including resolving disagreements between management and the independent registered public accounting firm regarding financial reporting;

approving engagements of the independent registered public accounting firm to render any audit or permissiblenon-audit services;

reviewing the qualifications and independence of the independent registered public accounting firm;

reviewing our financial statements and related disclosures and reviewing our critical accounting policies and practices;

reviewing the adequacy and effectiveness of our internal control over financial reporting;

establishing procedures for the receipt, retention and treatment of accounting and auditing related complaints and concerns;

preparing the audit committee report required by SEC rules to be included in our annual proxy statement;

reviewing and discussing with management and the independent registered public accounting firm the results of our annual audit, our quarterly financial statements and our publicly filed reports; and

reviewing and approving in advance any proposed related person transactions.

We believe that the functioning of our audit committee complies with the applicable requirements of the NYSE and SEC rules and regulations.

The members of our audit committee are Mr. Allison, Ms. Richardson and Mr. Shropshire. Since November 2015, our audit committee has been comprised of three entirely independent directors as defined under NYSE rules. Mr. Allison is our audit committee financial expert, as defined under SEC rules. Mr. Shropshire is the chairperson of our audit committee.

Our board of directors has considered the independence and other characteristics of each member of our audit committee. Audit committee members must satisfy the NYSE independence requirements and additional independence criteria set forth underRule 10A-3 of the Exchange Act of 1934 (the “Exchange Act”). In addition, the NYSE requires that, subject to specified exceptions, including certainphase-in rules, each member of a listed company’s audit committee be independent and that audit committee members also satisfy independence criteria set forth inRule 10A-3. In order to be considered independent for purposes ofRule 10A-3, an audit committee member may not, other than in his or her capacity as a member of the board, accept consulting, advisory or other fees from us or be an affiliated person of us. Our board of directors has determined that each of Mr. Allison, Ms. Richardson and Mr. Shropshire qualifies as an independent director pursuant to NYSE rules andRule 10A-3.

Our board of directors has adopted a written charter for the audit committee. The audit committee charter is available in the Corporate Governance section of our Investor Relations website at investors.moelis.com.

Compensation Committee

Our compensation committee advises on our compensation policies, plans and programs. The compensation committee is responsible for, among other things:

reviewing and recommending policies, plans and programs relating to compensation and benefits of our directors, officers and employees;

reviewing and recommending compensation and the corporate goals and objectives relevant to compensation of our executive officers, including our Chief Executive Officer;

evaluating the performance of our Chief Executive Officer and other executive officers in light of established goals and objectives; and

administering our equity compensation plans for our employees and directors.

The members of our compensation committee are Mr. Allison, Ms. Richardson and Mr. Shropshire. From February 2015, our compensation committee has been comprised of entirely independent directors meeting NYSE requirements. Ms. Richardson is the chairperson of the compensation committee.

As permitted under the 2014 Omnibus Incentive Plan, the board has authorized our Chief Operating Officer and Chief Financial Officer, acting together, to grant awards of up to 2,500,000 shares in any fiscal quarter.

Our board of directors has adopted a written charter for the compensation committee. The compensation committee charter is available in the Corporate Governance section of our Investor Relations website at investors.moelis.com.

Board and Committee Meetings; Annual Meeting Attendance

Between January 1, 2019 and December 31, 2019 our board of directors held seven meetings, our audit committee held six meetings and our compensation committee held five meetings. During 2019, each director attended at least 75% of the total number of meetings of the board of directors and committees on which the director served. The independent directors of the Company regularly meet in executive session with our CEO and without management. Under the Corporate Governance Guidelines adopted by our Board of Directors, the Lead Independent Director (or in his absence, another independent director designated by him) presides at such executive sessions.

Under our Corporate Governance Guidelines, directors are expected to attend the Company’s annual meetings of stockholders. A director who is unable to attend an annual meeting of stockholders (which it is understood will occur on occasion) is expected to notify the Chair of the Board of Directors. All directors attended our 2021 annual meeting.

Board Evaluation

Our Board and each committee conduct an annual self-evaluation, which is overseen by our Nominating and Corporate Governance Committee.

Director Qualifications and Nominating Process

In considering candidates for nomination, the Nominating and Corporate Governance Committee and Board of Directors take into consideration many factors, including the needs of the Board and the candidate’s

qualifications. At a minimum, director candidates must demonstrate high standards of ethics, integrity and professionalism, independence, sound judgment, and meaningful experience in business, law or accounting or other relevant areas. Candidates must also be committed to representing the long-term interests of our stockholders. The Board also considers other factors it deems appropriate based on current needs, including specific business and financial expertise currently desired, experience as a public company director, experience overseeing information technology or cybersecurity, gender, age and racial diversity.

Our full Board of Directors participates in the consideration of nominees to our Board of Directors other than as set forth below. The Board believes that recommendations from the Nominating and Corporate Governance Committee and input from all directors in the nominating process enhances the Company’s ability to identify, evaluate and select director nominees. In addition, the Stockholders Agreement provides that our Board of Directors will nominate individuals designated by Partner Holdings equal to a majority of the Board of directors, for so long as the Class B Condition is satisfied and, thereafter, one quarter of the candidates for so long as the Secondary Class B condition is satisfied. Partner Holdings is an entity controlled by our Chair and Chief Executive Officer, Kenneth Moelis, and the designees of Partner Holdings nominated by the Board of Directors for election at the Annual Meeting are currently Kenneth Moelis and Eric Cantor. Although the Class B Condition is satisfied, Partner Holdings has notified the Company that Partners Holdings will not designate a third nominee to our Board of Directors. This is because the Company, which is no longer a “controlled company” under NYSE rules, is required to satisfy NYSE independence requirements, including the requirement to have independent directors constitute a majority of our Board of Directors. See “Certain Relationships and Related Person Transactions—Transactions with Our Directors, Executive Officers and 5% Holders—Rights of Partner Holdings and Stockholders Agreement” below.

The Board of Directors will consider a candidate nominated by a stockholder in a manner consistent with its evaluation of potential nominees, so long as the nomination meets the requirements of our by-laws, as summarized below.

The notice of nomination should include the following information:

the stockholder’s name, record address, and name and principal place of business,

the name, age, business address, residence address, and principal occupation or employment of the nominee,

the class or series, and number of all shares of the Company’s stock owned beneficially or of record by the stockholder or the nominee,

whether and the extent to which any derivative or other instrument, transaction, agreement, or arrangement has been entered into by the stockholder or the nominee with respect to the Company’s stock,

a description of all agreements or arrangements to which the stockholder or the nominee is a party with respect to the nomination, the Company or the Company’s stock,

a description of agreements or arrangements entered into by the stockholder or the nominee with the intent to mitigate loss, manage risk or benefit from changes in the stock price or increase or decrease the stockholder’s voting power,

a representation that the stockholder will attend the meeting in person or by proxy to nominate the persons named in its notice, and

any other information related to the stockholder or the nominee required to be disclosed in the solicitation of proxies for election of directors under federal securities laws.

The notice must be accompanied by the nominee’s consent to be elected and to serve as a director and include certain representations and agreements by the nominee set forth in our by-laws.

This notice must be updated, if necessary, so that the information is true and correct as of the record date for the meeting.

Stockholder nominees should be submitted to the Company’s General Counsel and Secretary at the Company’s principal executive offices. Stockholder nominations may be made at any time. However, in order for a candidate to be included in the slate of director nominees for approval by stockholders in connection with a meeting of stockholders and for information about the candidate to be included in the Company’s proxy materials for such a meeting, the stockholder must submit the information required by our by-laws and other information reasonably requested by the Company within the timeframe described below under “Additional Information— Procedures for Submitting Stockholder Proposals.”

When the Company or the Board of Directors is required by contractual obligation (including pursuant to the Stockholders Agreement) to nominate candidates designated by any person or entity, the selection and nomination of these directors is not subject to the above process.

Shareholder Engagement

In 2021, we engaged with unaffiliated shareholders representing approximately 81% of the outstanding Class A shareholders at the time. In our meetings with shareholders, we primarily discussed feedback on our executive compensation program, financial performance, talent/ human capital management updates, among other matters.

We remain committed to having an open dialogue with shareholders, which allows us to better appreciate our shareholders’ perspective. Our senior management frequently meets with our shareholders during conferences, sell-side sponsored group meetings, and other ad-hoc interactions. We carefully consider their feedback while evaluating key business decisions. Finally, our investor presentation, and other relevant shareholder information can be found on our website as www.investors.moelis.com. The information on our website is not incorporated into this Proxy Statement.

Communication with the Board of Directors

Any stockholder or other interested parties who would like to communicate with the Board of Directors, the independent directors as a group or any specific member or members of the Board of Directors should send such communications to the attention of our General Counsel and Secretary at Moelis & Company, 399 Park Avenue, 4th Floor, New York, NY 10022. Communications should contain instructions on which member or members of the Board of Directors the communication is intended for. Such communications will generally be forwarded to the intended recipients. However, our General Counsel and Secretary may, in his sole discretion, decline to forward any communications that are inappropriate.

Corporate Responsibility

Moelis was founded in 2007 on the tenets of trust, partnership and commitment to long-term relationships and we remain true to these values in delivering differentiated advice to our clients, attracting and developing exceptional talent and maintaining a diverse, innovative and agile culture. We are focused on integrating these values into all facets of our business. Last year, we adopted environmental guidelines and a standalone anti-money laundering policy, updated our Code of Business Ethics and implemented the governance changes described elsewhere in this “Corporate Governance” section.

This year, we look forward to releasing our inaugural Corporate Responsibility and Sustainability report, which will detail Company focus areas in pursuit of our environmental, social and governance strategy. Below are highlights of our approach to our people.

Our People

We believe that our people are our most valuable asset. Our goal is to attract, retain and develop top talent in our industry across all levels. Our management team devotes significant time and resources to training and mentoring our employees and strives to foster a collaborative environment, and attract and retain talent that is passionate about our business and our culture.

As detailed below, during 2021, we remained committed to fostering diversity, equity and inclusion efforts, as well as executing our business strategy in light of the COVID-19 pandemic and prioritizing the health and safety of our employees.

Diversity & Inclusion

We are dedicated to maintaining an inclusive workplace that promotes and values diversity. Our commitment to uphold a culture of respect and inclusion is driven by our executive leadership and our Board of Directors. As a global firm we are committed to building a workforce with diversity of thought and perspective that are representative of the range of clients we advise around the world. Our ability to provide a rewarding career path in an environment focused on collaboration that brings together diverse perspectives and experiences results in best in class advice for our clients. Pipeline talent programs including our flagship Leadership Development Program, targeted coaching and development programs and our Employee Networks, provide an important opportunity for an exchange of ideas and relationship building among employees who identify as part of underrepresented groups and their allies. These firm-sponsored and employee-driven networks support our culture of inclusion and career development and create a framework for global connectivity and idea sharing.

We recruit from the world’s leading undergraduate and graduate programs and have developed relationships with a variety of associations and diversity groups at universities where we recruit. Since our inception we have had a dedicated campus recruiting effort through which we have hired many of our analysts and associates. We devote significant time and resources to training and mentoring our employees to ensure our junior professionals receive transaction experience across a wide range of products and industries. We believe this exposure enhances the investment banking experience and allows our developing talent to refine their proficiency in a broad variety of corporate finance matters at an early stage in their career. We are committed to talent retention and our goal is to develop our brightest and most ambitious junior professionals into productive Managing Directors.

Our Firm also supports diverse communities through volunteerism, fundraising efforts and partnerships. We support more than 40 employee selected nonprofit organizations around the world.

While the Firm has always been focused on the health and well-being of our employees, we have expanded access to mental health services and support for employees and their families as we faced the challenges of the pandemic together.

COVID-19 and Responsiveness

During 2021, our experienced management team continued to successfully lead the Firm through an extraordinary business and transaction environment during which we supported our global clients while essentially all of our employees continued to work from home for most of the year. Our unique culture of collaboration allowed our people to continue to come together in a hybrid work environment to creatively solve client challenges. Additionally, our investments in technology and cybersecurity enabled our teams to maintain a high level of productivity across their respective business functions, leading to record performance during 2021.

We prioritize employee health and safety as we focus on high levels of employee engagement. In 2021, this included enhancing behavioral health initiatives to support global Employee Assistance Programs and providing

resources for employees and their families. Throughout the year we utilized systematic management communication initiatives to connect and inform our employees around firmwide actions.

Our ability to respond to change and our continued focus on professional development and growth for our employees supported our performance. In 2021, we successfully transitioned our junior banker internship programs to a predominately virtual format with a near 100% offer acceptance rate. In addition, we implemented virtual onboarding, enhanced training programs for new employees and targeted skill based training for existing employees to adapt to a hybrid work environment.

Environmental Guidelines

In 2021, we adopted our Environmental Guidelines. We endeavor to implement efficiencies and environmental sustainability in our business practices and seek to operate our office footprint and daily operations more efficiently. We will continue to monitor our progress as we move forward in our corporate citizenship journey to reduce our environmental impact.

Code of Business Conduct and Code of Ethics

We have adopted a code of business conduct and ethics that is applicable to all of our employees, officers and directors, including our chief executive and senior financial officers. The code of business conduct and ethics is available in the Corporate Governance section of our Investor Relations website at investors.moelis.com. We expect that any amendment to the code, or any waivers of its requirements, will be disclosed on our website.

Corporate Governance Guidelines

Our Board of Directors has adopted Corporate Governance Guidelines to assist the Board of Directors in the exercise of its responsibilities. The Corporate Governance Guidelines are available in the Corporate Governance section of our Investor Relations website at investors.moelis.com.

Compensation Committee Interlocks and Insider Participation

None of our executive officers currently serves, or has served during the last completed fiscal year, on the compensation committee or board of directors of any other entity that has one or more executive officers serving as a member of our Board of Directors or Compensation Committee.

DIRECTOR COMPENSATION

Each of our non-employee directors receive annual compensation of $150,000, which is comprised of (i) $65,000 in the form of RSUs (the “RSU Grants”) and (ii) $85,000, which the director may elect to receive in the form of cash, RSUs or a combination thereof. Additionally, the Chairperson of each Board committee and the Lead Independent Director will receive $20,000 annually, which is comprised of (i) $5,000 of RSU Grants and (ii) $15,000, which the Chairperson or Lead Independent Director, as applicable, may elect to receive in the form of cash, RSUs or a combination thereof.

Cash compensation is paid quarterly in arrears. The annual RSU Grants generally vest upon grant and are settled following the second anniversary of grant. Any other RSUs elected to be received generally vest 25% on a quarterly basis over the one year period beginning July 1 of each year and are settled within 60 days following the applicable vesting date. We reimburse all directors for expenses incurred in connection with attending Board and committee meetings.

The following table shows compensation paid to the individuals who served as our non-employee directors in fiscal year 2021.

Name(1)

 Fees Earned or
Paid in Cash
($)
  Stock Awards
($)(2)
  Total
($)
 

John A. Allison IV

  46,250   121,659(3)   167,909 

Yolonda Richardson

  92,500   70,977(4)   163,477 

Kenneth L. Shropshire

              90,000               81,068(5)           171,068 

(1)

Our directors who also serve as our employees or executive officers do not receive any compensation for their service as directors and have thus been omitted from this table. These individuals consist of: (i) Mr. Moelis who is a named executive officer of the Company, regularly meet in executive session with our CEO and without management. Under the corporate governance guidelines adopted by our board of directors, the chairman(ii) Mr. Cantor, who is a Managing Director of the audit committee (orCompany. Additional information regarding Mr. Cantor’s employment agreement is included below in his absence, another independent director designated by him) presides at such executive sessions.

Under our corporate governance guidelines, directors are expected to attend the Company’s annual meetings of stockholders. A director who is unable to attend an annual meeting of stockholders (which it is understood will occur on occasion) is expected to notify the chairman of the board of directors. All directors attended our 2019 annual meeting.

Director Nomination Process

The Stockholders Agreement provides that our board of directors will nominate individuals designated by Partner Holdings equal to a majority of the board of directors, for so long as the Class B Condition is satisfied and, thereafter, one quarter of the candidates for so long as the Secondary Class B condition is satisfied. See “Certain Relationships and Related Person Transactions—Transactions with Our Directors, Executive Officers and 5% Holders—RightsEmployment Agreement with Eric Cantor.”

(2)

Amounts represent the grant date fair value of Partner Holdings and Stockholders Agreement” below. Our full board of directors participates inRSU awards made during 2021, as calculated under FASB ASC Topic 718. The amount excludes RSUs issued pursuant to the consideration of other nominees. The board believes that input from all directors in the nominating process enhances the Company’s ability to identify, evaluate and select director nominees. The board believes it is appropriate not to have a nominating committee because the full board effectively performs the functions of a nominating committee.

In considering candidates for nomination, the board of directors takes into consideration many factors, including the needs of the board and the candidate’s qualifications. At a minimum, director candidates must demonstrate high standards of ethics, integrity and professionalism, independence, sound judgment, and meaningful experience in business, law or accounting or other relevant areas. Candidates must also be committed to representing the long-term intereststerms of our stockholders. The board also considers other factors it deems appropriate based2014 Omnibus Incentive Plan as dividend equivalents on current needs, including specific business and financial expertise currently desired, experience as a public company director and diversity. The board does notthe underlying RSUs that have a formal policy regarding diversity; however, the board believes that it is important that the board be comprised of directors with diverse backgrounds, viewpoints and experiences.

The board of directors will consider a candidate nominated by a stockholder in a manner consistent with its evaluation of potential nominees, so long as the nomination meets the requirements of ourby-laws, as summarized below.

The notice of nomination should include the following information:

the stockholder’s name, record address, and name and principal place of business,

the name, age, business address, residence address, and principal occupation or employment of the nominee,

the class or series, and number of all shares of the Company’s stock owned beneficially or of record by the stockholder or the nominee,

whether and the extent to which any derivative or other instrument, transaction, agreement, or arrangement has been entered into by the stockholder or the nominee with respectaccumulated subsequent to the Company’s stock,

a description of all agreements or arrangements to which the stockholder or the nominee is a party with respect to the nomination, the Company or the Company’s stock,

a description of agreements or arrangements entered intogrant date held by the stockholder or the nominee with the intent to mitigate loss, manage risk or benefit from changes in the stock price or increase or decrease the stockholder’s voting power,

a representation that the stockholder will attend the meeting in person or by proxy to nominate the persons named in its notice,Mr. Allison, Mr. Shropshire and

any other information related to the stockholder or the nominee required to be disclosed in the solicitation of proxies for election of directors under federal securities laws.

The notice must be accompanied by the nominee’s consent to be elected and to serve as a director and include certain representations and agreements by the nominee set forth in ourby-laws.

This notice must be updated, if necessary, so that the information is true and correct as of the record date for the meeting.

Stockholder nominees should be submitted to the Company’s General Counsel and Secretary at the Company’s principal executive offices. Stockholder nominations may be made at any time. However, in order for a candidate to be included in the slate of director nominees for approval by stockholders Ms. Richardson in connection with a meeting of stockholders and for information about the candidate to be included in the Company’s proxy materials for such a meeting, the stockholder must submit the information required by ourby-laws and other information reasonably requesteddividends paid by the Company within the timeframe described below under “Additional Information—Procedures for Submitting Stockholder Proposals.”

When the Company or the boardto holders of directors is required by contractual obligation (including pursuant to the Stockholders Agreement) to nominate candidates designated by any person or entity, the selection and nomination of these directors is notits Class A common stock. Dividend equivalents are subject to the above process.

Communication withsame terms and conditions as the Board of Directors

Any stockholder or other interested parties who would like to communicate with the board of directors, the independent directors asunderlying RSUs. For a group or any specific member or memberssummary of the boardassumptions used in the valuation of directors should send such communicationsthese awards, please see Note 2 to the attentionaudited financial statements included in our 2021 Annual Report on Form 10-K.

(3)

Award comprised of our General Counsel and Secretary at Moelis & Company, 399 Park Avenue, 5th Floor, New York, NY 10022. Communications should contain instructions on which member or members of the board of directors the communication is intended for. Such communications will generally be forwarded to the intended recipients. However, our General Counsel and Secretary may, in his sole discretion, decline to forward any communications that are inappropriate.

Compensation Committee Interlocks and Insider Participation

None of our executive officers currently serves, or has served during the last completed fiscal year, on the compensation committee or board of directors of any other entity that has one or more executive officers serving as a member of our board of directors or compensation committee.

Code of Business Conduct and Code of Ethics

We have adopted a code of business conduct and ethics that is applicable to all of our employees, officers and directors, including our chief executive and senior financial officers. The code of business conduct and ethics is available in the Corporate Governance section of our Investor Relations website at investors.moelis.com. We expect that any amendment to the code, or any waivers of its requirements, will be disclosed on our website.

Corporate Governance Guidelines

Our board of directors has adopted corporate governance guidelines to assist the board of directors in the exercise of its responsibilities. The corporate governance guidelines are available in the Corporate Governance section of our Investor Relations website at investors.moelis.com.

DIRECTOR COMPENSATION

Per our Corporate Governance Guidelines, our compensation committee and board of directors periodically review the level and form of ournon-employee directors’ compensation. In the last review, the compensation committee recommended, and our board of directors approved, the compensation terms outlined below effective July 1, 2019. Thenon-employee director compensation year begins(i) 1,245 RSUs granted on July 1, and ends on June 30.Non-employee director annual compensation is $125,000 comprised of (i) $40,000 in the form of RSUs (the “RSU Grants”) and (ii) $85,000,2021 which the director may elect to receive in the form of cash, RSUs or a combination thereof. Additionally, the chairperson of the Audit Committee receives $15,000 annually, which the chairperson may elect to receive in the form of cash, RSUs or a combination thereof. The determination to amend our director compensation program was based on a review of our peers’ director compensation structures and levels and our increased revenues and market capitalization since 2014, when we initially set director compensation.

Prior to July 1, 2019, ournon-employee directors received annual compensation of $110,000 comprised of (i) $40,000 in the form of RSU Grants and (ii) $70,000, which the directors had the option to elect to receive in the form of cash, RSUs or a combination thereof. Additionally, audit committee members received $10,000 annually, which the directors had the option to elect to receive in the form of cash, RSUs or a combination thereof.

Cash compensation is paid quarterly in arrears. The annual RSU Grants generally vestvested upon grant and arewill be settled within 60 days following the second anniversary of grant. Any other RSUs elected to be received generally vest 25% on a quarterly basis over the one year period beginning July 1, 2023, and (ii) 889 RSUs granted on July 1, 2021, 222 of each yearwhich vested on October 1, 2021, 222 of which vested on January 1, 2022, 222 of which vested on April 1, 2022 and are223 which vest on July 1, 2022 and all of which were or will be settled within 60 days following the applicable vesting date. We reimburse all directorsCash amount reflects $7,500 for expenses incurred in connection with attending boardservice as Nominating and committee meetings.Corporate Governance Committee Chair.

(4)

TheAward comprised of 1,245 RSUs granted on July 1, 2021 which vested upon grant and will be settled within 60 days following table shows compensation paid to the individuals who servedJuly 1, 2023. Cash amount reflects $15,000 for service as ournon-employee directors in fiscal year 2019.Compensation Committee Chair.

 

Name(1)

  Fees Earned or
Paid in Cash
($)
   Stock
Awards
($)(2)
  Total
($)
 

John A. Allison IV

   41,250    82,931(3)   124,181 

Yolonda Richardson

   82,171    60,842(4)   143,013 

Kenneth L. Shropshire

   75,000    60,307(5)   135,307 
(5)

(1)

Our directors who also serve as our employees or executive officers do not receive any compensation for their service as directors and have thus been omitted from this table. These individuals consist of: (i) Messrs. Moelis, Mahmoodzadegan and Raich and Ms. Crain, each of whom is a named executive officer of the Company, and (ii) Mr. Cantor, who is a Managing Director of the Company. Additional information regarding Mr. Cantor’s employment agreement is included below in “Certain Relationships and Related Person Transactions—Transactions with Our Directors, Executive Officers and 5% Holders—Employment Agreement with Eric Cantor.”

(2)

Amounts represent the grant date fair value of RSU awards made during the identified fiscal year, as calculated under FASB ASC Topic 718. The amount excludes RSUs issued pursuant to the terms of our 2014 Omnibus Incentive Plan as dividend equivalents on the underlying RSUs that have accumulated subsequent to the grant date held by Messrs. Allison and Shropshire and Ms. Richardson in connection with dividends paid by the Company to holders of its Class A common stock. Dividend equivalents are subject to the same terms and conditions as the underlying RSUs. For a summary of the assumptions used in the valuation of these awards, please see note 2 to the audited financial statements included in our 2019 Annual Report on Form10-K.

(3)

Award comprised of (i) 1,164 RSUs granted on July 1, 2019 which vested upon grant and will be settled within 60 days following July 1, 2021, and (ii) 1,237 RSUs granted on July 1, 2019, 309Award comprised of (i) 1,245 RSUs granted on July 1, 2021 which vested upon grant and will be settled within 60 days following July 1, 2023, and (ii) 177 RSUs granted on July 1, 2021, 44 of which vested on October 1, 2021, 44 of which vested on January 1, 2022, 44 of which vested on April 1, 2022 and 45 which vest on July 1, 2022 and all of which were or will be settled within 60 days following the applicable vesting date. Cash amount reflects $13,500 for service as Audit Committee Chair.

October 1, 2019, 309 of which vested on January 1, 2020, 309 of which vested on April 1, 2020 and 310 of which vest on July 1, 2020 and all of which were or will be settled within 60 days following the applicable vesting date.

EXECUTIVE COMPENSATION

Compensation Discussion and Analysis

Our named executive officers for the fiscal year ended December 31, 2021, which consist of our Chief Executive Officer, our Chief Financial Officer and our three other most highly compensated executive officers who were serving as executive officers as of December 31, 2021 (the “NEOs” or “named executive officers”), are as follows:

 

(4)

Award comprised of (i) 582 RSUs granted on January 2, 2019 which vested upon grant and will be settled within 60 days following July 1, 2020, and (ii) 1,164 RSUs granted on July 1, 2019 which vested upon grant and will be settled within 60 days following July 1,

Kenneth Moelis, Chair and Chief Executive Officer;

Navid Mahmoodzadegan, Co-President, Managing Director;

Jeffrey Raich, Co-President, Managing Director;

Elizabeth Crain, Chief Operating Officer; and

Joseph Simon, Chief Financial Officer.

Performance Highlights

Our 2021 performance was exceptionally strong where we saw substantial growth in revenue, profitability, and returns to our shareholders on both an absolute and relative basis. Firmwide performance was a significant factor in determining our named executive officer compensation for 2021. The following are highlights of our 2021 performance:

Strong Growth in Revenue and Our Firm

We reported total record annual GAAP revenues of $1,540.6 million and Adjusted revenues of $1,558.0 3 million in 2021, up 65% from 2020, which was our previous record.

º

The increase in full year revenues reflects growth across all products and regions, with our M&A, Restructuring, and Capital Markets activity the highest they have ever been.

º

We completed a greater number of transactions during the year, and earned higher average fees per completed transaction as compared with the prior year period.

 

(5)

Award comprised of (i) 1,164 RSUs granted on July 1, 2019 which vested upon grant and will be settled within 60 days following July 1, 2021, and (ii) 582 RSUs granted on July 1, 2019, 145 of which vested on October 1, 2019, 145 of which vested on January 1, 2020, 146 of which vested on April 1, 2020 and 146 of which vest on July 1, 2020 and all of which were or will be settled within 60 days following the applicable vesting date.

EXECUTIVE COMPENSATION

Compensation Discussion and Analysis

Our named executive officers for the fiscal year ended December 31, 2019, which consist of our Chief Executive Officer, our Chief Financial Officer and our three other most highly compensated executive officers who were serving as executive officers as of December 31, 2019 (the “NEOs” or “named executive officers”), are as follows:

We advised on many of the largest and most complex transactions globally, demonstrating the continued momentum in our business.

We saw increases in productivity while remaining in a hybrid working environment in most of our global offices during 2021.

We continued to grow the Firm by increasing overall banker count by 7%.

We continued to exhibit strong internal talent development by promoting eight banker Managing Directors in early 2021 and 16 in early 2022 with respect to the 2021 year; nearly 50% of all Managing Directors are internal promotes.

Extraordinary Profitability

 

Kenneth Moelis, Chairman and Chief Executive Officer;

Navid Mahmoodzadegan,Co-President, Managing Director;

Jeffrey Raich,Co-President, Managing Director;

Elizabeth Crain, Chief Operating Officer; and

Joseph Simon, Chief Financial Officer.

Performance Highlights

Firmwide performance was a significant factor in determining our named executive officer compensation for 2019. The following are highlights of our 2019 performance.

We reported total annual revenuesdiluted net income per share of $747 million$5.40 on an Adjusted basis in 2019, down 16% compared to revenues for 2018.

Second half 2019 revenues of $455 million represented the strongest six month period of revenues in firm history.2021, up 86% from the prior year.4

 

We earned higher average fees per completed transaction across all transactions.

3

See Annex A for a reconciliation between GAAP and Adjusted financial information

4

We reported diluted net income of $5.34 on a GAAP basis for 2021. See Annex A for a reconciliation between GAAP and Adjusted financial information

Our Adjusted pre-tax margin of 34% in the current year led the public independent boutique investment banks.

We maintained a strong cash position and no debt.

Excellent Shareholder Returns

In total, for the 2021 performance year, we returned approximately $575 million in capital to shareholders through dividends and a record level of share repurchases.

º

Declared $6.85 per share in dividends with respect to the 2021 performance year.

 

º

We advised on many of the largest and most complex transactions globally, demonstrating the continued momentum in our business and maturation of our brand.

We reported diluted net income per share of $1.96 on an Adjusted basis in 20191.Increased regular dividend by 9% to $0.60 per share currently.

 

Non-compensation expenses declined 1% compared to 2018 while increasing average total employee headcount by 8%. Overall banker headcount increased by 9%.

º

We maintained our focus onhave declared a healthy balance sheet withspecial dividend in each year since becoming a strong cash position and no debt or goodwill.

We remained committed to returning all of our excess capital to shareholders.

Declared $2.76 per share in dividends with respect to 2019.

Executed record levels of share repurchases totaling 1.3 million shares.public company.

 

º

We continued to exhibit strong internal talent development by promoting five Managing Directors during the year; at year end 2019, one-third of all Managing Directors were internal promotes.Executed share repurchases totaling 1.9 million shares.

We hired six additional Managing Directors to enhance our capabilities in important products, regions and sectors and opened a new office in continental Europe to strengthen coverage of clients in the Benelux and Nordic regions.

We formed the North America Private Equity Solutions Group to deliver highly coordinated client coverage andbest-in-class advice and deal execution in M&A, capital markets, restructuring and recapitalization and fund raising to our private equity clients.

We recruited the largest and most diverse analyst and associate class in Firm history.

The outstanding results of this year served to guide and support our decisions on compensation.

1

We reported diluted net income of $1.89 per share on a GAAP basis for 2019. See Annex A for a reconciliation between GAAP diluted net income per share and Adjusted diluted net income per share.

Key Compensation Practices

The design of our executive compensation program is integral to the implementation of our compensation philosophy. The following chart provides highlights of our 2019

Key Compensation Practices

The design of our executive compensation program is integral to the implementation of our compensation philosophy. The following chart provides highlights of our 2021 compensation program.

WHAT WE DO

 

 

Align pay with firmwide performance. Our program emphasizes variable incentive compensation, versus fixed base salaries to reward for Company performance and the individual contributions and accomplishments of each named executive officer while retaining discretion.

 

 

Grant a significant portion of compensation in equity. Equity-based compensation as a percentage ofOur total incentive pay is delivered in the form of cash and equity -based compensation.The equity based compensation awarded for performance in 2019 is at least 50% andallocation is designed to align the interests of our named executive officers with those of our shareholders.shareholders, promote retention, and mitigate excessive risk taking. Almost 80% of 2021 total incentive compensation awarded to our CEO was equity-based compensation and a minimum of 40% of 2021 total incentive compensation awarded to our other named executive officers was equity- based.

 

 

Focus on long-term success with multi-year vesting.Multi-year vesting that is longer than most of our peers Five year pro rata. We have imposed a five-year vesting schedule defers deliveryfor the portion of equity awards over five years, whichincentive compensation that is delivered in unvested equity. We have elected a vesting schedule that is longer than the three-year standard deferral period amongof our peers and creates alignmentindustry because we believe it better aligns management’s interests with ourthose of shareholders.

 

 

Clawback Policies. ApplyWe apply clawback policies to annual incentive cash compensation in line with encouraging a long term focus.

 

 

Significant Equity Ownership by NEOs. All of our named executive officers currently have significant equity ownership as a result of multi-year vesting schedules applied to annual incentive equity compensation. As of December 31, 2021, each of our named executive officers own equity of the Company (in the form of vested and unvested equity, including LP Units and RSUs) representing greater than 10x their base salaries.

 

 

Hedging Prohibition.We prohibit hedging of our common stock and RSUsequity-based awards by our named executive officers and employees.

WHAT WE DON’T DO

 

 ×

No guaranteed incentive compensation

 

 ×

No severance payments or golden parachutes

 ×

No substantive tax gross ups

 

 ×

No excessive perquisites

 

 ×

No pension benefit accruals

How Compensation is Determined

Our Chairman and Chief Executive Officer, in consultationIn connection with the2021 compensation, committeeour Compensation Committee of the boardBoard of directors, takesDirectors took into account our compensation philosophy and our compensation framework to determine compensation for our named executive officers.

Our Compensation Committee has retained an independent compensation consultant, Willis Towers Watson (“WTW”), to assist it in collecting and evaluating external market data regarding executive compensation and performance and to advise the Compensation Committee on developing trends and best practices in executive compensation and equity and incentive plan design. In performing these services, WTW attends meetings of the Compensation Committee regularly, including portions of the meetings without management present, and separately with the Compensation Committee Chair. WTW is the Compensation Committee’s independent advisor and does not provide any other services to the Company or its executive officers that could jeopardize its independent status. The Company has affirmatively determined that no conflict of interest has arisen in connection with the work of WTW as compensation consultant for the Compensation Committee.

Compensation Philosophy

Our compensation program is designed to align the interests of our named executive officers and other employees with the long-term interests of the firmFirm and its shareholders.

Through our compensation program, we seek to:

 

 º

Attract, retain and motivate executives who are aligned in creating long-term shareholder value

 

 º

Promote a highly collaborative culture focused on delivering the highest quality advice to our clients

 

 º

Reinforce the long-term interests of the firmFirm over individual short-term interests

 

 º

Pay for firmFirm performance over the cycle

 

 º

Reinforce sound decision making and prudent risk taking

Framework to Determine Executive Compensation

In order to implement our compensation philosophy, for 2021, our Chairman and Chief Executive Officer, in consultation with the compensation committee,Compensation Committee took into account thefour key factors listed below in determining compensation of our named executive officers. These factors were used as the framework, together with our compensation philosophy, to guide compensation decisions for our named executive officers and other senior employees of the Company. Our compensation program allows us to take into account multiple aspects of the four key compensation factors (firmwide performance, performance of our peers, individual contributions and risk management assessment) based on our actual historical performance.

1.

Firmwide Performance

In assessing firmwide performance, the Company’s financial performance was evaluated with a focus on the Company’s revenues, operating margins, adjusted net income and total shareholder return and capital returns.return. These metrics were considered on both a year over year and multi-year basis, within the context of the global M&Ainvestment banking advisory market and the broader environment in which the Company operates. In addition, the firmwide

performance review takes into account the identification and execution of key strategic initiatives of the Company.Company, which may include strategic hiring or business expansion. Firmwide performance is a substantial factor in assessing NEO compensation levels.

2. Performance ofRelative to Our Peers

Our performance relative to the performance of our public company peer financial institutions was considered in determining 20192021 compensation. The companies included in the performance comparison were Evercore Inc., Greenhill & Co., Inc., Houlihan Lokey, Inc., Lazard Ltd, Perella Weinberg Partners1and PJT Partners Inc. We have achieved a three year total shareholder return of 19%145% compared to the peer group average of 22%85%, while maintaining a debt free balance sheet.sheet and all through organic growth. In addition, the prior year compensation structure of this peer group, along with third party surveys, is used to gauge pay practices and compensation trends. No specific metrics or targets for our performance relative to these competitors has been set and we do not benchmark compensation against these or any other companies.

 

LOGOLOGO

3. Individual Contributions

Key individual performance achievements of each of the named executive officers were considered in determining compensation for 2019.2021. Factors reviewed include each named executive officer’s roles responsibilities

1

Perella Weinberg Partners (“Perella”) became a publicly listed company in June 2021 and does not have a public three-year total shareholder return. Accordingly, Perella was excluded from the calculation and presentation of average three-year total shareholder returns in this section.

and responsibilities,role-specific performance and execution of strategic visionbusiness initiatives and initiatives, participation instrategy. In addition, leading client development and engagement, anddirect contributions to revenues.revenues and supporting other investment banking professionals in revenue generation and talent development are important determinants for compensation of our CEO and Co-Presidents.

The revenue contributions of named executive officers who maintain direct responsibility for client development and generating revenues as an investment banker are assessed according to the same framework used to assess and compensate other revenue producing investment bankers.

4. Risk Management Assessment

The named executive officers manage risk in the Company’s business. We take into account the impact of the named executive officers’ risk decisions on the business and the impactjudgement exercised to the Company of risk decisions by the named executive officers was taken into accountexcessive risk-taking in determining 2019 compensation.

2019 Say on Pay Vote

At last year’s Annual Stockholders Meeting, approximately 93% of all outstanding votes, and approximately 90% of Class A common stock votes cast, supported our compensation program. We believe these results reflect strong stockholder support for ourpay-for-performance linkage and our compensation structure that facilitates it. In this regard, we note that our program has not substantively changed since last year and has remained constant in its implementation methodology and fundamental philosophy.decisions.

Overview of Compensation Elements

Base Salary.Salary. Consistent with ourpay-for-performance philosophy, base salary comprises a small portion of our named executive officers’ total annual compensation. Base salaries for each of our named executive officers for 20192021 were $400,000. The amount of the base salary for the named executive officers was set in accordance with the terms of their respective employment agreements with us and may be adjusted from time to time in accordance with those agreements. Base salaries are reviewed annually. We did not increase the base salaries of our named executive officers in 2019.2021.

Annual Variable Incentive Compensation.Compensation.Annual variable incentive compensation comprises a majority of each of our named executive officer’s total compensation. Once the aggregate amount of the incentive compensation award is determined, a portion of the incentive compensation award is allocated in equity, typicallyconsisting of either restricted stock units (“RSUs”) or profits interest units in Moelis & Company Group Employee Holdings LP (“LP Units”), and the remainder is allocated in cash. For incentive compensation paid for 2021, a portion of each named executive officer’s total incentive compensation was awarded in vested LP Units subject to a three year restriction on any transfers and a three year non-compete requirement (these vested LP Units are referred to herein as the “Vested Restricted Equity” or “fully vested LP Units”). The Vested Restricted Equity awards were granted in lieu of cash to further align the interests of our named executive officers with our shareholders. Annual variable incentive compensation for performance in 20192021 was paid in the first quarter of 2020.2022. For compensation paid in respect of 20192021 performance, at least 50%40% of each of our named executive officer’s incentive compensation was awarded in the form of RSUs or LP Units, each of which are(other than the Vested Restricted Equity) is subject to a five yearfive-year vesting schedule, in line with our philosophy of aligning our named executive officer interests with creating long-term shareholder value. Annual incentive compensation paid to our named executive officers, including the amount awarded in the form of RSUs or LP Units, is discretionary.based on a discretionary assessment of performance. We did not (and do not as a matter of policy) provide guaranteed incentive compensation to any of our named executive officers in respect of 20192021 and did not set specific performance targets upon which the annual variable incentive compensation would become payable. The amount of variable incentive compensation awards is based on a discretionary assessment, taking into account the four factors described in our Framework of Compensation. The discretionary incentive compensation structure is preferable to a formulaic bonus structure based solely on the achievement of specificpre-established performance targets. Consistent with our compensation philosophy, the discretionary incentive compensation structure provides the flexibility to adjustbecause it adjusts to market cycles and accountaccounts for a variety of indicators of firmFirm and individual performance that a formulaic bonus structureapproach does not permit. See footnotes (1), and (2) and (5) to “ —SummarySummary Compensation Table for 20192021” for a discussion of the variable incentive compensation awarded to each named executive officer in respect of performance in 2019.2021.

In addition, in order to link the annual bonuses to our long-term success, and given that we did not defer payment of the cash bonuses to a later date, each of the bonuses that were paid to the named executive officers in respect of 2019 (other than the cash award described in the following sentence)2021 are subject to full repayment if the officer competes with us within 12 months following termination of employment or partial repayment if the officer competes with us within 12 through 21 months following termination of employment, in each case, under certain circumstances,

which is consistent with the bonuses paid to all of our managing directors. A portion of the cash bonus awarded to Mr. Mahmoodzadegan is subject to continuing service requirements as further described in footnote (5) “ —Summary Compensation Table for 2019”.

Process and Timing for Grants of Bonuses and Equity Awards. All annual bonus amounts (whether payable in cash, equity or other deferred compensation) to named executive officers are estimated at the end of December and are finally determined shortly after the end of the fiscal year after annual financial results are finalized. Base salariesThe bonuses for our named executive officers are determined based both on firmwide and individual performance. By extension, the amount of equity awards awarded are also reviewed at this time.linked to performance and supported by additional time-based vesting. The specific number of shares subject to equity awardsRSUs and the number of Group LP units for named executive officers with respect to 2019 performance was determined by dividing the dollar value of awarded equity by the average share price, calculated as of the five day trading period from February 6, 202010, 2022 through February 12, 2020.16, 2022.

20192021 Named Executive Officer Compensation

Listed below areIn determining 2021 annual incentive compensation for our named executive officers, the keyCompensation Committee considered the Company’s performance achievements and the other contributions of each of the named executive officers that were consideredofficer listed below.

The Company delivered record performance in determining compensation for 2019.2021, which included:

Adjusted revenues of $1,558 million in 2021, the largest annual revenues in the history of the Company

Revenue growth of 65% driven by outperformance in M&A and Capital Markets

Attractive returns to shareholders of 145% over a three-year period compared to the peer group average of 85%, while maintaining a debt free balance sheet and all through organic growth

Ken Moelis

Mr. Moelis providesprovided strategic leadership and visionvison for the Company as well as being a major contributorFirm and led the Firm’s business to record levels of performance. Mr. Moelis delivered an integrated business strategy and new business initiatives, characterized by growth across all sectors, products and existing client relationships. Throughregions. Mr. Moelis’s leadership the Company was involved in some of the largest and most complex transactions around the world in 2019. Mr. Moelis’ vision and leadership drive the culture of the Company which focuses ondrove collaboration, development of our people, disciplined execution of the business and shareholder value. The Company had revenues of $747 million in 2019,As the secondCEO and among the largest annual revenues in the historyshareholders of the Company, and attractive returns to shareholders over a three year period. The Company continues to generateMr. Moelis focused on generating excess capital while growing the firmFirm organically and maintaining a healthy balance sheet. Mr. Moelis drove enhanced franchise and global brand recognition, led new and existing client relationships and transactions and contributed directly to record levels of new business activity. As an industry leading advisor and deal maker, Mr. Moelis partnered with bankers across the Firm globally to drive business growth and talent development.

Navid Mahmoodzadegan

Mr. Mahmoodzadegan asCo-President provides significantprovided critical leadership in both overseeing the management of the Companyinvestment banking business, including, day to day management of bankers globally, and in cultivating important client relationships. For 2019, our CEO specifically considered Mr. Mahmoodzadegan’smade significant and direct contributions to our revenues given the numberclient development and size of client mandates that Mr. Mahmoodzadegan was involved with. Our CEO also considered that under Mr. Mahmoodzadegan’s leadership, our Media, Telecommunications and Technology business meaningfully increased revenues year over year. In partnership with Mr. Raich, hisCo-President, our global franchise continues to grow and in 2019 we promoted five Managing Directors, and we hired six additional Managing Directors. Mr. Mahmoodzadegan continues to playrevenue generation as an important management role in overseeing risk procedures of the Company including our conflict management. Lastly, our CEO considered the role Mr. Mahmoodzadegan serves in increasing our investor outreach and communications and his role in increasing our diversity and inclusion programs.investment banker.

i)

Strategic leadership: Under Mr. Mahmoodzadegan’s leadership, in partnership with Co-President Mr. Raich, our global franchise grew at record levels, including growth of key sectors overseen by Mr. Mahmoodzadegan. Mr. Mahmoodzadegan led the acquisition, development and promotion of talent specifically at the Managing Director level and oversaw our diversity and inclusion programs. In 2021, Mr. Mahmoodzadegan continued to provide management oversight of the Company’s risk procedures including our conflict management.

ii)

Direct contribution to client growth and revenue performance: Mr. Mahmoodzadegan continues to be one of the Firm’s leading revenue generating bankers. For 2021, our Compensation Committee specifically considered Mr. Mahmoodzadegan’s significant and direct contributions to our revenues given the number and size of client mandates that Mr. Mahmoodzadegan was involved with in addition to the

record revenues achieved by the global media franchise which he leads. Mr. Mahmoodzadegan’s revenue contributions are measured according to the same framework used to assess and compensate our other revenue producing investment bankers.

Jeffrey Raich

Mr. Raich asCo-President provides significantprovided critical leadership in both overseeing the management of the Companyinvestment banking business, including, day to day management of bankers globally, and in cultivating important client relationships. Our CEO considered that under Mr. Raich’s leadership, the firm has built a market-leading services franchise and Mr. Raich’s meaningful directmade significant contributions to the Company’s revenues. Our CEO also considered that under Mr. Raich’s leadership, in partnership with Mr. Mahmoodzadegan, hisCo-President, our global franchise continues to growclient development and in 2019 we promoted five Managing Directors, and we hired six additional Managing Directors. Mr. Raich continues to playrevenue generation as an important management role in

investment banker.

i)

Strategic leadership: Under Mr. Raich’s leadership, in partnership with Co-President Mr. Mahmoodzadegan, our global franchise grew at record levels, including growth of key sectors overseen by Mr. Raich. Mr. Raich led the acquisition, development and promotion of talent specifically at the Managing Director level and oversaw our diversity and inclusion programs. In 2021, Mr. Raich continued to provide management oversight of the Company’s risk procedures including our conflict management.

overseeing risk procedures of the Company including our conflict management. Lastly, our CEO considered the role Mr. Raich serves in increasing our investor outreach and communications and his role in increasing our diversity and inclusion programs.

ii)

Direct contribution to client growth and revenue performance: Mr. Raich is a leading M&A banker with deep client relationships in private equity and across multiple sectors. For 2021, our Compensation Committee specifically considered Mr. Raich’s direct contributions to significant fee events for the Firm. Mr. Raich’s revenue contributions are measured according to the same framework used to assess and compensate our other revenue producing investment bankers.

Elizabeth Crain

Ms. Crain has responsibility for theprovided leadership of worldwide operations of the Company including thecorporate strategy, business management and oversight of our business activity and personnel and pursuing new strategic opportunities. Our CEO considered Ms. Crain’s leadership on critical strategic and operational decisions,operations which contributed to the advancement of the firm’s strategic visionFirm’s banking platform and competitive positioning, in determining her compensation. In partnership with theCo-Presidents,positioning. Ms. Crain ledoversaw the expansion of global client coveragebanking capabilities through targeted business investment including the development and the recruitment of Managing Directors. In 2019,partnership with our CFO and General Counsel, Ms. Crain led operational risk oversight. Ms. Crain provided continued leadership through the development of the commercially oriented data analytics initiative,COVID-19 pandemic including recruitment of a Chief Data Officer,operational effectiveness, employee support and recruited global leadership for the firm’s human capital management function. In addition, our CEO considered Ms. Crain’s leadership in critical risk, expense managementengagement and operational programs.return to office direction.

Joseph Simon

Mr. Simon as Chief Financial Officer hasprovided strategic leadership over the worldwide responsibility for corporate finance, accounting, tax matters and information technology atfunctions for the Company. Our CEO considered the overall strength of the Company, and Mr. Simon’s contribution toward the achievement of the Company’s financial goals in determining his compensation. Our CEO also considered Mr. Simon’s management and oversight of the Moelis Australia strategic alliance and investment and his leadership of the firmwidenon-compensation expense reviewfinancial planning and reduction program.management contributed to core strategic decisions and leading capital efficiency initiatives. Mr. Simon serves as a key contact to theprovided operational risk oversight and led firmwide cyber and enterprise risk management initiatives. Mr. Simon led investor relations including developing and maintaining investor and research analyst community.relationships.

Other Compensation Program Features

No Guarantees

Historically, we have not guaranteed any named executive officer any additional compensation and have not provided any contractual entitlements to severance or additional payments triggered by termination.

Clawback Policies

Restricted stock unitsRSUs and unvested LP Units are forfeited by our named executive officers in the event of (1) a voluntary termination of employment other than for “good reason” (as defined in the 2014 Omnibus Incentive Plan) or (2) termination by the Company for cause. The cash component of 20192021 annual incentive compensation is subject to certain repayment provisions, including repayment if the officer competes with us within 12 months following termination of employment under certain circumstances. For a detailed discussion of the RSU and LP Unit forfeiture provisions, see “Overview of Compensation Elements” and “Moelis & Company Annual Equity Awards”.

Anti-Hedging Policy

Our named executive officers and other employees are prohibited from hedging or otherwise disposing of the economic risk of ownership of any of our securities owned by them. Certain forms of hedging or monetization transactions, such as forward sale contracts, allow a person to lock in much of the value of his or her stock holdings, often in exchange for all or part of the potential for upside appreciation in the stock. These transactions would allow a named executive officer to continue to own Moelis common stock, but without the full risks and rewards of ownership. When that occurs, the named executive officer may no longer have the same incentives or objectives as the Company’s other shareholders. Consequently, named executive officers are prohibited from engaging in hedging their exposure with respect to directly or indirectly owned Moelis common stock, whether obtained through compensation, open-market purchases, or otherwise. For purposes of this policy, ‘‘hedging’’ includes the purchase of financial instruments (including prepaid variable forward contracts, equity swaps, collars, and exchange funds), or otherwise engaging in transactions that hedge or offset, or are designed to hedge or offset, any decrease in the market value of Moelis common stock.

In addition, named executive officers are prohibited from engaging in directly or indirectly pledging owned Moelis common stock to secure obligations of a brokerage margin account as described above. Pledges of Moelis common stock by a named executive officer can result in the sale of shares without the consent of the officer if the obligation secured by the shares is in default, and if this occurs during a blackout period it could result in an insider trading violation by that officer. Pledges of Moelis common stock in a brokerage margin account (where shares are pledged to secure a loan to buy other securities) present significant insider trading risk because the shares can be sold automatically with a decline in the stock price. In addition, the reputation of the Company, as well as officers’ personal reputations, can be adversely affected if Moelis common stock is sold pursuant to a defaulted obligation.

2021 Say on Pay Vote

At last year’s Annual Stockholders Meeting, approximately 81% of all outstanding votes supported our compensation program. We believe that our compensation program continues to support our pay-for-performance culture and provides a strong alignment of the interests of our named executive officers with those of our stockholders more generally. We believe that it was also important to engage with our stockholders in order to get their input on our compensation program and the Firm’s performance.

As discussed above in the “Corporate Governance—Shareholder Engagement” section, we engaged shareholders representing approximately 81% of our outstanding shares then held by unaffiliated shareholders as of February 2021 to discuss our executive compensation program and other general corporate matters. We used this opportunity to discuss our compensation philosophy, along with the structure and components of our executive compensation program, and to solicit any comments or feedback from the shareholders. We had constructive conversations and received generally positive feedback. As a result of the positive feedback that we received, we did not make substantial changes to the executive compensation program. We understand the importance of engaging with our shareholders regarding our executive compensation program and expect to continue having these discussion and soliciting their input on an ongoing basis.

COMPENSATION COMMITTEE REPORT

We have reviewed and discussed the Compensation Discussion and Analysis with management. Based on our review and discussion with management, we recommended to the Board that the Compensation Discussion and Analysis be included in this Proxy Statement issued in connection with our Annual Meeting and in ourForm 10-K.

Compensation Committee

Yolonda Richardson (Chair)

John Allison

Ken Shropshire

The information in this report is not “soliciting material,” is not deemed filed with the SEC and is not to be incorporated by reference in any of our filings under the Securities Act or the Exchange Act whether made before or after the date hereof and irrespective of any general incorporation language in any such filings.

Summary Compensation Table for 20192021

The following table summarizes the total compensation paid to or earned by each of our named executive officers for the periods presented below, under SEC rules.

 

Name and Principal Position

  Year   Salary
($)
   Cash
Bonus
($)(1)
  Stock
Awards
($)(2)
   Option
Awards
($)
   All Other
Compensation
($)(3)
  Total
($)
 

Kenneth Moelis

Chairman and Chief Executive Officer

   2019    400,000    —     4,716,727    —      —     5,116,727 
   2018    400,000    3,475,000   4,907,200    —      18,328   8,800,528 
   2017    400,000    2,700,000   3,371,625    —      13,183(4)   6,484,808 

Navid Mahmoodzadegan

Co-President, Managing
Director

   2019    400,000    3,850,000(5)   5,432,916    —      13,525   9,696,441 
   2018    400,000    4,100,000   4,287,365    —      20,140   8,807,505 
   2017    400,000    2,700,000   3,371,625    —      13,915   6,484,820 

Jeffrey Raich

Co-President, Managing
Director

   2019    400,000    50,000   2,667,056    —      8,530   3,125,586 
   2018    400,000    2,150,000   4,287,365    —      14,413   6,851,778 
   2017    400,000    2,700,000   3,371,625    —      13,183   6,484,808 

Elizabeth Crain

Chief Operating Officer

   2019    400,000    400,000   928,525    —      10,420   1,738,945 
   2018    400,000    1,025,000   1,033,058    —      11,150   2,469,208 
   2017    400,000    750,000   684,093    —      9,632   1,843,725 

Joseph Simon

Chief Financial Officer

   2019    400,000    580,000   814,901    —      8,400   1,803,301 
   2018    400,000    875,000   872,927    —      8,250   2,156,177 
   2017    400,000    655,000   635,216    —      8,100   1,698,316 

Name and Principal Position

 Year  Salary
($)
  Cash
Bonus
($)(1)
  Stock
Awards
($)(2)
  Option
Awards
($)
  All Other
Compensation
($)(3)
  Total
($)
 

Kenneth Moelis

Chair and Chief Executive Officer

  

2021

2020

2019

 

 

 

  

400,000

400,000

400,000

 

 

 

  

5,100,000

4,800,000

 

 

 

  

8,829,314

4,648,523

4,716,727

 

 

 

  

      —

 

 

 

  

29,645

25,643

              —

 

 

 

  

14,358,959

9,874,166

5,116,727

 

 

 

Navid Mahmoodzadegan .

Co-President, Managing Director

  2021   400,000   11,260,000   8,327,639      52,437   20,040,076 
  2020   400,000   4,800,000   7,505,481      8,550   12,714,031 
  2019   400,000   3,850,000   5,432,916      13,525   9,696,441 

Jeffrey Raich .

Co-President, Managing Director

  2021   400,000   6,850,000   4,514,959      36,120   11,801,079 
  2020   400,000   1,100,000   2,469,515      8,550   3,978,065 
  2019   400,000   50,000   2,667,056      8,530   3,125,586 

Elizabeth Crain

Chief Operating Officer, Managing Director

  2021   400,000   2,062,000   1,553,093      10,875   4,025,968 
  2020   400,000   1,252,000   1,380,030      8,550   3,040,580 
  2019   400,000   400,000   928,525      10,420   1,738,945 

Joseph Simon .

Chief Financial Officer, Managing Director

  2021   400,000   1,630,000   923,030      10,875   2,963,905 
  2020   400,000   980,000   982,950      8,550   2,371,500 
  2019   400,000   580,000   814,901      8,400   1,803,301 

 

(1)

Amounts represent the annual cash incentive bonuses paid for performance in the identified fiscal year, whether or not paid in such year. The Company paid its cash bonuses for performance in each of 2017, 20182019, 2020 and 20192021 in the first quarter of the following year. Except as set forth in footnote 5, the cashCash bonuses are subject to repayment if the named executive officer competes with us within 12 months following termination of employment under certain circumstances. The repayment terms for 2017, 20182019, 2020 and 20192021 cash and equity incentive bonuses are described below under “Executive Officers—Other Compensation Program Features” and “—Moelis & Company Annual Equity Awards.Awards.

 

(2)

Amounts represent the grant date fair value of the awards granted during the identified fiscal year, as calculated under FASB ASC Topic 718. For a summary of the assumptions used in the valuation of these awards, please see Note 2 to the audited financial statements included in our 20192021 Annual Report on Form10-K. In accordance with SEC rules, the table includes equity awards for 2016 performance that were granted in 2017, equity awards for 2017 performance that were granted in 2018 and equity awards for 2018 performance that were granted in 2019, but excludes equity awards for 2019 performance that were granted in 2020.2020 and equity awards for 2020 performance that were granted in 2021, but excludes equity awards for 2021 performance that were granted in 2022. On February 13, 2020,17, 2022, Mr. Moelis received 122,523 RSUs251,159 LP Units, 113,646 fully vested LP Units and 28,979 long term incentive LP units for 20192021 performance. The grant date fair value of these awards granted in February 20202022 as calculated under FASB ASC Topic 718 is $4,648,523$18,784,112 for Mr. Moelis. On February 13, 2020,17, 2022, Mr. Mahmoodzadegan received 197,825 RSUs141,808 LP Units and 68,188 fully vested LP Units for 20192021 performance. The grant date fair value of these awards granted in February 20202022 as calculated under FASB ASC Topic 718 is $7,505,481$9,960,423 for Mr. Mahmoodzadegan. On February 13, 2020,17, 2022, Mr. Raich received 65,090 RSUs82,109 LP Units and 34,094 fully vested LP units for 20192021 performance. The grant date fair value of these awards granted in February 20202022 as calculated under FASB ASC Topic 718 is $2,469,515$5,538,893 for Mr. Raich. On February 13, 2020,17, 2022, Ms. Crain received 36,374 RSUs25,850 LP units and 6,818 fully vested LP Units for 20192021 performance. The grant date fair value of these awards granted in February 20202022 as calculated under FASB ASC Topic 718 is $1,380,030$1,577,835 for Ms. Crain. On February 13, 2020,17, 2022, Mr. Simon received 25,908 RSUs16,808 LP Units

and 5,682 fully vested LP units for 20192021 performance. The grant date fair value of these awards granted in February 20202022 as calculated under FASB ASC Topic 718 is $982,950$1,078,856 for Mr. Simon. The RSUsLP Units for Mr. Moelis, granted in February 2020 vest in equal installments on February 23, 2023, February 23, 2024 and February 23, 2025. The RSUs granted in February 2020 for Mr. Mahmoodzadegan, Mr. Raich, Ms. Crain and Mr. Simon granted in February 2022 vest 40% on February 23, 2024 and 20% on each of February 23, 2025, February 23, 2026 and February 23, 2027. The fully vested LP Units for Mr. Moelis, Mr. Mahmoodzadegan, Mr. Raich, Ms. Crain and Mr. Simon granted in February 2022 are fully vested at grant but cannot be transferred for three years from grant and are subject to a three year non-compete restriction. The long term incentive LP Units for Mr. Moelis granted in February 2022 vest in equal installments on February 23, 2021,2025, February 23, 2022, February 23, 2023, February 23, 20242026 and February 23, 2025.2027.

(3)

Amounts represent (i) contributions by the Company to each named executive officer in respect of the officer’s participation in our 401(k) plan and(ii) tax-related interest payments to each named executive officer that resulted from the timing of our annual cash bonus payments in relation to the date on which estimated taxes on such awards were required to be paid by the officer.

 

(4)

In addition to the amounts listed in this column, we reimbursed Mr. Moelis for costs in lieu of a hotel when traveling to New York City on business. The amount of this reimbursement approximated the cost of a comparable hotel room and does not constitute additional compensation.

(5)

This amount is comprised of (i) $1,000,000 cash award subject to repayment if Mr. Mahmoodzadegan competes with us within 12 months following termination of employment under certain circumstances and (ii) $2,850,000 cash award, a portion of which is subject to repayment if either (x) Mr. Mahmoodzadegan notifies the Company of his intent to terminate his employment other than for Good Reason (as defined in the 2014 Omnibus Incentive Plan of Moelis & Company) or (y) the Company notifies him that it intends to terminate him for Cause (as defined in the 2014 Omnibus Incentive Plan of Moelis & Company) (a “Termination Notice”) in accordance with the following schedule: 50% of the award is required to be repaid if a Termination Notice is given on or before March 1, 2021 and 20% of the award is required to be repaid if a Termination Notice is given after March 1, 2021 and on or before December 31, 2021.

Grants of Plan-Based Awards in 20192021

The following table summarizes grants of plan based awards to each of our named executive officers in fiscal year 2019.2021.

 

Name

  Grant
Date
   All other
stock
awards:
number of
shares of
stock  or
units
(#)(1) 
   Grant date
fair value of
stock and
option
awards
($)(2)
   Grant
Date
   All other
stock
awards:
number of
shares of
stock or
units
(#)(1)
  Grant date
fair value of
stock and
option
awards
($)(2)

Kenneth Moelis

   2/14/2019    102,160    4,716,727    2/19/2021   161,266  8,829,314

Navid Mahmoodzadegan

   2/14/2019    117,672    5,432,916    2/19/2021   152,103  8,327,639

Jeffrey Raich

   2/14/2019    57,766    2,667,056    2/19/2021   82,465  4,514,959

Elizabeth Crain

   2/14/2019    20,111    928,525    2/19/2021   28,367  1,553,093

Joseph Simon

   2/14/2019    17,650    814,901    2/19/2021   16,859  923,030

 

(1)

Stock awards were made in the form of RSUs.RSUs or LP Units as described below in the section entitled “—Moelis & Company Annual Equity Awards.” The terms and conditions of these RSUs and LP Units are described below in the section entitled “—Moelis & Company Annual Equity Awards.”

 

(2)

Amounts represent the grant date fair value of the awards of $46.17$54.75 per share as calculated under FASB ASC Topic 718.

Moelis & Company Annual Equity Awards

In February 2019,of 2021, we granted equity incentive awards in the form of LP Units or RSUs to our Managing Directors, including our named executive officers in respect of 20182020 performance. Mr. Moelis received 102,160 RSUs,161,266 LP Units, Mr. Mahmoodzadegan received 117,672 RSUs,152,103 LP Units, Mr. Raich received 57,766 RSUs,82,465 LP Units, Ms. Crain received 20,11120,121 RSUs and 8,246 long term incentive RSUs and Mr. Simon received 17,65016,859 RSUs. These RSUsThe LP units for Mr. Moelis, Mr. Mahmoodzadegan and Mr. Raich vest in equal installments40% on February 23, 2023 and 20% on February 23 of each of 20202024 through 2024.

In February 2020, we granted equity2026. The incentive awards in the form of RSUs to our Managing Directors, including our named executive officers in respect of 2019 performance. Mr. Moelis received 122,523 RSUs,

Mr. Mahmoodzadegan received 197,825 RSUs, Mr. Raich received 65,090 RSUs, Ms. Crain received 36,374 RSUs and Mr. Simon received 25,908 RSUs. The RSUs granted to Mr. Moelis in February 2020 vest in equal installments on February 23 of each of 2023 through 2025. The RSUs for Mr. Mahmoodzadegan, Mr. Raich, Ms. Crain and Mr. Simon vest in equal installments on February 23 of each of 20212022 through 2025.2026. The long term incentive RSUs for Ms. Crain vest in equal installments on February 23 of each of 2024 through 2026. The long term incentive RSUs granted to Mr. MoelisMs. Crain in February 20202021 are designated asnon-qualifying equity under the Company’s retirement plan.

In accordance with SEC rules, these RSUs are not includedFebruary of 2022, we granted equity incentive awards in the Summary Compensation Table above,form of LP Units or RSUs to our Managing Directors, including our named executive officers in respect of 2021 performance. Mr. Moelis received 251,159 LP Units, 113,646 fully vested LP Units and will instead28,979 long term incentive LP units, Mr. Mahmoodzadegan received 141,808 LP Units and 68,188 fully vested LP Units, Mr. Raich received 82,109 LP Units and 34,094 fully vested LP units, Ms. Crain received 25,850 LP units and 6,818 fully vested LP Units and Mr. Simon received 16,808 LP Units and 5,682 fully vested LP units. The LP Units for Mr. Moelis, Mr. Mahmoodzadegan, Mr. Raich, Ms. Crain and Mr. Simon granted in February 2022 vest 40% on February 23, 2024 and 20% on each of February 23, 2025, February 23, 2026 and February 23, 2027. The fully vested LP Units for Mr. Moelis, Mr. Mahmoodzadegan, Mr. Raich, Ms. Crain and Mr. Simon granted in February 2022 are fully vested at grant but cannot be includedtransferred for three years from grant and are subject to a three year non-compete restriction. The long term incentive LP Units for Mr. Moelis granted in February 2022 vest in equal installments on February 23, 2025, February 23, 2026 and February 23, 2027. The long term incentive LP Units granted to Mr. Moelis in February 2022 are designated as non-qualifying equity under the Summary Compensation Table in the proxy statement for our 2021 annual meeting of stockholders.Company’s retirement plan.

Our RSUs granted in connection with bonuses are granted subject to the terms of the 2014 Omnibus Incentive Plan and individual award agreements. A copy of the plan is included as Exhibit 99.1 to our Registration Statement onForm S-8 filed on August 8, 2014.

Each RSU granted to participants represents the right to receive upon settlement either, at our option, a share of our Class A common stock or an amount of cash equal to the fair market value of a Class A share. Participants have no rights as a stockholder with respect to the RSUs unless and until shares of our Class A common stock underlying the RSUs are actually delivered, provided that each participant will generally be eligible to receive additional RSUs in respect of any dividends we pay with respect to our Class A common stock, which additional RSUs will be forfeitable and subject to the same restrictions and conditions as the underlying RSUs.

Each LP Unit is intended to qualify as a “profits interest” for federal income tax purposes and is eligible to share in a specified portion of the profits of the Company created after the grant of the profits interest. The LP Units may be redeemed for shares of our Class A common stock after they become vested and a sufficient amount of appreciation in the value of Group LP is achieved and allocated to the LP Units to enable a redemption of the LP Units for shares of our Class A common stock on a one-for-one basis. Upon the satisfaction of these conditions, the LP Units will be redeemable for shares of Class A common stock provided that any sales or exchange restriction on these LP Units have lapsed and in no event earlier than two years following the grant date.

RSUs and unvested LP Units will not vest unless a participant remains in continuous employment or service with us through the applicable vesting date. Except as described in the following paragraphs, and for any qualifying retirement, if the participant’s employment or service with us is terminated for any reason, any unvested RSUs or LP Units will be forfeited as of the notice of termination date.

If the participant’s employment or service with us is terminated (i) by us without cause, (ii) by the participant for “good reason” (as defined in the 2014 Omnibus Incentive Plan) or (iii) by us due to disability, any unvested RSUs and LP Units will continue to vest on the originally scheduled vesting dates, provided that the participant has not engaged in any “detrimental activities” (as described below) through the applicable vesting date. If the participant engages in any detrimental activity following such termination, any unvested RSUs or LP Units will be forfeited. For purposes of these RSU and LP Unit awards, “detrimental activities” means any solicitation of our employees or certain clients, any interference with our relationships with certain clients, any failure to execute an attestation that the participant has not engaged in such acts prior to each applicable vesting date or other time reasonably requested by us or any failure to satisfy any obligation of the participant under any agreement with us with respect to confidentiality,non-disparagement, nonsolicitation or noncompetition. If the participant’s employment or service with us is terminated due to the participant’s death, any unvested RSUs or LP Units will immediately vest.

If the participant’s employment or service with us is terminated (i) by us without cause or (ii) by the participant for good reason, in each case on or within 12 months after the effective date of a “change in control” (as defined in the 2014 Omnibus Incentive Plan), any unvested RSUs and LP Units will immediately vest.

A retiring officer or employee generally will not forfeit certain qualifying incentive RSUs granted during employment in 2015 and 2016 if at retirement the officer or employee (i) is at least 54 years old and (ii) has provided at least 8 consecutive years of service to the Company, unless such officer or employee waives such retirement arrangements. In December of 2016, the Company amended its retirement policy. A retiring officer or employee generally will not forfeit certain qualifying incentive RSUsLP Units granted during employment in 2017 and thereafter if at retirement (i) the officer or employee is at least 56 years old, (ii) has provided at least 5 consecutive years of service to the Company and (iii) such officer’s or employee’s years of service plus age at the time of retirement equals 65, unless such officer or employee waives such retirement arrangements. In each case, any such RSUs will continuebe delivered pursuant to vest on their applicable vesting schedule, subject to noncompetition and other terms.

Employment Agreements

Employment Agreement with Kenneth Moelis

We entered into an employment agreement with Mr. Moelis in April 2014, pursuant to which he serves as our ChairmanChair and Chief Executive Officer. The employment agreement provides that Mr. Moelis receives an annual base salary of $400,000, is eligible to receive an annual discretionary performance bonus and is eligible to participate in our employee benefit plans and arrangements as in effect from time to time. Either party is permitted to terminate the agreement at any time with or without cause.

The employment agreement provides that upon a voluntary termination of Mr. Moelis’ employment other than for good reason, he will not compete with us for 90 days following the date of such termination. In addition, the agreement provides that Mr. Moelis will not solicit our employees, independent contractors, consultants, service providers or suppliers for one year following termination of his employment for any reason. The agreement also includes restrictions relating to confidentiality, intellectual property andnon-disparagement.

Mr. Moelis is subject to forfeiting his interest in vested Group LP partnership units he held as of our initial public offering if prior to the expiration of the Managing DirectorLock-Up he terminates his employment without good reason and competes with us within 12 months following such termination.

Group LP Class A partnership units and Moelis & Company Class A common stock held as of our initial public offering by our Managing Directors (including through Partner Holdings) are subject tolock-up agreements (the “Managing Director Lock Up”) and are exchangeable into Class A common stock or cash upon expiration of thelock-up provisions. Since the IPO, we have, from time to time, in connection with publicfollow-on equity offerings, waived the Managing DirectorLock-Up, and pursuant to redemptions, have repurchased Group LP Class A partnership units held by participatingpre-IPO Managing Directors for cash using the proceeds of a follow on public offering of shares of our Class A common stock. The remaining Group LP Class A partnership units held by Managing Directors will become eligible for exchange into Class A common stock or cash on the sixth anniversary of our initial public offering, April 22, 2020, and, once exchanged, such Moelis & Company Class A common stock held by such Managing Directors will become transferable. In order to satisfy the Class B Condition, Mr. Moelis must maintain directly or indirectly ownership of an aggregate of at least 4,458,445 shares of Class A Common Stock and Equivalent Class A Shares (which includes Group LP Class A partnership units and restricted stock units of the Company).

Employment Agreements with Navid Mahmoodzadegan and Jeffrey Raich

We entered into substantially similar employment agreements with Messrs. Mahmoodzadegan and Raich in April 2014. The employment agreements provide that Messrs. Mahmoodzadegan and Raich each receive an annual base salary of $400,000, are eligible to receive an annual discretionary performance bonus and are eligible to participate in our employee benefit plans and arrangements as in effect from time to time. In addition, the employment agreements provide that during their employment, Messrs. Mahmoodzadegan and Raich have the right to be a member of Group LP’s most senior decision and policy-making committee (currently, the Group Management Committee). Messrs. Mahmoodzadegan and Raich are permitted to terminate their agreements at

any time with or without cause; however, we may terminate the employment of Messrs. Mahmoodzadegan or Raich only for cause (as defined in the employment agreements).

The employment agreements provide that upon a voluntary termination of Messrs. Mahmoodzadegan’s or Raich’s employment other than for good reason while he is a member of our boardBoard of directorsDirectors or following his voluntary resignation from our boardBoard of directors,Directors, he will not compete with us for 90 days following the date of such termination. In addition, the employment agreements provide that Messrs. Mahmoodzadegan and Raich will not solicit our employees, independent contractors, consultants, service providers or suppliers for six months following termination of his employment (or if he voluntarily terminates his employment other than for good reason while he is a member of our board of directors or following his voluntary resignation from our board of

directors, for a period of 12 months following termination of his employment).employment. The agreements also include restrictions relating to confidentiality, intellectual property andnon-disparagement.

Each of Messrs. Mahmoodzadegan and Raich is subject to forfeiting his interest in vested Group LP partnership units he held as of the initial public offering if prior to the expiration of the Managing DirectorLock-Up he terminates his employment without good reason and competes with us within 12 months following such termination. Good reason means a material breach by the Company of a material provision of the employment agreement or any equity award agreement.

Outstanding Equity Awards at 20192021 Fiscal Year-End

The following table summarizes the outstanding equity awards held by each of our named executive officers as of December 31, 2019.2021.

 

  Option Awards   Stock Awards(1)  Stock Awards(1)

Name

  Number of
Securities
Underlying
Unexercised
Options
(#)
Exercisable
   Number of
Securities
Underlying
Unexercised
Options
(#)
Unexercisable
   Option
Exercise
Price
($)
   Option
Expiration
Date
   Number of
Shares of Stock
That Have Not
Vested (#)(2)
 Market Value
of Shares
of Stock
That Have Not
Vested  ($)(3)
  Number of
Shares of Stock
        That Have Not         

Vested (#)(2)
 Market Value
of Shares
of Stock
        That Have Not         

Vested ($)(3)

Kenneth Moelis

   —      —      —      —      410,364(4)  13,098,810   484,724(4)  30,300,095

Navid Mahmoodzadegan

   —      —      —      —      382,807(5)  12,219,212   521,422(5)  32,594,076

Jeffrey Raich

   —      —      —      —      317,451(6)  10,133,031   270,529(6)  16,910,765

Elizabeth Crain

   —      —      —      —      76,909(7)  2,454,925   100,440(7)  6,278,512

Joseph Simon

   —      —      —      —      66,753(8)  2,130,753   72,975(8)  4,561,649

 

(1)

Stock awards were made in the form of LP Units and RSUs. The terms and conditions of these RSUsawards are described in the section entitled “—Moelis & Company Annual Equity Awards.”

 

(2)

All LP Units or RSUs are subject to accelerated vesting upon the officer’s death or disability.

 

(3)

Fair market value is equal to the applicable number of unvested RSUs multiplied by the $31.92$62.51 closing price per share of our Class A common stock on the NYSE on December 31, 2019.2021.

 

(4)

Consists of (i) 33,10218,225 RSUs originally granted to Mr. Moelis in March 2015February 2017 in respect of 20142016 performance and 15,35710,703 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019,2021, which fully vested 100% on February 23, 2020,2022, (ii) 67,06031,584 RSUs originally granted to Mr. Moelis in February 20162018 in respect of 20152017 performance and 24,57615,503 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019,2021, which vest in equal installments on February 23 of each of 2020 through 2021 and (iii) 54,675 RSUs originally granted to Mr. Moelis in February 2017 in respect of 2016 performance and 14,943 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019, which vest in equal installments on February 23 of each of 2020 through 2022 and (iv) 63,166 RSUs originally granted to Mr. Moelis in February 2018 in respect of 2017 performance and 12,378 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019, which vest in equal installments on February 23 of each of 2020 through 2023, and (v) 11,415(iii) 7,611 RSUs originally granted to Mr. Moelis in February 2018 in recognition of significant contributions to franchise development with a focus on those contributions not fully realized in 2017 revenues and 2,2373,736 additional dividend equivalent RSUs with respect thereto that were held by him as of December 31, 2019,2021, which vest in equal installments on February 23 of each of 20212022 through 2023, and (vi) 102,160(iv) 61,296 RSUs originally granted to Mr. Moelis in February 2019 in respect of 2018 performance and 9,29522,066 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019,2021, which vest in equal installments on February 23 of each of 20202022 through 2024.

(5)

Consists of (i) 35,7082024, (v) 122,523 RSUs originally granted to Mr. MahmoodzadeganMoelis in March 2015February 2020 in respect of 20142019 performance and 16,56630,211 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019,2021, which vest 100%in equal installments on February 23 of each of 2023 through 2025 and (vi) 161,266 LP Units originally granted to Mr. Moelis in February 2021 in respect of 2020 (ii) 41,708performance with respect thereto that were held by him as of December 31, 2021, which vest 40% on February 23 of 2023 and 20% on February 23 of each of 2024 through 2026.

(5)

Consists of (i) 18,225 RSUs originally granted to Mr. Mahmoodzadegan in February 20162017 in respect of 20152016 performance and 15,28510,703 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019,2021, which vest in equal installmentsfully vested on February 23, of each of 2020 through 2021 and (iii) 54,6752022, (ii) 31,584 RSUs originally granted to Mr. Mahmoodzadegan in February 20172018 in respect of 20162017 performance and 14,94315,503 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019,2021, which vest in equal installments on February 23 of each of 20202022 through 2022, and (iv) 63,1662023, (iii) 70,604 RSUs originally granted to Mr. Mahmoodzadegan in February 20182019 in respect of 20172018 performance and 12,37825,417 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019,2021, which vest in equal installments on February 23 of each of 20202022 through 2023, and (v) 117,6722024, (iv) 158,260 RSUs originally granted to Mr. Mahmoodzadegan in February 20192020 in respect of 20182019 performance and 10,70639,023 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019,2021, which vest in equal installments on February 23 of each of 2022 through 2025 and (v) 152,103 LP Units

originally granted to Mr. Mahmoodzadegan in February 2021 in respect of 2020 performance with respect thereto that were held by him as of December 31, 2021, which vest 40% on February 23 of 2023 and 20% on February 23 of each of 2024 through 2024.2026.

 

(6)

Consists of (i) 35,70818,225 RSUs originally granted to Mr. Raich in March 2015February 2017 in respect of 20142016 performance and 16,56610,703 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019,2021, which vest 100%fully vested on February 23, 2020,2022, (ii) 41,70831,584 RSUs originally granted to Mr. Raich in February 20162018 in respect of 20152017 performance and 15,28515,503 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019,2021, which vest in equal installments on February 23 of each of 20202022 through 2021 and2023, (iii) 54,67534,660 RSUs originally granted to Mr. Raich in February 20172019 in respect of 20162018 performance and 14,94312,477 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019,2021, which vest in equal installments on February 23 of each of 20202022 through 2022, and2024, (iv) 63,16652,072 RSUs originally granted to Mr. Raich in February 20182020 in respect of 20172019 performance and 12,37812,840 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019,2021, which vest in equal installments on February 23 of each of 2022 through 2025 and (v) 82,465 LP Units originally granted to Mr. Raich in February 2021 in respect of 2020 throughperformance with respect thereto that were held by him as of December 31, 2021, which vest 40% on February 23 of 2023 and (v) 57,76620% on February 23 of each of 2024 through 2026.

(7)

Consists of (i) 3,698 RSUs originally granted to Mr. RaichMs. Crain in February 2017 in respect of 2016 performance and 2,172 additional dividend equivalent RSUs awarded with respect thereto that were held by her as of December 31, 2021, which fully vested on February 23, 2022, (ii) 7,610 RSUs originally granted to Ms. Crain in February 2018 in respect of 2017 performance and 3,735 additional dividend equivalent RSUs awarded with respect thereto that were held by her as of December 31, 2021, which vest in equal installments on February 23 of each of 2022 through 2023, (iii) 12,067 RSUs originally granted to Ms. Crain in February 2019 in respect of 2018 performance and 5,2564,344 additional dividend equivalent RSUs awarded with respect thereto that were held by her as of December 31, 2021, which vest in equal installments on February 23 of each of 2022 through 2024, (iv) 29,100 RSUs originally granted to Ms. Crain in February 2020 in respect of 2019 performance and 7,175 additional dividend equivalent RSUs awarded with respect thereto that were held by her as of December 31, 2021, which vest in equal installments on February 23 of each of 2022 through 2025, (v) 19,069 RSUs originally granted to Ms. Crain in February 2021 in respect of 2020 performance and 2,251 additional dividend equivalent RSUs awarded with respect thereto that were held by her as of December 31, 2021, which vest in equal installments on February 23 of each of 2022 through 2026 and (vi) 8,246 long term incentive RSUs originally granted to Ms. Crain in February 2021 in respect of 2020 performance and 973 additional dividend equivalent RSUs awarded with respect thereto that were held by her as of December 31, 2021, which vest in equal installments on February 23 of each of 2024 through 2026.

(8)

Consists of (i) 3,275 RSUs originally granted to Mr. Simon in February 2017 in respect of 2016 performance and 1,923 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019,2021, which vest in equal installmentsfully vested on February 23, of each of 2020 through 2024.

(7)

Consists of (i) 6,1512022, (ii) 6,431 RSUs originally granted to Ms. Crain in March 2015 in respect of 2014 performance and 2,854 additional dividend equivalent RSUs awarded with respect thereto that were held by her as of December 31, 2019, which vest 100% on February 23, 2020, (ii) 9,978 RSUs originally granted to Ms. Crain in February 2016 in respect of 2015 performance and 3,657 additional dividend equivalent RSUs awarded with respect thereto that were held by her as of December 31, 2019, which vest in equal installments on February 23 of each of 2020 through 2021 and (iii) 11,094 RSUs originally granted to Ms. Crain in February 2017 in respect of 2016 performance and 3,032 additional dividend equivalent RSUs awarded with respect thereto that were held by her as of December 31, 2019, which vest in equal installments on February 23 of each of 2020 through 2022, and (iv) 15,220 RSUs originally granted to Ms. CrainMr. Simon in February 2018 in respect of 2017 performance and 2,982 additional dividend equivalent RSUs awarded with respect thereto that were held by her as of December 31, 2019, which vest in equal installments on February 23 of each of 2020 through 2023, and (v) 20,111 RSUs originally granted to Ms. Crain in February 2019 in respect of 2018 performance and 1,830 additional dividend equivalent RSUs awarded with respect thereto that were held by her as of December 31, 2019, which vest in equal installments on February 23 of each of 2020 through 2024.

(8)

Consists of (i) 5,422 RSUs originally granted to Mr. Simon in March 2015 in respect of 2014 performance and 2,5153,157 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019,2021, which vest 100%in equal installments on February 23 2020, (ii) 9,160of each of 2022 through 2023, (iii) 10,590 RSUs originally granted to Mr. Simon in February 20162019 in respect of 20152018 performance and 3,3573,812 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019,2021, which vest in equal

installments on February 23 of each of 20202022 through 2021 and (iii) 9,8252024, (iv) 20,727 RSUs originally granted to Mr. Simon in February 20172020 in respect of 20162019 performance and 2,6855,111 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019,2021, which vest in equal installments on February 23 of each of 20202022 through 2022,2025 and (iv) 12,861(v) 16,054 RSUs originally granted to Mr. Simon in February 20182021 in respect of 20172020 performance and 2,5201,895 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019,2021, which vest in equal installments on February 23 of each of 20202022 through 2023, and (v) 16,872 RSUs originally granted to Mr. Simon in February 2019 in respect of 2018 performance and 1,535 additional dividend equivalent RSUs awarded with respect thereto that were held by him as of December 31, 2019, which vest in equal installments on February 23 of each of 2020 through 2024.2026.

*

Note that any equity awards with a vesting date that falls on a weekend day may vest on the preceding business day or the next business day as determined by the compensation committeeCompensation Committee as administrator of the Omnibus Plan.

Options Exercised and Stock Vested in 20192021

The following table summarizes options granted and stock vested in fiscal year 20192021 for our named executive officers.

 

  Option awards   Stock Awards  Stock Awards

Name

  Number
of shares
acquired
on
exercise
(#)
   Value
realized
on
exercise
($)(1)
   Number
of shares
acquired
on
exercise
(#)
   Value
realized on
exercise
($)
  Number
of shares
acquired
on

        vesting        
(#)
  Value
realized on
        vesting        

($)

Kenneth Moelis

   —      —      169,415    6,353,076  127,944      6,945,452    

Navid Mahmoodzadegan

   —      —      146,724    5,502,149  151,446  8,221,263

Jeffrey Raich

   13,934    244,849    146,724    5,502,149  107,273  5,823,301

Elizabeth Crain

   21,669    333,841    34,641    1,299,022  28,695  1,565,658

Joseph Simon

   17,528    296,899    50,179    1,876,694  25,613  1,396,508

(1)

Value realized on exercise is equal to the fair market value of a share of our Class A common stock on the date of exercise less the exercise price of the applicable option.

Nonqualified Deferred Compensation for 20192021

There were no deferred cash awards granted to any named executive officer for 20192021 performance.

Potential Payments upon Termination of Employment or Change in Control

Other than with respect to the potential continued or accelerated vesting of outstanding equity awards that each of our named executive officers may be entitled to in connection with termination without cause, retirement, disability, death or change in control, our named executive officers are not entitled to any additional payments or benefits following a change in control or upon termination of employment, and are only entitled to payments and benefits that are available generally on anon-discriminatory basis to all salaried employees, such as continuation of health care benefits through the end of the month of the termination of employment and retirement benefits.

The following table describes the potential incremental payments and benefits to which our NEOs would be entitled upon retirement, disability, death or a change in control. All calculations in this table are based on an assumed termination date of December 31, 2019.2021.

 

Name

 Value of
Shares of
Common
Stock –
Termination
Without
Cause
(Continuation
of Vesting)(1)
($)
 Value of Shares of
Common Stock –
Retirement
(Continuation of
Vesting)(1)
($)
 Value of Shares of
Common Stock –
Disability
(Continuation of
Vesting)(1)
($)
 Value of
Shares of
Common
Stock –  Death
(Acceleration)(2)
($)
 Value of
Common
Stock –
Change in
Control  Event
(Acceleration)(2)
($)
  Value of
Shares of
Common
Stock –
Termination
Without
Cause
(Continuation
of Vesting)(1)
($)
 Value of Shares of
Common Stock –
Retirement
(Continuation of
Vesting)(1)
($)
 Value of Shares of
Common Stock –
Disability
(Continuation of
Vesting)(1)
($)
 Value of
Shares of
Common
Stock – Death
(Acceleration)(2)
($)
 Value of
Common
Stock –
Change in
Control  Event
(Acceleration)(2)
($)
 

Kenneth Moelis

 13,098,810(4)  9,105,400(3)  13,098,810(4)  13,098,810(4)  13,098,810(4)  30,300,095(4)     14,832,434(3)     30,300,095(4)     30,300,095(4)     30,300,095(4)    

Navid Mahmoodzadegan(5)

 12,219,212  12,219,212  12,219,212  12,219,212  12,219,212 

Jeffrey Raich(6)

 10,133,031  10,133,031  10,133,031  10,133,031  10,133,031 

Elizabeth Crain(7)

 2,454,925  2,454,925  2,454,925  2,454,925  2,454,925 

Joseph Simon(8)

 2,130,753  2,130,753  2,130,753  2,130,753  2,130,753 

Navid Mahmoodzadegan(5)

 32,594,076 32,594,076 32,594,076 32,594,076 32,594,076

Jeffrey Raich(6)

 16,910,765 16,910,765 16,910,765 16,910,765 16,910,765

Elizabeth Crain

 6,278,512(7) 5,702,221(8) 6,278,512(7) 6,278,512(7) 6,278,512(7)

Joseph Simon(9)

 4,561,649 4,561,649 4,561,649 4,561,649 4,561,649

 

(1)

Upon termination without Cause, retirement or disability, equity awards will continue to vest on the applicable original vesting schedule. Cause is defined in our 2014 Omnibus Incentive Plan. Unvested equity

that continues to vest in the event of a Termination without Cause is subject to forfeiture in the event the named executive officer participates in Detrimental Activities (as defined in the Statement of Terms and Conditions of the 2014 Incentive Restricted Stock Unit Award for Managing Directors).

 

(2)

Upon (i) death or (ii) (x) a Change in Control (as defined in our 2014 Omnibus Incentive Plan) and (y) an NEO’s employment or service is terminated without Cause by the Company or by the NEO for Good Reason on or after the effective date of the Change in Control but prior to twelve (12) months following the Change in Control (“Change in Control Event”), vesting and delivery will accelerate to the date of death or upon a Change in Control Event.

 

(3)

Amount represents the value of 285,256.88237,280.98 of unvested RSUs and LP Units. For purpose of this table, the value of the equity award was determined based on the closing price of our Class A common stock on December 31, 20192021 ($31.92)62.51). 125,106.83The remaining 247,442.98 unvested RSUs are not eligible for continued vesting upon retirement.

 

(4)

Amount represents the value of 410,363.71484,723.96 of unvested RSUs and LP Units. For purpose of this table, the value of the equity award was determined based on the closing price of our Class A common stock on December 31, 2021 ($62.51).

(5)

Amount represents the value of 521,421.78 of unvested RSUs and LP Units. For purpose of this table, the value of the equity award was determined based on the closing price of our Class A common stock on December 31, 2021 ($62.51).

(6)

Amount represents the value of 270,528.96 of unvested RSUs and LP Units. For purpose of this table, the value of the equity award was determined based on the closing price of our Class A common stock on December 31, 2021 ($62.51).

(7)

Amount represents the value of 100,440.12 unvested RSUs based on the closing price of our Class A common stock on December 31, 20192021 ($31.92)62.51).

 

(5)(8)

All amounts representAmount represents the value of 382,807.3891,220.93 unvested RSUs based on the closing price of our Class A common stock on December 31, 20192021 ($31.92)62.51). The remaining 9,219.18 unvested RSUs are not eligible for continued vesting upon retirement.

 

(6)(9)

Amounts representAmount represents the value of 317,450.8472,974.71 unvested RSUs based on the closing price of our Class A common stock on December 31, 20192021 ($31.92)62.51).

(7)

Amount represents the value of 76,908.67 unvested RSUs based on the closing price of our Class A common stock on December 31, 2019 ($31.92).

(8)

Amount represents the value of 66,752.91 unvested RSUs based on the closing price of our Class A common stock on December 31, 2019 ($31.92).

Other Compensation Arrangements

Retirement Arrangements.We have a 401(k) savings plan for eligible employees, including our named executive officers, and may, in our sole discretion, provide annual matching contributions to 401(k) plan participants. We do not have a defined benefit pension plan.

Employee Benefits.Eligible employees, including our named executive officers, participate in broad-based and comprehensive employee benefit programs, including medical, dental, vision, life and disability insurance. Our named executive officers participate in these programs on the same basis as eligible employees generally.

Assessment of Risk of Our Compensation Program

Our compensation program is designed to discourage excessive risk taking. The base salary component of compensation does not encourage risk taking because it is a fixed amount and a relatively small percentage of total compensation. Bonuses for our employees are based an assessment of a variety of quantitative and qualitative factors, including appropriate risk management. A substantial portion of bonuses for our managing directors, including our named executive officers, are paid in equity to align their interests with shareholders and the long-term objectives and success of the firm.Firm.

CEO Pay Ratio

Pursuant to Item 402(u) of RegulationS-K, presented below is the total compensation of our median employee, the annual total compensation of our CEO, and the ratio of those two values:

 

The 20192021 annual total compensation of our median employee (other than our CEO), calculated in accordance with Item 402(c) of RegulationS-K, was $236,400;$259,113;

 

The 20192021 annual total compensation of our CEO, Mr. Moelis, calculated in accordance with Item 402(c) of RegulationS-K and as reported in the Summary Compensation Table in this Proxy Statement, was $5,116,727;$14,358,959; and

 

For 2019,2021, the ratio of the annual total compensation of Mr. Moelis to the annual total compensation of our median employee was 21.655.4 to 1.

This reflects analysis of our global workforce of 875972 employees as of December 31, 2019.2021. We did not include independent contractors in our determination.

In order to identify our median employee,For purpose of this disclosure, we ranked each of our employees (other than our CEO) based on 2019 awarded compensation. For this purpose, 2019 awarded compensation was comprised of each employee’s (i) base salary or wages earned during 2019, (ii) annual cash bonus (if any) paid in respect of 2019 performance, and (iii) equity incentive awards (if any) granted in 2020 in respect of 2019 performance.

Once we identifieddetermined the median employee, we determined that individual’semployee’s annual total compensation for 2021 in accordance with the requirements of Item 402(c) of RegulationS-K consistent with the calculation of the 20192021 annual total compensation of our CEO as reported in the Summary Compensation Table in this Proxy Statement.

This pay ratio is a reasonable estimate calculated in a manner consistent with SEC rules based on our payroll and employment records and the methodology described above. The SEC rules for identifying the median compensated employee and calculating the pay ratio based on that employee’s annual total compensation allow companies to adopt a variety of methodologies, to apply certain exclusions, and to make reasonable estimates and assumptions that reflect their compensation practices. As such, the pay ratio reported by other companies may not be comparable to the pay ratio reported above, as other companies may have different employment and compensation practices and may utilize different methodologies, exclusions, estimates and assumptions in calculating their own pay ratios.The information disclosed in this section was developed and is provided solely to comply with specific, new legal requirements. We do not use this information in managing our company.Company.

COMPENSATION COMMITTEE REPORT

We have reviewed and discussed the Compensation Discussion and Analysis with management. Based on our review and discussion with management, we recommended to the Board that the Compensation Discussion and Analysis be included in this Proxy Statement issued in connection with our Annual Meeting and in our Form 10-K.

Compensation Committee

Yolonda Richardson (Chair)

John A. Allison IV

Kenneth L. Shropshire

The information in this report is not “soliciting material,” is not deemed filed with the SEC and is not to be incorporated by reference in any of our filings under the Securities Act or the Exchange Act whether made before or after the date hereof and irrespective of any general incorporation language in any such filings.

PROPOSAL 2: ADVISORY VOTE ON EXECUTIVE COMPENSATION

In accordance with the requirements of Section 14A of the Exchange Act and Exchange Act Rule14a-21(a), we are including in the Proxy Statement a separate resolution to approve, in anon-binding, stockholder advisory vote, the compensation paid to our named executive officers as disclosed on page 23. This vote represents our firstnon-binding, stockholder advisory vote on executive compensation.31.

While the results of the vote arenon-binding and advisory in nature, we intend to consider the results of this vote in making future compensation decisions.

The language of the resolution is as follows:

“RESOLVED, that the compensation paid to the company’s Named Executive Officers, as disclosed in this Proxy Statement pursuant to the rules of the SEC, including the Compensation Discussion and Analysis, compensation tables and any related narrative discussion, is hereby APPROVED.”

In considering their vote, stockholders are encouraged to read the Compensation Discussion and Analysis, the accompanying compensation tables, and the related narrative disclosure included in this proxy statement.Proxy Statement.

Our Board of Directors recommends that you vote “FOR” the approval, on an advisory basis, of the compensation of our named executive officers.

STOCK OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth information regarding the beneficial ownership of our Class A common stock and Class B common stock held by (i) each of our directors, (ii) each of our named executive officers, (iii) our directors and executive officers as a group and (iv) each person known to us to beneficially own more than 5% of our Class A common stock and Class B common stock. For our directors and officers, the information is as of April 9, 2020.7, 2022. For other stockholders who own more than 5% of our Class A common stock, the information is as of the most recent Schedule 13G filed by each such stockholder with the SEC.

The number of shares and percentage of beneficial ownership set forth below is based upon 53,419,33664,956,709 shares of Class A common stock and 10,397,9154,685,898 shares of Class B common stock outstanding on the Record Date.

Beneficial ownership is determined in accordance with the rules of the SEC.

 

  Number of
Shares of
Class A
Common
Stock
 % of
Class A
Common
Stock
 Number of
Shares of
Class B
Common
Stock
 % of
Combined
Voting
Power
   Number of
Shares of
Class A
Common
Stock
 % of
Class A
Common
Stock
 Number of
Shares of
Class B
Common
Stock
 % of
Combined
Voting
Power
 

Directors and Named Executive Officers(1)

          

Kenneth Moelis

   836,161(2)(3)  1.6 10,397,915(4)  66.6   436,397(2)   0.7  4,685,898   42.3

Navid Mahmoodzadegan

   72,632 (5)  *   —    *    145,796   0.2  0   0.1

Jeffrey Raich

   48,546 (6)  *   —    *    97,894   0.2  0   0.1

Eric Cantor

   72,162  *   —    *    136,691   0.2  0   0.1

Elizabeth Crain

   —  (7)  *   —    *    14,116   0.0  0   0.0

Joseph Simon

   12,370   0.0  0   0.0

John A. Allison IV

   9,566  *   —    *    14,367   0.0  0   0.0

Yolonda Richardson

   —    *   —    *    2,084   0.0  0   0.0

Kenneth L. Shropshire

   6,100  *   —    *    5,125   0.0  0   0.0

Joseph Simon

   28,456(8)  *   —    * 

All executive officers and directors as a group (10 persons)

   1,082,226(9)  2.0 10,397,915(4)  66.7   864,971(4)   1.3      4,685,898(3)   42.7

Holders of 5% or more of Class A Common Stock

          

Kayne Anderson Rudnick Investment Management, LLC(10)

   5,313,115  10.0  —    3.4

The Vanguard Group(11)

   4,738,844  8.9  —    3.0

BlackRock, Inc.(12)

   4,263,375  8.0  —    2.7

Capital Research Global Investors(13)

   2,986,500  5.6  —    1.9

JP Morgan Chase & Co. (14)

   2,841,530  5.3  —    1.8

London Company of Virginia(15)

   2,594,476  4.9  —    1.6

The Vanguard Group(5)

   6,419,483   9.88  —         5.7

Kayne Anderson Rudnick Investment Management, LLC(6)

   5,572,758   8.58  —         5.0

BlackRock, Inc.(7)

   4,580,783   7.05  —         4.1

London Company of Virginia(8)

   3,419,982   5.27  —         3.1

AllianceBernstein L.P.(9)

   2,539,942   3.91  —         2.3

 

*

Less than 1%

 

(1)

The address of each of our directors and executive officers is c/o Moelis & Company, 399 Park Avenue, 5th4th Floor, New York, NY 10022.

 

(2)

This number includes 671,831 shares of Class A common stock held by certain employees of the Company and its affiliates and entities holding shares of Class A common stock for such employees. Mr. Moelis has sole voting power over these 671,831 shares. Mr. Moelis has shared dispositive power over these shares with such employees. Mr. Moelis does not have a pecuniary interest in these shares.

(3)

ThisThe number excludes 4,876,3144,076,314 shares of Class A common stock issuable in exchange for Class A partnership units of Group LP, held by Partner Holdings on behalf of The Moelis Family Trust, of which Mr. Moelis is a beneficiary. Mr. Moelis shares voting and dispositive power over the assets of The Moelis Family Trust with Mrs. Julie Moelis. Mr. Moelis has a pecuniary interest in the Group LP Class A partnership units held by Partner Holdings on behalf of The Moelis Family Trust. These shares of Class A common stock represent approximately 7.4%5.8% of the shares of Class A common stock that would be

outstanding as of April 9, 20205, 2022 if all outstanding Group LP Class A partnership units were exchanged and all outstanding shares of the Company’s Class B common stock were converted at that time.

 

(4)(3)

Shares of Class B common stock are held by Partner Holdings. This number correlates to the aggregate number of vested and unvested Group LP Class A partnership units held by Partner Holdings. Partner Holdings is controlled by Mr. Moelis. Each share of Class B common stock has ten votes and is convertible into 0.00055 shares of Class A common stock.

(5)(4)

This number excludes 1,195,848 shares of Class A common stock issuable in exchange for Class A partnership units of Group LP, held by Partner Holdings on behalf of certain trusts. 1,089,265 of the Group LP Class A partnership units held by Partner Holdings are held on behalf of The Mahmoodzadegan-Gappy Trust, of which Mr. and Mrs. Mahmoodzadegan are the trustees and their children are the primary beneficiaries. Mr. Mahmoodzadegan shares voting and dispositive power over the assets of The Mahmoodzadegan-Gappy Trust with Mrs. Joanne Mahmoodzadegan. Mr. Mahmoodzadegan has a pecuniary interest in the Group LP Class A partnership units held by Partner Holdings on behalf of The Mahmoodzadegan-Gappy Trust. 106,583 of the Group LP Class A partnership units held by Partner Holdings are held on behalf of The Mahmoodzadegan-Gappy 2010 Irrevocable Trust, of which Mr. and Mrs. Mahmoodzadegan’s children are the primary beneficiaries. Mr. Mahmoodzadegan may have indirect voting power and dispositive power over the assets of The Mahmoodzadegan-Gappy 2010 Irrevocable Trust as a result of his relationship to the trustee. Mr. Mahmoodzadegan does not have pecuniary interest in the Group LP Class A partnership units held by Partner Holdings on behalf of The Mahmoodzadegan-Gappy 2010 Irrevocable Trust. These shares of Class A common stock represent approximately 1.8% of the shares of Class A common stock that would be outstanding as of April 9, 2020 if all outstanding Group LP Class A partnership units were exchanged and all outstanding shares of the Company’s Class B common stock were converted at that time.

(6)

This number excludes 633,464 shares of Class A common stock issuable in exchange for Class A partnership units of Group LP, held by Partner Holdings on behalf of Mr. Raich and certain trusts. Mr. Raich has a pecuniary interest in 364 of the Group LP Class A partnership units held by Partner Holdings on his behalf. 578,298 of the Group LP Class A partnership units held by Partner Holdings are held on behalf of The Raich Trust, of which Mr. and Mrs. Raich are the trustees and the beneficiaries. Mr. Raich shares voting and dispositive power over the assets of The Raich Trust with Mrs. Robin Raich. Mr. Raich has a pecuniary interest in the Group LP Class A partnership units held by Partner Holdings on behalf of The Raich Trust. 54,802 of the Group LP Class A partnership units held by Partner Holdings are held on behalf of The Raich 2010 Irrevocable Trust, of which Mr. and Mrs. Raich’s children are the primary beneficiaries. Mr. Raich may have indirect voting power and dispositive power over the assets of The Raich 2010 Irrevocable Trust as a result of his relationship to the trustee. Mr. Raich does not have pecuniary interest in the Group LP Class A partnership units held by Partner Holdings on behalf of The Raich 2010 Irrevocable Trust. These shares of Class A common stock represent approximately 1.0% of the shares of Class A common stock that would be outstanding as of April 9, 2020 if all outstanding Group LP Class A partnership units were exchanged and all outstanding shares of the Company’s Class B common stock were converted at that time.

(7)

This number excludes 86,557 shares of Class A common stock issuable in exchange for Class A partnership units of Group LP, held by Partner Holdings on behalf of Ms. Crain and certain trusts. Ms. Crain has a pecuniary interest in 74,102 of the Group LP Class A partnership units held by Partner Holdings on her behalf. 12,455 of the Group LP Class A partnership units held by Partner Holdings are held on behalf of Trust U/Article Second (B) of the Elizabeth A. Crain Trust (the “Crain Trust”), of which Ms. Crain’s children are the primary beneficiaries. Ms. Crain may have indirect voting power and dispositive power over the assets of the trust as a result of her relationship to the trustee. Ms. Crain does not have a pecuniary interest in the Group LP Class A partnership units held by Partners Holdings on behalf of The Crain Trust. These shares of Class A common stock represent approximately 0.1% of the shares of Class A common stock that would be outstanding as of April 9, 2020 if all outstanding Group LP Class A partnership units

were exchanged and all outstanding shares of the Company’s Class B common stock were converted at that time.

(8)

This number excludes 12,829 shares of Class A common stock issuable in exchange for Class A partnership units of Group LP, held by Partner Holdings on behalf of certain trusts. These shares of Class A common stock represent approximately 0.02% of the shares of Class A common stock that would be outstanding as of April 9, 2020 if all outstanding Group LP Class A partnership units were exchanged and all outstanding shares of the Company’s Class B common stock were converted at that time.

(9)

This number excludes 6,833,5554,104,857 shares of Class A common stock issuable in exchange for Group LP Class A partnership units held by Partner Holdings on behalf of our executive officers and directors. These shares of Class A common stock represent approximately 10.3%5.8% of the shares of Class A common stock that would be outstanding if all outstanding Group LP Class A partnership units were exchanged and all outstanding shares of Class B common stock were converted.

 

(10)(5)

Based on the Schedule 13G filed with the SEC on February 10, 2022 by The Vanguard Group on behalf of itself and certain wholly-owned subsidiaries named in the Schedule 13G. The address of the filer is 100 Vanguard Boulevard, Malvern, PA 19355.

(6)

Based on the Schedule 13G filed with the SEC on February 14, 20202022 by Kayne Anderson Rudnick Investment Management, LLC on behalf of itself. The address of the filer is 1800 Avenue of the Stars, Second Floor, Los Angeles, CA 90067.

 

(11)(7)

Based on the Schedule 13G filed with the SEC on February 12, 2020 by The Vanguard Group on behalf of itself and its wholly-owned subsidiaries Vanguard Fiduciary Trust Company and Vanguard Investments Australia, Ltd. The address of the filer is 100 Vanguard Boulevard, Malvern, PA 19355

(12)

Based on the Schedule 13G filed with the SEC on February 5, 20203, 2022 by BlackRock, Inc. on behalf of itself and certain wholly-owned subsidiaries named in the Schedule 13G. The address of the filer is 55 East 52nd Street, New York, NY 10055.

 

(13)(8)

Based on the Schedule 13G filed with the SEC on February 14, 2020 by Capital Research Global Investors, on behalf of SMALLCAP World Fund, Inc. The address of the filer is 333 South Hope Street, 55th Floor, Los Angeles, CA 90071.

(14)

Based on the Schedule 13G filed with the SEC on January 24, 2020 by JP Morgan Chase & Co., on behalf of itself and certain wholly-owned Subsidiaries named in the Schedule 13G, J.P. Morgan Investment Management Inc., JPMorgan Chase Bank, National Association, J.P. Morgan Securities LLC. The address of the filer is 383 Madison Avenue, New York, NY 10179.

(15)

Based on the Schedule 13G filed with the SEC on February 10, 20202022 by London Company of Virginia, on behalf of itself. The address of the filer is 1800 Bayberry Court, Suite 301, Richmond, VA 23226.

(9)

Based on the Schedule 13G filed with the SEC on February 14, 2022 by AllianceBernstein L.P., on behalf of itself. The address of the filer is 1345 Avenue of the Americas, New York, NY 10105.

DELINQUENT SECTION 16(a)16(A) REPORTS

Section 16(a) of the Exchange Act requires the Company’s directors, executive officers and persons who beneficially own more than 10% of the Company’s common stock, to file reports of beneficial ownership and reports of changes in beneficial ownership with the SEC. Such persons are required by SEC regulations to furnish the Company with copies of all Section 16(a) reports that they file. We assist our directors and officers with their Section 16(a) filings. Based solely on a review of reports filed with the SEC and written representations from directors and executive officers, we believe that all required reports under Section 16(a) were timely filed during 2019, except as reported on one Form 4 for Joseph Simon, which due to inadvertent administrative oversight, did not report an exempt transaction related to the withholding of a portion of an equity award for the payment of FICA tax associated with that equity award.2021.

CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS

In addition to the director and executive officer compensation arrangements discussed above in the section entitled “Executive Compensation,” this section describes transactions, or series of related transactions, since January 1, 2017 to which we were a party or will be a party required to be disclosed under Item 404 ofRegulation S-K, in which:

 

the amount involved exceeded or will exceed $120,000; and

 

any of our directors, executive officers or beneficial owners of more than 5% of any class of our capital stock (each a “5% Holder”), or any members of the immediate family of and any entity affiliated with any such person, had or will have a direct or indirect material interest.

Transactions with Our Directors, Executive Officers and 5% Holders

Agreements with Kenneth Moelis

On August 30, 2014, Moelis & Company Manager LLC (the “Manager”) acquired a new aircraft with funds received solely from its managing member (Mr. Moelis). The aircraft is used and operated by the Company pursuant to an Aircraft Dry Lease entered into on July 12, 2019, which replaces the initial Aircraft Dry Lease entered into on September 23, 2014 between Manager, Mr. Moelis and the Company (the “2014 Lease”). The parties to the 2014 Lease determined to enter into the new Aircraft Dry Lease in anticipation of the expiration of the 2014 Lease on December 31, 2019. We and Mr. Moelis are lessees under the lease. The lessees will pay the lessor monthly rent for the aircraft based on their respective usage. For the year ended December 31, 2019,2021, the Company incurred $1,674,000$1,295,000 in aircraft lease costs to be paid to Manager. The lessees will generally assume all costs related to the maintenance and operation of the aircraft during the term of the lease. The lessees will bear the risk of loss, theft, confiscation, damage to or destruction to the aircraft. The lessees will also indemnify the lessor and its successors and assigns against any losses in connection with the aircraft, subject to certain limitations. The lease will terminate on December 31, 2022, but may be extended by one or more of the lessees at their option. We also entered into a new Cost Sharing and Operating Agreement on July 12, 2019 with Mr. Moelis to replace the existing Cost Sharing and Operating Agreement. The new agreement provides that each lessee will have exclusive use of the aircraft during the times scheduled by such lessee. The lease payments and fixed operating costs (including, without limitation, insurance premiums, storage and scheduled maintenance) related to the aircraft will be allocated among the lessees based upon their respective use of the aircraft. Each lessee will be responsible for the direct operating costs (including, without limitation, fuel and service charges) for its use of the aircraft and will indemnify the other lessees for any losses arising from such use.

Moelis & Company granted a license to Mr. Moelis’ progeny, under which they have the right to use trademarks incorporating the term “Moelis” for certain purposes, including in connection with financial services activities.

RSUs granted to Mr. Moelis as compensation in fiscal years 2016, 2017 and 2018 were designated asnon-qualifying equity for purposes of the Company’s retirement policy at the time of grant. There are currently 155,169 unvested RSUs remaining from the original grants, including dividend equivalents issued in respect of the original grants (collectively, the “Designated Awards”). In December 2018, the Company determined to waive thenon-qualifying designation and redesignate the Designated Awards as qualifying equity for purposes of the Company’s retirement policy. As a result of the redesignation, upon a qualifying retirement, the Designated Awards will not be forfeited; the Designated Awards will continue to vest in accordance with their terms and subject to the qualifications and limitations (including potential forfeiture) under the Company’s applicable retirement policy. For a description of the Company’s retirement policies see the section entitled “—Moelis & Company Annual Equity Awards.” As a result of the redesignation, the Company recognized $4.3 million of

compensation expense in 2018. Without the redesignation, the Company would have amortized $4.3 million of compensation expense through 2023.

Rights of Partner Holdings and Stockholders Agreement

We are party to the Stockholders Agreement with Partner Holdings, pursuant to which, for so long as the Class B Condition is satisfied, Partner Holdings has approval rights over the following transactions:

 

any incurrence of indebtedness (other than inter-company indebtedness) in excess of $20 million;

 

any issuance by us of equity or equity-related securities (other than preferred stock) that would represent, after such issuance or upon conversion, exchange or exercise, as the case may be, at least three percent (3%) of the total voting power of our outstanding shares of Class A common stock (except in certain circumstances);

 

the issuance by us of preferred stock;

any debt or equity investment by us (including any commitment to invest) in an amount greater than $20 million;

 

any entry by us into a new line of business that requires a principal investment in excess of $20 million;

 

the adoption of stockholder rights plans;

 

the appointment or termination of Section 16 officers;

 

any amendments to Moelis & Company’s amended and restated certificate of incorporation orby-laws;

 

any amendments to Group LP’s amended and restated limited partnership agreement;

 

renaming Moelis & Company;

 

the adoption of annual budgets and business plans;

 

distributions to stockholders (except in certain circumstances);

 

entry into any merger, consolidation, recapitalization, liquidation or sale of Moelis & Company or all or substantially all of its assets or certain similar transactions involving Moelis & Company or entering into any agreement providing therefor (except in certain circumstances);

 

voluntarily initiating any liquidation, dissolution or winding up of Moelis & Company or permitting the commencement of a proceeding for bankruptcy, insolvency, receivership or similar action with respect to Moelis & Company or any of its subsidiaries or controlled affiliates;

 

the entry into or amendment of certain material contracts;

 

the entry into related party transactions;

 

the initiation or settlement of material legal actions; and

 

changes to our taxable or fiscal year.

The effect of the agreement is that Partner Holdings may maintain control over our significant corporate transactions even if it holds less than a majority of the combined total voting power of our shares of Class A and Class B common stock.

Our boardThe Stockholders Agreement provides that our Board of directorsDirectors will nominate individuals designated by Partner Holdings equal to a majority of the boardBoard of Directors, and to take all actions necessary to cause such directors to continue in office, for so long as the Class B Condition is satisfied and, thereafter, one quarter of the candidates for so long as the Secondary Class B condition is satisfied. Partner Holdings is an entity controlled by our Chair and Chief Executive Officer, Kenneth Moelis, and the designees of Partner Holdings nominated by the Board of Directors for election at the Annual Meeting are currently Kenneth Moelis and Eric Cantor. Although the Class B Condition is satisfied, Partner Holdings has notified the Company that Partners Holdings will not designate a third nominee to our Board of Directors this year. This is because the Company, which is no longer a “controlled company” under NYSE rules, is required to satisfy NYSE independence requirements, including the requirement to have independent directors constitute a majority of our Board of Directors. In addition, in the event that a vacancy is created at any time by the death, disability, retirement, resignation or removal of any director who is designated by Holdings in accordance with the stockholders agreement, the Company agrees to take at any time and from time to time all actions necessary to cause the vacancy created thereby to be filled as promptly as practicable by a designee of Holdings, including without limitation, in the event of a resignation of a Holdings’ designee as a result of a failure to obtain a majority vote.

The “Class B Condition” is defined as Mr. Moelis satisfying all of the following conditions:

(i) he maintains directly or indirectly ownership of an aggregate of at least 4,458,445 shares of Class A common stock of Moelis & Company and Equivalent Class A Shares (as defined below), subject to customary adjustments, which represent approximatelyone-third of his ownership immediately following our initial public offering;

(ii) he maintains directly or indirectly beneficial ownership (as defined below) of at least five percent (5%) of the Class A common stock of Moelis & Company (calculated, without duplication, on the basis that all issued and outstanding Group LP Class A partnership units not held by Moelis & Company or its subsidiaries had been exchanged for shares of Class A common stock of Moelis & Company);

(iii) he has not been convicted of a criminal violation of a material U.S. federal or state securities law that constitutes a felony or a felony involving moral turpitude;

(iv) he is not deceased; and

(v) his employment agreement has not been terminated in accordance with its terms because of a breach of his covenant to devote his primary business time and effort to the business and affairs of the Company and its subsidiaries or because he suffered an “incapacity” (i.e., order of incompetence or of insanity or permanent physical incapacity).

“Equivalent Class A Shares” means, on any date, the number of shares of Class A common stock represented by any shares, units, interests, options, warrants, evidence of indebtedness, stock awards or other securities or awards which by their terms are directly or indirectly convertible into, exchangeable for, exercisable for or pursuant to which the holder is entitled to receive shares of Class A common stock, whether immediately, only after the passage of time or only after the satisfaction of conditions and notwithstanding any right to pay cash in lieu of shares of Class A common stock.

“Beneficial ownership” has the same meaning given to it in Section 13(d) under the Exchange Act and the rules thereunder, except that a person will be deemed to have “beneficial ownership” of all securities that person has the right to acquire, whether the right is exercisable immediately, only after the passage of time or only after the satisfaction of conditions and notwithstanding any right to pay cash in lieu of such securities.

After the Class B Condition ceases to be satisfied, for so long as the Secondary Class B Condition is satisfied, Partner Holdings will have certain approval rights over the following transactions:

 

the appointment or termination of the Chief Executive Officer;

 

any amendments to Moelis & Company’s amended and restated certificate of incorporation orby-laws that materially and adversely affect in a disproportionate manner the rights of Mr. Moelis; and

 

any amendments to Group LP’s amended and restated limited partnership agreement that materially and adversely affect in a disproportionate manner the rights of Mr. Moelis.

After the Class B Condition ceases to be satisfied, for so long as the Secondary Class B Condition is satisfied, our boardBoard of directorsDirectors will nominate individuals designated by Partner Holdings equal to one quarter of the boardBoard of directors.Directors.

For so long as either the Class B Condition or the Secondary Class B Condition is satisfied, Partner Holdings will retain the right to remove any director previously designated by it.

The “Secondary Class B Condition” is defined as Mr. Moelis satisfying all of the following conditions:

 

he maintains directly or indirectly ownership of an aggregate of at least 2,229,222 shares of Class A common stock of Moelis & Company and Equivalent Class A Shares, subject to customary adjustments, which represent approximately one-sixth of his ownership immediately following our initial public offering; and

adjustments, which represent approximatelyone-sixth of his ownership immediately following our initial public offering; and

 

conditions (ii)-(v) required under the Class B Condition.

Employment Agreement with Eric Cantor

We entered into an employment agreement with Mr. Cantor pursuant to which he serves as the Vice Chairman of Group LP and a Managing Director. The employment agreement provides that Mr. Cantor receives an annual base salary of $400,000, is eligible to receive an annual discretionary performance bonus and is eligible to participate in our employee benefit plans and arrangements as in effect from time to time.

The employment agreement provides that upon a voluntary termination of Mr. Cantor’s employment other than for good reason, he will not compete with us for 90 days following the date of such termination. In addition, the employment agreement provides that Mr. Cantor will not solicit Group LP’s employees, independent contractors, consultants, service providers or suppliers for one year following termination of his employment for any reason (except for certain employees who joined in connection with Mr. Cantor). The agreement also includes restrictions relating to confidentiality, intellectual property andnon-disparagement.

For calendar year 2015, in addition to other compensation and pursuant to the employment agreement, we paid to Mr. Cantor $400,000 in incentive RSUs, payable in equal quarterly installments (the “Quarterly RSUs”). For fiscal years 2016 through 2019, Mr. Cantor was granted annually $400,000 in Quarterly RSUs as part of his annual discretionary incentive compensation. The Quarterly RSUs generally have the same vesting schedule as incentive RSUs granted to other Managing Directors. The remaining unvested Quarterly RSUs will be forfeited if we terminate Mr. Cantor’s employment for cause or if Mr. Cantor terminates his employment other than (i) for good reason or (ii) after the second anniversary of the grant date, to take a full-time elected or appointed position in federal government, state government, or a national political party.

Transactions with Moelis Asset Management LP

Prior to our initial public offering, our business was owned by Old Holdings, an entity controlled by Kenneth Moelis, our ChairmanChair and Chief Executive Officer. In connection with our initial public offering, a reorganization of the existing businesses of Old Holdings was effected, pursuant to which the advisory business was transferred to our subsidiary, Group LP. Old Holdings retained its asset management business, which includes managers of direct lending funds, hedge funds, private equity funds, collateralized loan obligation funds and certain other asset management businesses, and was renamed Moelis Asset Management LP.

Master Services Agreement

We are party to a master services agreement with MAM. Under the master services agreement, we provide corporate and relatedcertain administrative services and office space to MAM. Old HoldingsMAM pays us mutually agreed-upon fees for these services, which are based on our costs of providing the shared services. The charges for the shared services generally are intended to allow us to recover the costs directly associated with providing the services, plusout-of-pocket costs and expenses, generally without profit. Under the master services agreement, MAM is able to use our services for a fixed term established on aservice-by-service basis, which may be extended by mutual written agreement. MAM may terminate any of the specified services for any reason with 90 days prior written notice to us. Generally, each party agreed to indemnify the other party and its respective directors, officers, employees and agents against losses resulting from the transitional services, except, in the case of indemnification by MAM and its subsidiaries, to the extent of our gross negligence or intentional misconduct, not to exceed the amount of fees paid to us. Under this agreement, we allocated $248,000approximately $220,000 in costs to MAM for fiscal year ended December 31, 2019.2021.

Master Separation Agreement

We entered into a master separation agreement with MAM in connection with the reorganization. The agreement set forth, among other things, MAM’s principal transactions with us necessary to separate the advisory and asset management businesses of MAM. The agreement identified the assets that were transferred, the liabilities assumed and the contracts assigned to us as part of the reorganization, and provided for when and how these transfers, assumptions and assignments occurred. Information in this Proxy Statement with respect to the assets and liabilities of the parties is presented based on the allocation of such assets and liabilities pursuant to the reorganization, unless the context otherwise requires.

The agreement provides for cross-indemnities that generally place the financial responsibility on us and our subsidiaries for all liabilities associated with the current and historical advisory business and operations, and

generally places MAM and its subsidiaries the financial responsibility for liabilities associated with all of MAM’s current and historical asset management businesses and operations.

License Agreements

We have granted a license to MAM and certain affiliates, under which MAM and such affiliates have the right to use trademarks incorporating the term “Moelis” for certain purposes, including in connection with asset management activities. MAM is not be able to use the trademarks if it is engaged in investment banking advisory services, and cannot use the trademark “Moelis & Company” or any derivations of it. The license isnon-exclusive,non-sublicensable (except under certain conditions) and royalty-free. The license agreement continues in perpetuity unless terminated in accordance with its terms. We may terminate the license if Old HoldingsMAM becomes insolvent, makes an assignment of the trademark for the benefit of its creditors, takes actions that cause any government or creditors to condemn or expropriate its assets or materially breaches the license agreement and fails to cure such breach.

NexPhase Capital LLC

Moelis Capital Partners (“MCP”) is a middle market private equity business owned by MAM, which has two main funds (the “MCP Funds”). On January 1, 2016, the managing partners of MCP (the “Managing Partners”), together with other members of the MCP investment team, separated from MCP (the “NexPhase Separation”) to form a new private equity firm, NexPhase Capital LP (“NexPhase”). At the time of the NexPhase Separation, NexPhase entered into a subcontractor agreement with MCP to manage the MCP Funds in exchange for management fees payable to MCP by the MCP Funds. In consideration for the NexPhase Separation, NexPhase agreed to pay MAM a combination of MAM units, Group LP units and deferred cash, a payment calculated based on the percentage of the commitments made to the next two funds to be raised by NexPhase (“Fund III” and Fund IV” and collectively the “NexPhase Funds”) and 25% and 20%, respectively, of carried interest for each of Fund III and Fund IV. MAM and Mr. Moelis committed and funded an aggregate of 3.0%, or $15 million, of NexPhase Fund III and have committed to fund an aggregate of 1.5% of NexPhase Fund IV, subject to a maximum commitment of $12 million.

In connection with the NexPhase Separation, we agreed to (i) waive the forfeiture provisions of 3,274 Group LP units and 21,400 options (the “NexPhase Employee Equity”) held by NexPhase employees and (ii) apply thelock-up period that is applicable to current MAM employees to the NexPhase Employee Equity, in each case so long as such NexPhase employee is employed and in good standing with NexPhase and NexPhase remains the subcontractor to MCP. In addition, we agreed to waive thelock-up applicable to 86,456 Group LP units (the “Transferred Group LP Units”) that the Managing Partners transferred to MAM as consideration for the NexPhase Separation, permitted MAM to exchange such Transferred Group LP Units for our common stock and permitted the economic equivalent of certain tax benefits associated with such exchange to be provided to the Managing Partners.

We also entered into an engagement letter with NexPhase to provide NexPhase access to our investment bankers for investment ideas and opportunities, industry advice and due diligence assistance. NexPhase agreed to

pay Moelis up to $500,000 per year commencing on January 1, 2016 through the final close of Fund III, at which point the retainer will be 0.2% of third party commitments made to Fund III and then, upon the final closing of Fund IV, 0.2% of third party commitments made to Fund IV through the end of the Fund IV investment period. The retainer is subject to a cap of $1.0 million per year and can be accrued without payment for up to five years. Certain portions of the accrued retainer can be offset through certain fees paid by NexPhase, the MCP Funds or their respective portfolio companies to Moelis on certain future advisory mandates. NexPhase retained us to act as aco-agent on the NexPhase Fund III capital raise.

Archean Capital Partners GP LLC

In 2016, MAM and Veritable LP (“Veritable”) formed a 50/50 joint venture, Archean Capital Partners GP LLC (“Archean”) to source, evaluate and invest seed capital in high quality, first-time private equity managers. For each fund, Archean will establish a single fund special purpose vehicle.

In January 2017, Archean closed Archean Capital Partners I LP (“Archean I”). and, in March 2021, Archean I provided a $100 million commitment of initial seed capital to Petrichor Healthcareclosed Archean Capital ManagementPartners II LP (“Petrichor”Archean II”), a newly formed private equity firm that makes structured credit, royalty, and equity investments in the healthcare sector.. Affiliates of Mr. Moelis collectively committed $10,000,000 to Archean I and funded 10%, or $10,000,000 ofto Archean I. MAM has a 49.9% interest in Archean. II.

In consideration for introducing Veritableintroductions made to MAM and Petrichor to Archean, MAM will pay to the Company 50% of the investment economics paid to MAM by Archean. The Archean, economics to MAM arewhich is comprised of (i) the annual Archean I management fee of 0.5% of $100 millionfees and (ii) 12.5% of the Archean Ia revenue share of all Petrichor revenue,from the private equity managers that receive capital from Archean, if any, net of certain expenses, subject to a cap based upon overall return on invested capital to Archean I. In addition,capital. Under this arrangement, the Company will act as private placement agent to Petrichor in exchange for customary private placement fees.received $734,861 from MAM during 2021.

The Company expects to continue to provide to Archean, through its Private Funds Advisory Group and others at the Company, assistance in introducing private equity managers. In addition, it may provide private placement services to the sourced private equity managers. Compensation for such services will be negotiated on a transaction by transaction basis.

Other Transactions

We may enter into engagement letters to provide investment banking services to MAM and its subsidiaries from time to time. For the year ended December 31, 2019, we2021, no revenues were earned revenues of approximately $210,000 for investment banking services pursuant to engagement letters with funds managed by subsidiaries of MAM and portfolio companies of such funds.

Transactions with Atlas Crest

We have an affiliation with the sponsors (collectively referred to herein as “Atlas Crest Sponsors”) of Atlas Crest Investment Corp. II (“Atlas Crest II”) and Atlas Crest Investment Corp. III (formerly Atlas Crest Investment Corp. V) (“Atlas Crest III”), each a special purpose acquisition company (each an “Atlas Crest Entity” and collectively, the “Atlas Crest Entities”).

Mr. Moelis is a founding member of the Atlas Crest Sponsors and serves as Non-Executive Chairman of the Atlas Crest Entities. Mr. Moelis (or an affiliate of Mr. Moelis) is the managing member of each of the Atlas Crest Sponsor Entities. The Company’s executive officers and management Directors have invested an aggregate $2,434,000 in the sponsor of Atlas Crest II in 2021 and an aggregate $1,510,000 in the sponsor of Atlas Crest III.

During 2021, the Company invested $762,902 in the sponsor of Atlas Crest II and $1,131,750 in the sponsor of Atlas Crest III.

In addition, we had an affiliation with the sponsor of Atlas Crest Investment Corp. (“Atlas Crest I”, also referred to as an Atlas Crest Entity and the sponsor of Atlas Crest I referred to as an Atlas Crest Sponsor). Atlas Crest I completed its initial business combination with Archer Aviation Inc. (“Archer”) on September 16, 2021 (the “AC I Initial Business Combination”) and a distribution of the Archer common stock and warrants held by the sponsor of Atlas Crest I following the AC I Initial Business Combination was completed.

Business Combination Marketing Agreements

On October 27, 2020, the Company and Atlas Crest I entered into a Business Combination Marketing Agreement to engage the Company to provide certain advisory services in connection with an initial business combination of Atlas Crest I, including, organizing meetings with stockholders, introductions to potential investors, assistance in obtaining stockholder approval for the business combination and assistance with press releases and public filings in connection with the business combination (the “Business Combination Marketing Agreement”) for a fee of 1.5% of the total amount of the initial public offering, or $6,250,000, payable to the

Company upon consummation of an initial business combination. The Business Combination Marketing Agreement fee was paid to the Company upon consummation of the AC I Initial Business Combination, 50% of which was received in cash and the remaining 50% in common stock of Archer.

On February 3, 2021, the Company and Atlas Crest II entered into a Business Combination Marketing Agreement for a fee of 1.5% of the total amount of the initial public offering, or $4,312,500, payable upon consummation of an initial business combination.

In connection with the proposed initial public offerings of Atlas Crest III, which is currently anticipated to raise $200,000,000, it is anticipated that the Company will enter into a Business Combination Marketing Agreement with each entity for a fee of 1.5% of the total amount of the initial public offering and such fee shall be payable upon the consummation of an initial business combination.

Advisory and Placement Agency Services

In connection with the initial business combination of Atlas Crest I and Archer, the Company was engaged by Atlas Crest I to provide financial advisory and placement agency services to Atlas Crest I pursuant to customary engagement letters. An aggregate of $24,000,000 of M&A advisory fees and placement agent fees was paid to the Company by Atlas Crest I upon consummation of AC I Initial Business Combination, 50% of which was received in cash and the remaining 50% in common stock of Archer.

Services Agreements

In October 2020, the Company began providing office space, secretarial, administrative and other corporate services for a fee of $10,000 a month to Atlas Crest I. In February 2021, the Company began providing these services to Atlas Crest II and is expect to provide these services to Atlas Crest III in connection with its initial public offering for a fee of $10,000 per month and an agreement from each of the entities and the associated sponsors to indemnify the Company for any losses arising out of the provisions of services, subject to certain exceptions and limitations. This arrangement shall continue with each Atlas Crest Entity until such Atlas Crest Entity consummates a business combination or is liquidated.

In accordance with our related persons transaction policy, management presented the above transactions to our Audit Committee and our Audit Committee reviewed and approved the transactions.

Director and Officer Indemnification and Insurance

We have entered into indemnification agreements with certain of our directors and executive officers, and purchased directors’ and officers’ liability insurance. The indemnification agreements and our amended and restated certificate of incorporation andby-laws require us to indemnify our directors and officers to the fullest extent permitted by Delaware law.

Policies and Procedures for Related Person Transactions

Our boardBoard of directorsDirectors has adopted a written statement of policy regarding transactions with related persons, which we refer to as our “related person policy.” Our related person policy requires that a “related person” (as defined in paragraph (a) of Item 404 ofRegulation S-K) must promptly disclose to our General Counsel any “related person transaction” (defined as any transaction that is anticipated to be reportable by us under Item 404(a) ofRegulation S-K in which we were or are to be a participant andregardless of the amount involved exceeds $120,000 and in which any related person had or will have a direct or indirect material interest) and all material facts with respect thereto. The General Counsel will then promptly communicate that information to our boardBoard of

directors. Directors. No related person transaction will be executed without the approval or ratification of our boardBoard of directorsDirectors or a duly authorized committee of our boardBoard of directors.Directors. It is our policy that directors interested in a related person transaction will recuse themselves from any vote on a related person transaction in which they have an interest.

PROPOSAL 3: RATIFICATION OF INDEPENDENT AUDITOR

Our audit committeeAudit Committee has appointed Deloitte as our independent registered public accounting firm for the fiscal year ending December 31, 2020.2022. Although stockholder ratification of the appointment of Deloitte is not required by law, we are submitting the appointment to our stockholders for ratification as a matter of good corporate governance. The ratification of the appointment of Deloitte requires the affirmative vote of a majority of the votes cast at the Annual Meeting. If stockholders do not ratify the appointment of Deloitte, the audit committeeAudit Committee will reconsider the appointment. Even if stockholders ratify the appointment of Deloitte, the audit committeeAudit Committee retains the discretion to appoint a different independent auditor at any time if it determines that such a change would be in the best interests of the Company and its stockholders.

Representatives of Deloitte are expected to attend the Annual Meeting, will have an opportunity to make a statement if they desire to do so and are expected to be available to respond to appropriate questions.

The boardBoard of directorsDirectors recommends that you vote “FOR” the ratification of Deloitte as our independent registered public accounting firm for the fiscal year ending December  31, 2020.2022.

Deloitte Fees

The following table presents aggregate fees billed to the Company for services rendered by Deloitte during the years ended December 31, 20192021 and December 31, 2018.2020.

 

  2019   2018  2021 2020 

Audit fees(1)

  $2,043,332   $2,087,527   $      2,213,878        $      2,074,582      

Audit-related fees

   —      —     —          —        

Tax fees(2)

   1,721,872    1,747,503   1,589,421        1,523,562      

All other fees(3)

   4,126    5,868   4,126        4,126      
  

 

   

 

  

 

  

 

 

Total

  $3,769,330   $3,840,898   $      3,807,425        $      3,602,270      
  

 

   

 

  

 

  

 

 

 

(1)

Audit fees include fees for the audit of our 20192021 and 20182020 consolidated financial statements, fees billed in the respective periods for professional consultations with respect to accounting issues, and issuance of consents required by statute or regulation and similar matters. Audit fees for 20192021 and 20182020 include fees for the audit of the effectiveness of internal control over financial reporting as required by Section 404 of the Sarbanes-Oxley Act.

(2)

Tax fees include fees billed in the respective periods for tax compliance and consultations regarding the tax implications of certain transactions.

(3)

All other fees include subscriptions to Deloitte’son-line accounting research tool.

Audit CommitteePre-Approval

Since our initial public offering, all services performed by Deloitte for the Company and its subsidiaries have beenpre-approved by the audit committee.Audit Committee.

The audit committeeAudit Committee has adopted apre-approval policy, which requires that, before the independent auditor is engaged for any services, the audit committeeAudit Committee must approve these services, including the fees and terms.terms, subject to the de minimis exception for non-audit services described in Section 10A(i)(1)(B) of the Exchange Act that are approved by the Audit Committee prior to completion of the audit. Services are reviewed taking into account the terms of the policy, and, for types of services notpre-approved in the policy, the rules of the SEC and the Public Company Accounting Oversight Board.

AUDIT COMMITTEE REPORT

The information contained in this report shall not be deemed “soliciting material” or otherwise considered “filed” with the SEC or subject to the liabilities of Section 18 of the Securities Exchange Act of 1934, as amended, and such information shall not be incorporated by reference into any future filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Company specifically incorporates such information by reference in such filing.

The audit committeeAudit Committee is responsible primarily for assisting the boardBoard of directorsDirectors in fulfilling its legal and fiduciary obligations with respect to matters involving the accounting, auditing, financial reporting, internal control and legal compliance functions of the Company and its subsidiaries. The committee assists in the board’sBoard’s oversight of the integrity of the Company’s financial statements, the Company’s compliance with legal and regulatory requirements, the Company’s independent auditors’ qualifications and independence, and the performance of the Company’s independent auditors and the Company’s internal audit function.

The Company’s management is responsible for the preparation and presentation of the Company’s financial statements, the effectiveness of internal control over financial reporting, and procedures that are reasonably designed to assure compliance with accounting standards and applicable laws and regulations. The Company’s independent registered public accounting firm, Deloitte & Touche LLP (“Deloitte”), is responsible for performing an independent audit of the Company’s financial statements in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”). The audit committeeAudit Committee does not itself prepare financial statements or perform audits, and its members are not auditors or certifiers of the Company’s financial statements or disclosures.

The audit committeeAudit Committee has reviewed and discussed the audited financial statements for the year ended December 31, 20192021 with the Company’s management and Deloitte. The audit committeeAudit Committee has discussed with the independent auditors the matters required to be discussed by the statement on Auditing Standards No 1301 as adopted by the PCAOB.

The audit committeeAudit Committee has received the written disclosures and the letter from Deloitte required by applicable requirements of the PCAOB regarding Deloitte’s communications with the audit committeeAudit Committee concerning independence, and has discussed with Deloitte its independence.

Based on such review and discussions, the audit committeeAudit Committee recommended to the Company’s boardBoard of directorsDirectors that the financial statements referred to above be included in the Annual Report onForm 10-K for the fiscal year ended December 31, 2019.2021.

Audit Committee

John A. Allison IV

Yolonda Richardson

Kenneth L. Shropshire (Chair)

ADDITIONAL INFORMATION

Procedures for Submitting Stockholder Proposals

Stockholder proposals intended to be presented at the 20212023 Annual Meeting of Stockholders, (the “2021 Meeting”), pursuant to Exchange ActRule 14a-8 must be delivered to the Corporate Secretary at our principal executive offices no later than December 26, 202025, 2022 in order to be included in the our proxy materials for that meeting. Such proposals must also comply with all applicable provisions of Exchange ActRule 14a-8 and ourby-laws.

Under ourby-laws, stockholder proposals submitted for consideration at any annual meeting of stockholders, but not submitted for inclusion in our proxy materials pursuant to Exchange ActRule 14a-8, including nominations for candidates for election as directors, must be delivered to our Secretary at our principal executive offices not less than 90 days or more than 120 days before the first anniversary of the prior annual meeting of stockholders. However, if the annual meeting occurs more than 25 days before or after this anniversary date, proposals must be delivered on or before the tenth day following the earlier of (i) the date that the meeting notice is mailed or (ii) the first public announcement of the meeting date. Director nominations for consideration at any special meeting of stockholders called for the purpose of electing directors must be delivered on or before the tenth day following the earlier of (i) the date that the meeting notice is mailed or (ii) the first public announcement of the meeting date. If the 20212022 Meeting is held within 25 days before or after June 4, 2021,2, 2023, stockholder proposals and nominations under ourby-laws must be delivered no earlier than February 4, 20212, 2023 and no later than March 4, 2021.2, 2023.

Stockholder proposals and nominations must include all required information concerning the stockholder and the proposal or nominee set forth in ourby-laws.

ANNEX A:NON-GAAP FINANCIAL MEASURES

The Company prepares its Consolidated Financial Statements using accounting principles generally accepted in the United States (GAAP). This Proxy Statement includes certain Adjusted results that arenon-GAAP financial measures. The Securities and Exchange Commission defines a “non-GAAP financial measure” as a numerical measure of historical or future financial performance, financial position, or cash flows that is subject to adjustments that effectively exclude, or include amounts from the most directly comparable measure calculated and presented in accordance with GAAP. Non-GAAP financial measures disclosed by the Company are provided as additional information to analysts, investors and other stakeholders in order to provide them with greater transparency about, or an alternative method for assessing our financial condition, operating results, or capital adequacy. Adjusted results are a non-GAAP financial measure which better reflectprovide additional information on management’s view of operating results. These measures are not in accordance with, or a substitute for GAAP, and may be different from or inconsistent with non-GAAP financial measures used by other companies. Whenever we refer to a non-GAAP financial measure, we will also generally define it or present the most directly comparable financial measure calculated and presented in accordance with GAAP, along with a reconciliation of the differences between the non-GAAP financial measure we reference and such comparable GAAP financial measure. The Company’s Adjusted revenues includes amounts reflected within other income (expenses) which are considered the equivalent of revenues for compensation. Such adjustments include gains on founder investments where our employees and the Moelis advisory platform contributed meaningfully to the value creation; or the mark-to-market impact of equity instruments held by the Company that were originally received as payment for our banking services and included in revenues. We believe these adjustments are useful to allow comparability of period-to-period operating performance and compensation levels.

The Company’s Adjusted compensation and benefits expenses includes amounts reflected within other income (expenses) associated with compensation awards forfeited due to the enforcement of noncompete provisions. Management views the credits associated with such forfeitures as an offset to compensation and benefits expenses since the Firm will utilize the forfeited economics to recruit and or retain talent. We believe the netted presentation of forfeiture credits and compensation expenses are useful to allow comparability of period-to-period operating performance. The Company’s Adjusted other income (expenses) excludes amounts related to revenues and compensation and benefits expenses discussed above and adjustments to our provision for income taxes, which are discussed below.

The Company’s Adjusted provision (benefit) for income taxes is adjusted to illustrate the result as if 100% of the Firm’s income is being taxed at our corporate effective tax rates for the periods presented. Adjusted provision (benefit) for income taxes periodically includes the tax impact related to the settlement of share-based awards, the reclassification of TRA liability adjustments, or adjustments to our deferred tax assets and liabilities that occur in connection with new tax legislation. Such adjustments increase the comparability of our financial performance across reporting periods and versus our peers.

The Company’s Adjusted basic and diluted shares of Class A common stock outstanding is presented for each period as if all outstanding Class A partnership units have been exchanged into Class A common stock. The Adjusted presentation helps analysts, investors, and other stakeholders understand the effect of the Firm’s ownership structure on its results, including the impact of all the Firm’s income becoming subject to corporate-level tax.

We believe that the disclosed Adjusted measures and any adjustments thereto, when presented in conjunction with comparable GAAP measures, are useful to investors to understand the Firm’sCompany’s operating results by removing the significant accounting impact ofone-time charges associated with the Firm’sCompany’s IPO and assuming all Class A partnership units have been exchanged into Class A common stock. These measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. A reconciliation of GAAP results to Adjusted results is presented below.

Reconciliation of GAAP to Adjusted(non-GAAP) Financial Information

Unaudited

(dollars in thousands, except share and per share data)

 

  Twelve Months Ended December 31, 2019   Twelve Months Ended December 31, 2021 

Adjusted Items

  GAAP   Adjustments Adjusted
(non-GAAP)
   GAAP                   Adjustments                    Adjusted
    (non-GAAP)    
 

Revenues

   $    1,540,611    $        17,386 (a)(b)              $1,557,997 

Compensation and benefits

  $488,439   $(18,185)(a)(b)(c)  $470,254    913,909            (2,987) (c)                  910,922 

Other income (expenses)

   32,962    (17,085)(b)(c)  15,877    40,396                (21,727) (a)(b)(c)(d)    18,669 

Income (loss) before income taxes

   147,505    1,100  148,605    536,313    (1,354)                       534,959 

Provision for income taxes

   11,813    2,610(d)  14,423 

Provision (benefit) for income taxes

   113,335        11,370 (d)(e)              124,705 
  

 

   

 

  

 

   

 

   

 

   

 

 

Net income (loss)

   135,692    (1,510 134,182    422,978    (12,724)                       410,254 

Net income (loss) attributable to noncontrolling interests

   30,597    (30,597)(e)   —      57,765    (57,765) (f)                   
  

 

   

 

  

 

   

 

   

 

   

 

 

Net income (loss) attributable to Moelis & Company

  $105,095   $29,087  $134,182    $365,213    $45,041                        $        410,254 
  

 

   

 

  

 

   

 

   

 

   

 

 

Weighted-average shares of Class A common stock outstanding Diluted

   55,513,149    13,003,248(e)  68,516,397            68,435,579    7,605,285 (f)                   76,040,864 
  

 

   

 

  

 

   

 

   

 

   

 

 

Net income (loss) attributable to holders of shares of Class A common stock per share Diluted

  $1.89    $1.96    $5.34      $5.40 
  

 

    

 

   

 

     

 

 

 

(a)

ExpenseReflects a reclassification of $20.2 million of other income to revenues related to a gain associated with the amortizationCompany’s sale of RSUs and stock options granted in connection with the IPO. In accordance with GAAP, amortization expense6.0 million shares of RSUs and stock options granted in connection with the IPO will be recognized over the five year vesting period; as of April 2019 such awards have been fully expensed.MA Financial Group Limited.

 

(b)

Reflects a reclassification of $4.8$2.8 million of other expenses to revenues related to unrealized losses from the mark-to-market impact on shares received in lieu of cash as partial payment for advisory services provided on certain transactions.

(c)

Reflects a reclassification of $3.0 million of other income to compensation and benefits expense associated with the forfeitureenforcement of fully vested awards and enforcement ofnon-compete provisions.

 

(c)(d)

Reflects the reclassification of $12.3 million of compensation and benefits expense associated with the Firm’s $20.7 million gain on its sale of 20.5 million shares of Moelis Australia. The net gain remaining withinTax receivable agreement (“TRA”) liability adjustments are made to other income (expenses) associated with this sale is $8.4 million.for GAAP purposes. These adjustments are reclassified to provision (benefit) for income taxes to reflect the net tax-economic impact.

 

(d)(e)

An adjustment has been made to illustrate the result as if 100% of the Firm’sCompany’s income is being taxed at our corporate effective tax rate of 9.7% for the period stated. Our tax provision includes an excessa tax benefit related to the settlement of share-based awards of $22.7$20.3 million; excluding such discrete benefit, our effective tax rate for the period presented would have been 25.0%27.1%. Our tax provision and effective tax rate exclude any benefits or costs related to the adjustment to the TRA liability originated from past partnership unit exchanges; such adjustment for this period was a net economic benefit of $1.4 million which is not included in the corporate effective tax rate for the period presented.

 

(e)(f)

Assumes all outstanding Class A partnership units have been exchanged into Class A common stock.

  Twelve Months Ended December 31, 2018                   Twelve Months Ended December 31,  2020             

Adjusted Items

  GAAP   Adjustments Adjusted
(non-GAAP)
   GAAP           Adjustments           Adjusted
(non-GAAP)
 

Compensation and benefits

  $513,863   $(4,561)(a)(b)  $509,302    $560,803    $        (1,291) (a)         $559,512 

Other income (expenses)

   11,671    (961)(b)(c)  10,710    4,404    (2,393)(a)(b)     2,011 

Income (loss) before income taxes

   238,452    3,600  242,052    270,113    (1,102)              269,011 

Provision for income taxes

   30,448    9,316(c)(d)  39,764 

Provision (benefit) for income taxes

   51,675    8,272 (b)(c)     59,947 
  

 

   

 

  

 

   

 

   

 

   

 

 

Net income (loss)

   208,004    (5,716 202,288    218,438    (9,374)              209,064 

Net income (loss) attributable to noncontrolling interests

   67,324    (67,324)(e)   —      39,607    (39,607) (d)        —  
  

 

   

 

  

 

   

 

   

 

   

 

 

Net income (loss) attributable to Moelis & Company

  $140,680   $61,608  $202,288    $178,831    $30,233               $209,064 
  

 

   

 

  

 

   

 

   

 

   

 

 

Weighted-average shares of Class A common stock outstanding Diluted

   50,690,528    16,649,446(e)  67,339,974        60,723,365    11,226,666(d)           71,950,031 
  

 

   

 

  

 

   

 

   

 

   

 

 

Net income (loss) attributable to holders of shares of Class A common stock per share Diluted

  $2.78    $3.00   $2.95      $2.91 
  

 

    

 

   

 

     

 

 

 

(a)

Expense associated with the amortization of RSUs and stock options granted in connection with the IPO. In accordance with GAAP, amortization expense of RSUs and stock options granted in connection with the IPO will be recognized over the five year vesting period.

(b)

Reflects a reclassification of $1.0$1.3 million of other income to compensation and benefits expense associated with the forfeiture of fully vested awards and enforcement ofnon-compete provisions.

 

(c)(b)

Reflects the netting of $0.1 million of GAAPTRA liability adjustments are made to the amount pursuantother income (expenses) for GAAP purposes. These adjustments are reclassified to the Company’s Tax Receivable Agreement against provision for income taxes.taxes to reflect the net tax-economic impact.

 

(d)(c)

An adjustment has been made to illustrate the result as if 100% of the Firm’sCompany’s income is being taxed at our corporate effective tax rate of 16.4% for the period stated, whichstated. The tax provision includes a tax benefits of $21.5 million primarilybenefit related to the settlement of share-based awards. Excludingawards of $8.7 million; excluding such benefits,discrete benefit, our effective tax rate for the period presented would have been 25.3%25.5%. Our corporate effective tax rate of 16.4% excludes any benefits or costs relating to the adjustment to thestep-up in tax basis in Group LP assets in connection with the partnership unit exchanges and offerings. Such adjustment was a net economic benefit of $1.0 million which is not included in the corporate effective tax rate for the period presented.

 

(e)(d)

Assumes all outstanding Class A partnership units have been exchanged into Class A common stock.

LOGOLOGO

THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. KEEP THIS PORTION FOR YOUR RECORDS
DETACH AND RETURN THIS PORTION ONLYSignature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) DateKEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY D82897-P70220 Nominees: 3. Proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. 2. To withhold authority to vote for any
individual nominee(s), mark “For All Except” and writeapprove, on an advisory basis, the number(s)compensation of the nominee(s) on the line below. 0 0 0 0 0 0 0 0 0 0 0 0
0000461723_1 R1.0.1.18our Named Executive Officers. 1. Election of Directors 1a. Kenneth Moelis 1b. Eric Cantor 1c. John A. Allison IV 1d. Yolonda Richardson 1e. Kenneth L. Shropshire For Withhold For All All All ExceptAgainst Abstain MOELIS & COMPANY The Board of Directors recommends you vote FOR the following:
1. Election The Board of Directors Nominees 01 Kenneth Moelis 02 Navid Mahmoodzadegan 03 Jeffrey Raich 04 Eric Cantor 05 El izabeth Crain 06 John A. Allison IV 07 Yolonda Richardson 08 Kenneth L. Shropshirerecommends you vote FOR proposals 2 and 3. MOELIS & COMPANY 399 PARK AVENUE, 5TH4TH FLOOR NEW YORK, NY 10022 NOTE: In their discretion, upon such other matters that may properly come before the meeting or any adjournment or adjournments thereof. The shares represented by this proxy when properly executed will be voted in the manner directed herein by the undersigned stockholder. IF NO SUCH DIRECTIONS ARE MADE, THIS PROXY WILL BE VOTED FOR THE ELECTION OF EACH DIRECTOR NOMINEE LISTED IN PROPOSAL 1, FOR PROPOSAL 2 AND FOR PROPOSAL 3. Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! For Against Abstain VOTE BY INTERNET - INTERNET—www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit your voting instructions and for electronic delivery of information. Vote byinformation up until 11:59 P.M. ETp.m. Eastern Time on 06/03/2020.June 1, 2022. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years. VOTE BY PHONE - PHONE—1-800-690-6903
Use any touch-tone telephone to transmit your voting instructions. Vote byinstructions up until 11:59 P.M. ETp.m. Eastern Time on 06/03/2020.June 1, 2022. Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
The Board of Directors recommends you vote FOR proposals 2, 3 and 4. For Against Abstain 2. To approve, on an advisory basis, the compensation of our Named Executive Officers. 3. Proposal to ratify the appointment of Deloitte SCAN TO VIEW MATERIALS & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020. 4. In their discretion, upon such other matters that may properly come before meeting or any adjournment or adjournments thereof. The shares represented by this proxy when properly executed will be voted in the manner directed herein by the undersignedstockholder. IF SUCH DIRECTIONS ARE MADE, THIS PROXY WILL BE VOTED FOR THE ELECTION OF ALL DIRECTOR NOMINEES LISTED IN PROPOSAL 1, FOR PROPOSAL 2 AND FOR PROPOSAL 3. Please sign exactly as your name(s) appear(s) hereon. When signing as
attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.VOTE w


LOGOLOGO

0000461723_2 R1.0.1.18 Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice &and Proxy Statement and Form 10-K is/are available at www.proxyvote.comwww.proxyvote.com. D82898-P70220 MOELIS & COMPANY Annual Meeting of Stockholders
June 4, 20202, 2022 8:30 AM This proxy is solicited by the Board of Directors The stockholder(s) hereby appoint(s) Kenneth Moelis, Elizabeth Crain, Joseph Simon and Osamu Watanabe, or any of them, as proxies, each with the power to appoint (his/her)his or her substitute, and hereby authorize(s) them to represent and to vote, as designated on the reverse side of this ballot, all of the shares of Class A and Class B common stock of Moelis & Company that the stockholder(s) is/are entitled to vote at the Annual Meeting of Stockholders, to be held at 8:30 a.m.AM (Eastern Time) on June 4, 2020,2, 2022, at the offices of Moelis & Company, located at 399 Park Avenue, 4th Floor, New York, NY 10022, and any adjournment or postponement thereof. THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED AS DIRECTED BY THE STOCKHOLDER(S). IF NO SUCH DIRECTIONS ARE MADE, THIS PROXY WILL BE VOTED FOR THE ELECTION OF ALLEACH DIRECTOR NOMINEESNOMINEE LISTED IN PROPOSAL 1, FOR PROPOSAL 2 AND FOR PROPOSAL 3. Continued and to be signed on reverse side